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Glucocorticoid (GC) hormones secreted upon activation of the HPA axis following stress or circadian 
input are vital regulators of many important physiological processes. In the brain, genomically acting 
mineralocorticoid receptors (MRs) and glucocorticoid receptor (GRs), orchestrate the cellular and 
molecular effects of GCs. Upon receptor occupancy, MRs and GRs translocate to the nucleus where 
they bind the DNA to transactivate or transrepress GC-target gene expression. Here, we conducted 
hippocampal ChIP- and RNA-seq to investigate the genome-wide binding of MRs and GRs and the 
transcriptomic response following elevations in corticosterone, the primary GC in the rat, in response 
to an acute stressor (Forced swimming – FS) or the circadian rise of GC secretion. ChIP-seq revealed 
a strikingly distinct profile of MR- and/or GR-binding to over 1,000 loci, while RNA-seq identified 
transcriptional responses in over 1,000 genes. Cross-correlation of both datasets was carried out for 
the first time, while extensive pathway analysis highlighted many promising novel targets for further 
exploration. Of these targets, we further investigated the Krüppel-like factors (KLFs) in a separate cohort 
of rats while validating findings of ChIP- and RNA-seq. We extended our examination to other brain 
regions such as the amygdala, PFC and neocortex which showed substantial MR DNA-binding in these 
regions despite previous reports describing a localised expression of this receptor primarily in the 
hippocampus. Subsequently, we investigated whether the increases in binding were in fact the 
underlying events responsible for the observed transcriptional responses by blocking the actions of 
genomically acting MRs and GRs, using receptor antagonists, inhibitors of corticosterone synthesis and 
surgical adrenalectomy. This thesis has provided novel insights into the genomic actions of MRs and 
GRs under physiological conditions of relevance for GC secretion, while providing the groundwork for 
future experiments aiming to elucidate further the genomic mechanisms underlying GC hormone action 
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Chapter 1 Introduction 
1.1 Glucocorticoid hormones: importance for life  
1.1.1 The role of glucocorticoid hormones in homeostasis, adaptation and survival  
Glucocorticoids (GCs) are a class of steroid hormones synthesised and secreted by the adrenal glands 
which are part of the hypothalamic-pituitary-adrenal (HPA) axis; a major mammalian neuroendocrine 
system responsible for the regulation of numerous physiological processes. GCs regulate the sleep-
wake cycle, body temperature, renal plasma flow and cardiovascular activity in order to maintain 
homeostasis in response to environmental changes (De Kloet and Derijk, 2004). Adaptation and 
survival are also dependent on GC hormone action in the brain, where GCs promote resilience to 
external stressors. Memory consolidation and behavioural changes mediated by GC hormones facilitate 
appropriate adaptation to stress, thus preventing physical and psychological disease (Reul et al., 2015). 
These vital GC hormone actions are orchestrated via receptors found within GC target tissues, of which 
two have been characterised. The mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) 
can be found at the cellular membrane or in the cytoplasm, where they mediate rapid non-genomic or 
slower genomic effects, respectively (Groeneweg et al., 2012). For the purpose of this thesis, GC 
hormone activity in the brain via genomically acting MRs and GRs will be discussed. Once activated by 
GCs, MRs and GRs elicit genome-wide effects, exerting transcriptional effects in thousands of GC-
target genes involved in circadian variation as well as the brain’s response to stress. 
1.1.2 The circadian rhythm and the stress response  
The secretion of GC hormones by the HPA axis is under circadian control and can also be stimulated 
by exposure to stress. The central circadian pacemaker, the suprachiasmatic nucleus (SCN) of the 
anterior hypothalamus, is the main driver of circadian input to the HPA axis and mediates a rhythmic 
pattern of GC secretion corresponding to the animal’s activity phase (Dunlap, 1999). Consequently, 
circulating levels of GCs are maintained low during the inactive phase and rise during the active phase 
of the animal (Dickmeis, 2009). The circadian rhythm is shaped by an ultradian rhythm of hourly pulses 
of GCs (Spiga et al., 2014). Input of stress signals to the HPA axis, via the brain stem and limbic system, 
elicits what is referred to as the “stress response”. The role of the stress response is to allow an animal 





the event that a similar stressor is reencountered in the future, the animal is better equipped to respond 
(Mifsud and Reul, 2018). Following an acute stressor, plasma levels of circulating GCs are increased 
up to 100-fold (Mifsud et al., 2016) and the stress response is eventually “switched off”, as GCs restore 
the HPA axis to baseline activity via negative feedback.  
Following HPA axis activation by circadian input or by stress (Figure 1.1), paraventricular neurons of 
the hypothalamus secrete corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) in 
the Median Eminence. After transport through the hypothalamic-pituitary portal system, these 
neuropeptides act upon the anterior pituitary, to induce the synthesis and secretion of 
adrenocorticotropic hormone (ACTH) (Vale et al., 1981). ACTH stimulates the zona fasciculata of the 
adrenal cortex, resulting in the synthesis of cortisol or corticosterone (CORT); the primary GC hormones 
found in man and in rat, respectively, by a process known as steroidogenesis. Within a subset of 
adrenocortical steroidogenic cells, ACTH binds its endogenous receptor; the melanocortin type-2 
receptor (MC2R) (Chhajlani and Wikberg, 1992). Via a rapid non-genomic pathway, ACTH stimulates 
steroidogenesis via protein kinase A (PKA) activation. PKA phosphorylates and activates hormone 
sensitive lipase (HSL) and steroidogenic acute regulatory protein (StAR). HSL increases levels of the 
steroid precursor, cholesterol, while StAR promotes the transport of cholesterol into the mitochondria 
(Walker et al., 2015). Via a slower, genomic mechanism, ACTH also induces the expression of 
steroidogenic genes (Chung et al., 2011). Once transported to the mitochondria, cholesterol is 
converted to cortisol or CORT via a series of enzymatic reactions (Figure 1.2). GCs are secreted into 
the blood stream where they are transported to target tissues and can bind GC-binding receptors. GC 
hormones exert negative feedback on HPA axis activity via GR action at the anterior pituitary, 
hypothalamus and hippocampus, thus terminating the stress response.  
The degree to which tissues are exposed to GC hormones is tightly regulated by a transport protein, 
corticosteroid-binding globulin (CBG). Less than 6% of circulating GCs are unbound or “free” in plasma, 
with 80-90% of circulating GCs bound by CBG and the remainder bound by plasma albumin (Lewis et 
al., 2005). CBG maintains a steady state concentration of GCs (Henley et al., 2016), and following a 
(stress-induced) rise in plasma GC levels, CBG is released from the liver, limiting the proportion of free 
hormone available to penetrate tissues (Qian et al., 2011). Only the “free” unbound form of GC hormone 



















Figure 1.1 A schematic diagram of the hypothalamic-pituitary-adrenal (HPA) axis activated 
following stress or circadian input 
Activation of the HPA axis following acute stress or circadian input resulting in the synthesis and 
secretion of GC hormones from the adrenal gland. GC hormones exert negative feedback via the 
anterior pituitary and hypothalamus, terminating the stress response. Paraventricular nucleus (PVN), 









1.1.3 Animal models to elucidate GC hormone action 
Animal models are commonly used to elucidate the effects of GC hormone action on the brain following 
exposure to an acute stressor. Many behavioural models are dependent on GC hormone action in the 
hippocampus to induce learning and memory formation, including the forced swim test (Veldhuis et al., 
1985), Morris water maze (Sandi et al., 1997) and contextual fear conditioning (Cordero and Sandi, 
1998). Restraint stress is a psychogenic stressor which triggers GC receptor action in the hippocampus 
(Wang et al., 2012), however does not result in an adaptive learning response, and is often used to 
investigate the negative effects of acute or chronic stressors on the brain (Furay et al., 2008).  
The forced swim (FS) test is a widely used behavioural paradigm in which the effects of an acutely 
stressful situation can be examined on the formation of long-term memories associated with that 
situation. During the FS test, rats are placed in a water filled beaker from which there is no escape. 
Upon being placed in the water, rats will initially swim and climb against the wall of the beaker in an 
attempt to escape from the beaker, however after some time the rat begins to spend less time struggling 
and more time in an immobile position. After 15 min, the rat is removed from the water and returned to 
their home cage (Porsolt et al., 1977). Rats exhibit significantly elevated levels of circulating plasma 
CORT following exposure to the FS test, however levels return to baseline within 3 hrs after the onset 
of FS (Mifsud and Reul, 2016). Upon re-exposure to the FS test, rats display increased immobility 
behaviour, which is an adaptive phenomenon reflecting learning and memory formation in response to 
the stressor (De Pablo et al., 1989). This enhanced immobility behaviour is seen in rats tested up to 4 
weeks after the initial FS test (Gutierrez-Mecinas et al., 2011), indicating that the rat has formed a long-
term memory of the previous experience, remembering that escape is not possible and adapting its 
behaviour to conserve energy by assuming an immobile position, as this is the best strategy for survival. 
Furthermore, the rat may remember that it had been taken from the water eventually at the time of the 
first test (Reul, 2014). Behavioural immobility in the re-test is critically dependent on GC action via GRs 
during the hours after the initial test and is prevented in the absence of GC hormones or upon blockade 
of GR activity (Jefferys et al., 1983, Veldhuis et al., 1985, Bilang-Bleuel et al., 2005, Gutierrez-Mecinas 






1.1.4 Pharmacological and surgical manipulation of the HPA axis  
Pharmacological agents which manipulate the HPA-axis are widely used in research to elucidate GC 
hormone action and the genomic activity of MRs and GRs. Commonly used methods of targeting the 
stress response include the administration of synthetic GCs, inhibitors of GC synthesis, or antagonists 
of GC receptors. Some of the effects of GC hormones can be mimicked using the synthetic GC, 
dexamethasone (DEX). The drug is capable of selectively binding and activating GRs with high affinity 
in vivo (Reul et al., 1987) and is widely used in cell lines and animal models to investigate GC hormone 
action (Strahle et al., 1987, Roozendaal et al., 1999). Inhibiting GC hormone action can be achieved by 
targeting the steroidogenic pathway (Figure 1.2) thus preventing hormone synthesis. Metyrapone 
(MET) is commonly used in research (Liu et al., 1999, Roozendaal et al., 1996) and as therapeutics for 
the treatment of Cushing’s syndrome. MET can reduce GC hormone synthesis by blocking the enzyme 
11-β-hydroxylase (CYP11B2), thereby preventing the conversion of deoxycorticosterone to CORT 
(Strashimirov and Bohus, 1966) in the adrenal gland. The genomic effects of MRs and GRs can be 
blocked by the antagonists Spironolactone (SPIRO) (Yau et al., 1999) and RU486 (RU) (Baulieu, 1991), 
respectively.  
Adrenalectomy (ADX), a surgical intervention involving the removal of the adrenal glands, is widely 
used in stress research (Borrell et al., 1983, Jefferys et al., 1983, Veldhuis et al., 1985) as a method of 
removing the endogenous source of CORT to examine GC hormone activity (Reul et al., 1987). 
Although ADX may be considered as a more reliable approach over pharmacological intervention due 
to a lack of pharmacokinetic influences, there are disadvantages as the procedure itself will  induce a 
surgical stress response involving HPA axis activation (Ioannidis et al., 2018). Furthermore, ADX has 
been shown to induce behavioural changes, such as increased anxiety levels (File et al., 1979) and 
elicit various side effects in the brain similar to those induced by stress; including oxidative damage and 
changes in neurotransmitter levels (Hu et al., 1997, Helmreich et al., 1996). In addition, long-term ADX 










Figure 1.2 Adrenal steroidogenesis and its hormonal regulation  
ACTH acts upon ACTH receptors within adrenocortical steroidogenic cells triggering the activation of 
the ACTHR/cAMP/PKA/CREB signalling cascade, inducing the expression of steroidogenic genes. 
StAR transports cholesterol and CYP11A1 to the nucleus, where a number of enzymatic reactions result 
in the synthesis of corticosterone or cortisol. The steroidogenic pathways for cortisol and corticosterone 
are identical, apart from an initial step occurring only during cortisol synthesis, where pregnenolone is 
converted to 17α-hydroxypregnenolone. Adrenocorticotropic hormone (ACTH), ACTH receptor 
(ACTHR), cyclic adenosine mono phosphate (cAMP), protein kinase A (PKA), cAMP response element 
binding protein (CREB), steroidogenic acute regulatory protein (StAR), cytochrome P450 family 11 
subfamily A member 1 (CYP11A1), hydroxy-delta-5-steroid-dehydrogenase, 3-beta (HSD3B), steroid 
21-hydroxylase (CYP21), cytochrome P450 family 11 subfamily B member 2 (CYP11B2), cytochrome 










1.1.5 Dysregulated GC hormone signalling: circadian- and stress-related disorders 
Robust HPA axis activity is critical for the maintenance of health and well-being and dysregulations in 
the acute stress response, chronic stress exposure or impaired circadian rhythms can have detrimental 
effects on physical and mental health. Evidence suggests that the HPA axis may be involved in the 
aetiology of many disorders such as Alzheimer’s disease and schizophrenia. Exposure to chronic stress 
has been linked to cognitive impairments and the development of stress-related neuropsychiatric 
disorders such as anxiety, depression and post-traumatic stress disorder (PTSD) (Finsterwald and 
Alberini, 2014).  
Circadian-related disorders arise due to irregular HPA axis activity, leading to abnormal GC hormone 
levels. Cushing’s syndrome is characterised by an excess of GC hormones and is often accompanied 
by an impaired circadian rhythm and circadian-related symptoms such as sleep disruptions. 
Corticotropin-producing tumours which overstimulate the adrenal cortex or abnormal adrenocortical 
tissue which produces an excess of GCs are often the underlying cause of hypercortisolism in Cushing’s 
syndrome (Chung et al., 2011). Neuropsychiatric disorders are frequently observed in patients with 
Cushing’s syndrome, such as cognitive impairment, anxiety and major depression (Pivonello et al., 
2015). Symptoms such as irritability, depressed mood, anxiety and social withdrawal were reported by 
patients with Cushing’s syndrome and a significant correlation has been observed between depressed 
mood and plasma ACTH levels (Starkman et al., 1981). The cognitive impairments and affective 
symptoms experienced by patients may be caused by brain atrophy observed in the disease. 
Decreased volume of the hippocampus (Starkman et al., 1992), cerebral cortex (Bourdeau et al., 2002) 
and right amygdala (Santos et al., 2017) have all been reported in patients with Cushing’s syndrome. 
Furthermore, a correlation was found between reduced amygdalar volumes, depression and anxiety in 
patients with active Cushing’s syndrome (Santos et al., 2017). Impairments in cognitive function has 
also been shown to correlate with reduced hippocampal volume and hypercortisolism (Starkman et al., 
1992). Although brain atrophy in all three brain regions was shown to be reversed following the 
correction of hypercortisolism (Bourdeau et al., 2002, Santos et al., 2017, Starkman et al., 1999), the 
affective and cognitive symptoms may persist after correction of the disease. Anxiety scores reported 





in cognitive performance was observed in a group of Cushing’s syndrome patients six months after 
hypercortisolism was corrected by surgery (Forget et al., 2002). 
Exposure to stress during the prenatal period or during early life has been shown to result in HPA axis 
changes which may predispose individuals to the development of stress-related neuropsychiatric 
disorders. During important periods of foetal brain development, exposure of the mother to prenatal 
stress may lead to aberrant stress responses in the offspring (Lemaire et al., 2000). Furthermore, 
exposure of young rat pups to stressors during the early post-natal stages of development in which a 
stress hyporesponsive period is observed may induce profound negative effects on the developing pups 
(Sapolsky and Meaney, 1986). Adult rats exposed to prenatal stress (PNS) exhibited an enhanced 
plasma CORT response following exposure to restraint stress, accompanied by increased anxiety-like 
behaviours in the open-field and elevated plus maze tests (Vallee et al., 1997). PNS exposure was also 
shown to impair spatial learning in the MWM and decrease in neurogenesis within the DG in response 
to MWM training (Lemaire et al., 2000). Rats exposed to postnatal maternal deprivation (MD) stress 
and foot shock during the stress hyporesponsive period exhibited significantly increased plasma levels 
of ACTH and significantly decreased CRH levels in the anterior pituitary compared with non-deprived 
controls (Ladd et al., 1996). Decreased hippocampal expression of the neurotrophin Brain-derived 
neurotrophic factor (Bdnf) and NMDA receptor subunits NR-2A and NR-2B was reported in MD exposed 
adult rats (Roceri et al., 2002). Exposure of young rats to social isolation for 2 months, beginning at 
postnatal day 16, led to reduced plasma CORT levels under basal conditions and following restraint 
stress. Socially isolated rats also exhibited blunted activation of pituitary ACTH-containing cells 
following exposure to restraint stress and smaller pituitary corticotrophs compared with control animals 
(Sanchez et al., 1998).  
Chronic stress involves the exposure to high levels of GC hormones for prolonged periods of time and 
has been reported to cause changes to the HPA axis and in the brain. Rats exposed to a 2-week chronic 
stress protocol showed increased levels of plasma CORT, which may reflect a stress hyper-responsive 
state. Irregularities in the distribution of CRH among many brain regions was also observed, including 
the hippocampus and hypothalamus. Increased CRH concentration was shown in the anterior 
hypothalamic nucleus while CRH was decreased in the ventral hippocampus and medial prefrontal 





expression of Bdnf is observed in the hippocampus and prefrontal cortex (PFC) of patients with 
schizophrenia and in the hippocampus of rats exposed to chronic restraint stress for 3 weeks (Seo et 
al., 2018). In a post-mortem human study, abnormal GR messenger RNA (mRNA) and protein isoform 
expression was reported in the PFC of patients that had suffered from schizophrenia and bipolar 
disorder. Levels of GR mRNA were decreased in the PFC of schizophrenia patients relative to matched 
controls, while no differences in MR mRNA was detected. Furthermore, increased protein levels of the 
truncated GRα isoform, GRα-D1 was seen in schizophrenia and bipolar patients, while the full-length 
isoform of GRα was increased in bipolar patients relative to with schizophrenia patients (Sinclair et al., 
2011). Alzheimer’s disease has also been linked to chronic stress. Increased CRH mRNA in the PVN 
and increased neuronal CRH mRNA has been observed in Alzheimer’s patients (Raadsheer et al., 
1995). Furthermore, exposure to chronic variable stress for 2 weeks resulted in mild cognitive 
impairments in young mice and severe cognitive impairments in aged mice, as well as increased 
hippocampal, amygdalar and prefrontal cortex expression of a gene involved in the beta-amyloid 
pathology of Alzheimer’s disease, Beta-Secretase 1 (Bace1) (Cordner and Tamashiro, 2016).  
Many animal and human studies have established a role of the HPA axis in depression and PTSD. The 
dexamethasone suppression test (DST), a test initially developed as a diagnostic for Cushing’s 
syndrome, demonstrated a high prevalence of HPA axis abnormalities in depressed patients (Carroll, 
1982). CORT has been shown to significantly reduce mRNA levels of Bdnf in the rat PFC and 
hippocampus, an effect which is reversed by antidepressant treatment (Dwivedi et al., 2006). FS has 
been shown to result in decreased mRNA levels of Bdnf within the rat hippocampal DG, CA1, CA3 and 
CA4 subregions. Antidepressant treatment or exercise attenuated the FS-induced decrease in Bdnf 
mRNA while a combination of both antidepressant treatment and exercise significantly enhanced 
mRNA levels of Bdnf in all 4 hippocampal subregions (Russo-Neustadt et al., 2001). Rats treated with 
the tricyclic antidepressant drug, imipramine, for 8 weeks exhibited significantly increased mRNA levels 
of MR in the hippocampus and decreased mRNA levels of CRH in the PVN, pro-opiomelanocortin 
(POMC) in the anterior pituitary and GR in the pituitary. Decreased plasma pituitary ACTH secretion 
was also observed alongside increased weight of the adrenal glands (Brady et al., 1991). Patients 
suffering from PTSD and major depression were shown to have significantly increased 24h secretion 
of urinary cortisol, compared with normal volunteers (Maes et al., 1998), while plasma cortisol levels of 





healthy controls (Wong et al., 2000). Females with depression or depression alongside dementia were 
reported to exhibit higher CRH levels in the cerebrospinal fluid (CSF) compared with neurological 
controls (Banki et al., 1992). Patients with depression also exhibited large increases in the number of 
CRH neurons and CRH mRNA in the PVN (Raadsheer et al., 1995).  
The use of genetically altered animals has also provided evidence for a role of GC receptors in 
depression. Exposure to chronic mild stress in a transgenic mouse overexpressing GR (GRox) in the 
forebrain resulted in increased anxiety-like behaviour in the open field test. Greater behavioural 
sensitivity to cocaine (20 mg/kg) was seen in GRox mice, demonstrated by increases locomotor activity 
in the OF compared with WT animals. Increased behavioural immobility was also reported in the FS 
test in GRox mice compared with WT mice, which was reduced with antidepressant treatment (Wei et 
al., 2004). Interpretation of this finding, however, is difficult, given the incorrect interpretation of the FS 
test as a measure of depression rather than adaptation and learning driven by GC hormones (Molendijk 
and de Kloet, 2015). Zebra fish homozygous for a mutant GR with disrupted transcriptional activity 
exhibited higher levels of CORT under non-stressed conditions. Moreover, exposure to stress failed to 
induce a significant surge in CORT as would be expected. Dysregulated HPA-axis activity was 
accompanied by reduced exploratory behaviour and reduced habituation to an anxiogenic environment. 
Additional changes, such as freezing behaviour and tank wall avoidance, strongly suggested the 
presence of an anxiety-like phenotype. Upon treatment with the antidepressant, fluoxetine, behavioural 
changes were reversed, suggesting a role for GR in affective disorders (Ziv et al., 2013). 
 
1.2 Genomic actions of GC hormones  
1.2.1 Glucocorticoid-binding receptors: orchestrators of GC hormone genomic action 
In the rat brain, CORT acts upon regions expressing MRs and GRs to exert a multitude of effects on 
behaviour, emotion, cognition, and learning and memory. The MR and the GR were originally identified 
in the brain by radioligand binding assays (Reul and de Kloet, 1985) and initially referred to as “Type I” 
and “Type II” receptors, respectively. Despite the ability of MRs and GRs in the hippocampus to bind 
CORT, marked differences in their properties have been identified. One of the most pivotal initial studies 





both receptors throughout the brain (Reul and de Kloet, 1985). Radioligand binding assays performed 
on micro-dissected brain tissue of rats revealed a discrete localisation of MR expression to the 
hippocampus, lateral septum and central amygdala, and a widespread distribution of GRs to regions 
such as the lateral septum, neocortex, cortical amygdala, paraventricular nucleus and locus coeruleus. 
A strong co-localisation of both receptors was observed in the hippocampus. Findings of this study also 
demonstrated that MRs display a very high affinity for CORT (Kd ~ 0.5nM) and are occupied by GCs to 
a large extent under all physiological conditions, while GRs have a much lower affinity for CORT (Kd ~ 
5.0nM) (Reul et al., 1987) and become occupied when CORT levels are significantly elevated such as 
during the circadian rise or following acute stress (de Kloet, 2013).  
The discrete hippocampal localisation of MR and GR mRNA in the rat hippocampus was further 
examined in later studies using in situ hybridization, revealing a widespread distribution of MR among 
all hippocampal subfields, in particular the cornu ammonis (CA) subfield, CA3. In contrast, the highest 
concentration of GR mRNA was found in the CA1 and CA2 subfields (Herman et al., 1989, Van Eekelen 
et al., 1988). Furthermore, radioligand binding studies revealed marked differences in their affinity for 
and occupancy by ligand (Reul and de Kloet, 1985, Reul et al., 1987). The distribution of MR and GR 
proteins have also been investigated. In the developing mouse brain, MR protein levels were 
investigated at different timepoints until adulthood, revealing exclusive expression of the MR within the 
nuclei of neuronal cell types and a complete lack of glial expression. At adulthood, MR expression was 
observed in the granule and pyramidal cell layers of the hippocampus, with the strongest expression 
levels observed in the CA2 (Kretz et al., 2001). In the rat brain, investigation of mRNA and protein levels 
of GR revealed a high presence of GR mRNA in the cytoplasm, while GR protein was predominantly 
observed the cell nucleus. The amygdala and hippocampus were among the brain regions where the 
highest densities of GR mRNA and protein were observed, with a differential pattern of GR protein and 
mRNA seen in the hippocampus. In the CA1-4, high levels of mRNA were observed, however protein 
GR was seen highest in the CA1 and CA2. The granule cell layer of the DG exhibited the highest level 
of GR mRNA and protein (Morimoto et al., 1996).  
The MR is encoded by the Nuclear Receptor Subfamily 3 Group C Member 2 (Nr3c2) gene located on 
chromosome 19, while the GR is encoded by the Nuclear Receptor Subfamily 3 Group C Member 1 





variants and translational isoforms of the corresponding receptor proteins have been identified, arising 
from both alternative promoter usage and splicing (Meijer et al., 2019). Alternative splicing of exons 
within Nr3c1 has been shown to produce splice variants such as GRα and GRβ (Hollenberg et al., 
1985), GR-A and GR-P (Moalli et al., 1993) and GR-γ (Rivers et al., 1999). Translational isoforms of 
these GR splice variants also arise due to alternative translation initiation, with the GRα mRNA transcript 
resulting in 8 GRα subtypes (Oakley et al., 2018). Multiple splice variants of the MR have been identified 
with differential expression occurring across the rat hippocampus (Zennaro et al., 1995). Alternative 
splicing usage within the 5’ untranslated region (UTR) gives rise to three MR variants, however these 
do not lead to alternative MR protein isoforms. A splice variant within a coding region does give rise to 
alternative MR protein isoform (Bloem et al., 1995), while a splice variant with a 10 bp deletion in the 
C-terminal domain producing a truncated MR protein has also been identified in the rat (Zhou et al., 
2000). Alternative promoter usage giving rise to variation in the 5-UTR region of the MR and GR may 
be important for tissue specific receptor expression (Turner et al., 2006). 
Both receptors exhibit a structure characteristic of the steroid receptor superfamily (Figure 1.3.a), 
comprising of a DNA-binding domain (DBD), a hinge region (HR), a ligand-binding domain (LBD) and 
an amino terminal domain (NTD). A high degree of similarity between the DBD and LBD of both 
receptors was observed upon cloning of the MR (Arriza et al., 1987), while the NTD varies considerably 
between both receptors (Meijer et al., 2019). Many structural features of MRs and GRs facilitate their 
genomic activity. The DBD contains two zinc finger motifs which recognise target DNA sequences, 
allowing MRs and GRs to activate or repress the transcription of GC-target genes (Oakley and 
Cidlowski, 2013). Nuclear localisation signals, NL1 and NL2, found within the junction of the DBD/hinge 
region and the LBD, respectively (Oakley and Cidlowski, 2013), facilitate nuclear translocation of the 
receptors. Two activation domains, activation function-1 (AF-1) and activation function-2 (AF-2) located 
within the NTD and LBD, respectively, regulate the transcriptional activity of MRs and GRs via 
interactions with coactivator proteins (Kumar and Thompson, 2012).  
In their inactive form, both receptors form a heteromeric complex with heat-shock proteins (hsps), 
immunophilins and other cochaperone proteins (Figure 1.3.b). The 90-kDa heat-shock protein Hsp90 
binds, as a homodimer, the LBD and DBD of unligated MRs and GRs (Baulieu, 1991). Hsp90-receptor 





receptor associated immunophilin, FK506 binding protein 51 (FKBP5) (Sanchez, 1990). FKBP5 also 
acts as a negative regulator of GR function, by reducing the affinity of the GR for GCs and the nuclear 
translocation of the receptor (Jaaskelainen et al., 2011). Following ligand binding and activation, MRs 
and GRs undergo a structural rearrangement which exposes the nuclear localisation signals, NL1 and 
NL2 (Oakley and Cidlowski, 2013). FKBP5 is exchanged for FK506 binding protein 52 (FKBP4), which 
interacts, via a peptidylprolyl isomerase domain (Galigniana et al., 2002), to cytoplasmic dynein; a 
molecular motor which transports MRs and GRs, along microtubular tracks to the nucleus (Harrell et 
al., 2004). The receptor-cochaperone complex passes through the nuclear pore and dissociation of the 
receptors from the cochaperone complex occurs in the nucleoplasm (Galigniana et al., 2010). 
1.2.2 Genomic activity of MRs and GRs 
Following nuclear translocation and dissociation from co-chaperone proteins, activated MRs and GRs 
form various dimeric complexes and exert transactivation or transrepression on GC target genes via 
interactions with DNA. Ambiguities surrounding the location of dimer formation and dimer composition 
have been circulating for decades. Initial studies reported nuclear translocation and DNA-binding to 
precede dimerization (Luisi et al., 1991), however the formation of dimers in the cytoplasm has been 
reported in vivo (Savory et al., 2001). MRs and GRs have been described as monomers (Wrange et al., 
1986), homodimers (Wrange et al., 1989), heterodimers (Trapp et al., 1994, Mifsud and Reul, 2016) 
and tetramers (Presman et al., 2016). MR and GR dimers bind to consensus sequences within the DNA 
known as glucocorticoid response elements (GREs), thus regulating the expression of target genes.  
The high degree of similarity within the DBDs of the MR and GR allows both receptors to interact with 
the same responsive elements. Positive GREs ((+)GREs) mediate target gene transactivation, while 
negative GREs ((-)GREs) mediate target gene transrepression. Both sequences have been 
approximated as “g/aGnACAnnnTGTnCt/c” (Strahle et al., 1987) and “CTCC(n)0-2GGAGA” (Hudson et 
al., 2013), respectively. The 3 nucleotide spacer located between the two 6-bp half sites facilitate 
receptor dimerization at (+)GREs (Luisi et al., 1991), however the variable 0-2 nucleotide spacer in (-
)GRE sequences indicates that dimerization may not be necessary for gene transrepression (Hudson 
et al., 2013). MRs and GRs have been found to bind to many variations of these motifs (So et al., 2007). 
5 positions of the (+)GRE sequence have been shown to be invariant, and specific contact has been 


















Figure 1.3 Steroid receptor superfamily structure and a schematic representation of the 
heteromeric GR complex before and after ligand binding 
(a) The MR and GR are modulator proteins containing a poorly conserved N-terminal transactivation 
domain (NTD), a hinge region (HR), a highly conserved DNA-binding domain (DBD) and a ligand-
binding domain (LBD). The activation domains, activation function-1 (AP-1) and activation function-2 
(AP-2) lie within the NTD and LBD, respectively. Taken from (Ratman et al., 2013). (b) (1) The unligated 
GR remains sequestered in the cytoplasm by heat-shock proteins (Hsp90), the small cochaperone 
protein p23 and the steroid receptor associated immunophilin, FKBP5. In this conformation, GR has a 
low affinity for cortisol. (2) Once the GR becomes occupied by cortisol, FKBP5 is exchanged for FKBP4 
which binds dynein, (3) allowing the translocation of the GR-complex into the nucleus. GR can bind to 
GREs within the DNA and exert transcriptional effects. (4) The GR increases FKBP5 transcription and 
translation, (5) thus conferring higher GR resistance, completing an ultra-short negative feedback loop 







An in-depth analysis of MR binding motifs is currently lacking, however genome-wide sequencing has 
revealed many additional motifs to which GRs may bind and exert transcriptional effects on target 
genes. Motifs such as activation protein 1 (AP1), zinc finger and BTB containing 3 (Zbtb3), specificity 
protein 1 (SP1) (Polman et al., 2012, Polman et al., 2013) and neuronal differentiation 1 (NeuroD1) 
(Pooley et al., 2017) have been predicted within sites of the genome bound by GRs. Once bound to 
GREs or other responsive elements, MRs and GRs undergo additional conformational changes leading 
to the recruitment of coregulators and chromatin-remodelling complexes that modulate gene 
transcription rates by affecting the activity of RNA-polymerase (Oakley and Cidlowski, 2013).  
1.2.3 Chromatin architecture as a mediator of MR and GR genomic and non-genomic activity 
The ability of MRs and GRs to modulate transcription is dependent on a number of factors, one of which 
involves the accessibility of GRE sequences for binding. Within the cell, genetic material is condensed 
into a complex collectively known as chromatin. 147 base pairs (bps) of DNA coil around an octameric 
assembly of histone proteins to form an individual nucleosome unit, which is joined to adjacent 
nucleosomes by variable lengths of linker DNA (Swygert and Peterson, 2014). Chromatin architecture 
is a major determining factor in the accessibility of DNA sequences for TF binding, and densely packed 
chromatin can repress transcription by impeding protein-DNA interactions (King et al., 2012). An 
association between regions of accessible chromatin and GR binding has been demonstrated in vitro. 
A study employing genome-wide DNase I profiling alongside ChIP-seq demonstrated that the majority 
of GR binding, in mouse mammary adenocarcinoma cells following DEX treatment, occurred within 
areas of the genome which were pre-accessible prior to GC exposure or accessible following GC 
exposure (John et al., 2011). A high correlation between GR binding and chromatin accessibility in A1-
2 cells treated with DEX was also demonstrated by formaldehyde assisted isolation of regulatory 
elements (FAIRE), a technique which isolates nucleosome-depleted DNA from chromatin (Burd et al., 
2012). 
The N-terminal tails of the core histone proteins, H2A, H2B, H3 and H4, which form the histone octamer 
core are often targets of covalent post-translational modifications (Wang et al., 2015) as they form 
flexible bonds with the DNA and adjacent nucleosomes which are easily adapted to allow dynamic 
changes in the accessibility of the underlying genome (Cheung et al., 2000). A subset of amino acid 





phosphate groups, including lysine (K), serine (S) and threonine (T) residues (Taverna et al., 2007). 
Post translational modifications of histone H3 have been associated with transcriptional activation 
(Taniura et al., 2007), and following exposure to stress may facilitate the transcriptional activity of MRs 
and GRs. Exposure to an acute FS stressor has been shown to result in phosphorylation of serine10 
(S10) and acetylation of lysine14 of histone 3 [H3S10p-K14ac] exclusively within mature neurons of the 
rat hippocampal DG. Antagonism of the GR was also shown to prevent the formation of this histone 
modification and of the acquired immobility response upon re-exposure to FS, which is representative 
of learning and memory formation in response to an acute stressor (Bilang-Bleuel et al., 2002).  
Further studies demonstrated that the induction of the immediately early gene, Fos Proto-Oncogene 
AP-1 Transcription Factor Subunit (Fos), was closely linked to the formation of this histone modification 
within DG granule neurons (Chandramohan et al., 2007). The formation of the H3S10p-K14ac histone 
modification has also been shown to involve a novel non-genomic mechanism of GR action between 
activated GRs, the N-methyl-D-aspartate (NMDA)-receptor and downstream histone modifying 
enzymes (Figure 1.4). Following FS, the NMDA receptor (NMDAR) initiates an intracellular signalling 
cascade known as the mitogen-activated protein kinase (MAPK) extracellular regulated kinase (ERK) 
(MAPK/ERK) cascade. Activation of this pathway leads to the downstream phosphorylation of mitogen- 
and stress- activated kinase 1 (MSK1) by extracellular regulated kinase 1/2 (ERK1/2). GR may act as 
a critical scaffold in this pathway for pERK1/2, enabling phosphorylation of MSK1 and of ELK-1, which 
induce the H3S10p-K14ac histone mark to de-condense chromatin structure, exposing target genes for 
transcription. Antagonism of the NMDAR, blockade of ERK1/2 or double knock out of MSK1/2 (MSK1/2 
KO) attenuated the formation of the H3S10p-K14ac histone modification, and also prevented the 
adaptive learning (immobility behaviour) induced by FS. MSK1/2 KO also lead to a reduction in the 
number of DG Fos-positive neurons, further supporting that the immediate early gene is a transcriptional 
target of this pathway (Chandramohan et al., 2008). The acquired immobility behaviour demonstrated 
by rats in the 24 hr FS retest was shown to be maintained for at least 4 weeks (Gutierrez-Mecinas et 
al., 2011). The number of early growth response protein (Egr-1) positive DG neurons was also shown 
to increase significantly following FS, an effect which was attenuated by antagonism of the GR 





Figure 1.4 Schematic representation of the intracellular signalling cascade leading to the 
phosphorylation and acetylation of histone H3 within dentate gyrus granule neurons following 
exposure to psychological stress  
Activation of the NMDA receptor initiates the MAPK/ERK signalling cascade and downstream 
phosphorylation of MSK1 and ERK 1/2. Ligand bound GRs may enhance the phosphorylation of MSK1 
by pERK1/2. The red circles indicate a phosphorylated state or phosphorylation process, whereas the 
green circles indicate an acetylated state or acetylation process. N-methyl-D-aspartate (NMDA), Taken 










1.2.4 Coregulators as mediators of MR and GR genomic activity 
Coregulators comprise a large and diverse group of proteins recruited by MRs and GRs that exert 
transcriptional effects without binding DNA. Coregulators can be subdivided into two classes based on 
their transcriptional activity, with coactivators inducing transactivation and corepressors inducing 
transrepression of GC target genes. The induction of gene expression by coactivators can occur via 
many mechanisms including chromatin remodelling, histone modification, transcription initiation, 
elongation of RNA chains and RNA splicing (Yang and Young, 2009) while corepressors can interfere 
with transactivation by inducing histone deacetylase (HDAC) activity, making inhibitory contacts with 
transcriptional machinery or interfering with the assembly of the transcriptional preinitiation complex 
(Goodson et al., 2005). MRs and GRs recruit numerous coregulators via their AF-1 and AF-2 domains 
within the NTD and LBD, respectively. Binding of coregulators within the AF-2 domain is a ligand 
dependent process often occurring via a conserved nuclear receptor box containing one or more LXXLL 
motifs (L = leucine, X = amino acid) (Heery et al., 1997), while coregulator recruitment via the AF-1 
domain is a ligand independent process not involving the LXXLL motif (Yang and Young, 2009). Due 
to the high sequence similarity between the LBD of MRs and GRs, the receptors share many AF-2 
interacting coregulators (Zalachoras et al., 2013), however many MR- and GR-specific coregulators 
have also been identified.  
An ATP-dependent chromatin remodelling complex known as the switch/sucrose non-fermentable 
(SWI/SNF) complex was identified in yeast as one of the first GR coactivators (Yoshinaga et al., 1992). 
This complex utilises energy derived from ATP hydrolysis to separate the bonds between histones and 
DNA in order to reposition nucleosomes (King et al., 2012). The ATPase activity of SWI/SNF is 
mediated by one of the two highly homologous catalytic subunits, Brahma (BRM) or Brahma-related 
gene 1 (BRG1) (Johnson et al., 2008). Several BRM/BRG1 associated factors (BAFS) associate with 
the catalytic subunit to make up the SWI/SNF complex (King et al., 2012). The transcriptional activity 
of SWI/SNF has been demonstrated in mouse mammary adenocarcinoma cell lines expressing the 
steroid responsive mouse mammary tumour virus-long terminal repeat (MMTV-LTR), which contains a 
high number of GR binding sites. Cells transfected with GR alongside either BRG1 or BRM, were 
treated with the synthetic GC DEX, resulting in a 33- and 77-fold induction of MMTV transcription, 





coactivators of both MRs and GRs, with SRC-1 to be the first discovered (Onate et al., 1995) of the 
three distinct subtypes SRC-1, 2 and 3. Expression of SRC-3 has been shown in the hippocampus 
(Nishihara et al., 2003), while the SRC-1 splice variant, SRC1-a has been found in the hypothalamus 
and anterior pituitary (Meijer et al., 2000). SRC-1a has been shown to enhance GR-activated MMTV 
promoter activity in HeLa and A204 cells (Sheppard et al., 1998). This study also demonstrated 
coregulator activity of CREB binding protein (CBP) and p300, two closely related histone 
acetyltransferases which also act as coregulators of MRs and GRs. P300 was also shown to enhance 
GR-activated MMTV promoter activity, while CBP supressed the activity of the GC-responsive MMTV 
promoter in a dose-dependent manner (Kino et al., 1999). SRCs interact with MRs and GRs via the 
LXXLL motif within the AF-2 domain or via the AF-1 domain and can stimulate transcription by exerting 
direct histone acetyltransferase activity or recruiting CBP/p300 (Meijer et al., 2005). MRs have been 
shown to form a complex with SRC-1 in human embryonic kidney cells, as treatment with aldosterone 
demonstrated the assembly of MR, SRC-1 and a small ubiquitin-related modifier-1 (SUMO-1) 
conjugating enzyme, Ubc9, at a promoter of the MR target gene, Epithelial sodium channel (Yokota et 
al., 2007).  
Nuclear receptor co-repressors (NCoR) and Silencing mediator of retinoic acid and thyroid hormone 
receptor (SMRT) have both been identified as corepressors of the MR and GR and shown to exert 
HDAC activity. GR repression of Thymic Stromal Lymphopoietin (TSLP) cytokine gene expression was 
shown to be mediated by GR binding within negative GREs and the formation of a NCoR/SMRT 
transrepression complex, alongside the HDAC activity of HDAC2 and HDAC3 (Surjit et al., 2011). GR 
repressed the transcription of Nr3c1 mRNA in A549 cells, by forming a cis-acting repression complex 
with NCoR1 and HDAC3 at the transcriptional start site of Nr3c1. Within exon 6, GR and NCoR1 binding 
was also detected, and chromosome conformation capture (3C) revealed a chromatin loop formation 
between exon 6 and the promoter-proximal region of Nr3c1, allowing the repression complex to 
assemble and inhibit the initiation of Nr3c1 transcription (Ramamoorthy and Cidlowski, 2013). MRs and 
GRs can regulate the transcription of target genes by physically interacting with other transcription 
factors (TFs) (Oakley and Cidlowski, 2013). GR monomers have been shown to bind and repress 
proinflammatory transcription factors such as AP-1 (Pearce and Yamamoto, 1993) and nuclear factor 
kappa B (Nf-kB) (Ronacher et al., 2009) while MR has been shown to transactivate AP-1 (Dougherty et 






















Figure 1.5 The recruitment of GR coactivators and corepressors mediating gene transcription 
Ligand-bound GR enters the nucleus and binds glucocorticoid response elements (GREs) within 
chromatin. Co-regulators such as SRC-1 and CBP/p300 are recruited. The BRG1 complex SWI/SNF is 
recruited to the promoter through an interaction with GR and nucleosomes are repositioned. This allows 
transcription factors such as NF1 and the octamer transcription factors (OTFs) as well as the TATA-
binding protein (TBP). Finally, mediator proteins are recruited and the preinitiation complex forms 





1.2.5 Elucidation of genome-wide MR and GR activity by next generation sequencing  
Next generation sequencing (NGS) is emerging as a useful technology to elucidate the genomic actions 
of MRs and GRs. It is rapidly replacing microarray technology, which is limited to detecting predefined 
sequences, is associated with high background noise, cross hybridization problems, and is limited to 
measuring the relative abundance of transcripts (t'Hoen et al., 2008). Regions of the genome to which 
MRs and GRs bind are identified by sequencing DNA obtained by chromatin immunoprecipitation 
(ChIP), a technique where DNA-binding proteins are crosslinked to DNA with formaldehyde, the DNA 
is sheared into fragments, and specific antibodies extract DNA fragments bound by the target DNA-
binding protein (Park, 2009). Alongside ChIP-seq, RNA-sequencing (RNA-seq) can be used to analyse 
the entire transcriptome to determine expression levels of genes which may be under MR and GR 
regulation. The combined use of ChIP-seq and RNA-seq to determine which genes are targeted by GC 
action appears promising, however integration of data arising from both technologies remains a 
significant challenge (Angelini and Costa, 2014). 
Sequencing technology has rapidly advanced since the emergence of Sanger dideoxynucleotide 
sequencing (Sanger et al., 1977) which was limited to sequencing at the single gene level. Many 
advances have led to the introduction of massively parallel sequencing with higher throughput and 
improved accuracy, launching the next generation in sequencing technologies. The concept underlying 
NGS involves a DNA polymerase catalysing the incorporation of fluorescently labelled 
deoxyribonucleotide triphosphates (dNTPs) into a DNA template strand during sequential cycles of DNA 
synthesis. During each cycle, at the point of incorporation, the nucleotides are identified by fluorophore 
excitation. This process is extended across millions of fragments in a massively parallel fashion. Many 
NGS platforms have been developed based on this concept, however the majority of the world’s 
sequencing data has been generated by the Illumina sequencing platform (Illumina, 2017) which has 
four basic steps (Figure 1.6).  
Following the alignment, bioinformatic analysis of ChIP-seq and RNA-seq data is performed. For 
analysis of ChIP-seq data, “peaks” or regions of the genome significantly bound by the target 
transcription factor are annotated to the nearest gene. Differential binding analysis of ChIP-seq data 
can determine whether the binding of a given transcription factor is significantly upregulated or 





mapped, counted and normalised to determine expression levels. Differential expression analysis 
(Hitzemann et al., 2014) is widely used on RNA-seq data to determine whether the expression of a 
given gene is significantly upregulated or downregulated between experimental conditions. 
A number of studies have been carried out using ChIP-seq and RNA-seq to elucidate the genomic 
actions of MRs and GRs under various experimental conditions. ChIP-seq and RNA-seq of human A549 
lung epithelial carcinoma cells treated with DEX revealed over 4,000 significant GR peaks and 
differential expression of over 200 genes in response to DEX treatment. GR peaks were primarily found 
in regions upstream of the transcriptional start site (TSS), while the majority of GR peaks located within 
genes were found in introns. 62% of GR peaks were found to contain a GRE, while the predominant 
motif among peaks lacking a GRE was identified as an AP-1 binding site. The majority of genes 
identified by RNA-seq were upregulated (59%) compared to downregulated (41%), and the upregulation 
was slightly but significantly stronger than the downregulation. ChIP-seq and RNA-seq datasets were 
cross-examined, which revealed that 47% of significantly upregulated genes contained a GR peak 
within 10 kilobases (kbs). GR peaks were located much further from significantly downregulated genes 
(Reddy et al., 2009).  
Later studies identified fewer peaks, with over 1000 significant GR binding sites in neuronal PC12 cells 
by ChIP-seq (Polman et al., 2012), with more than 50% containing a GRE. These GR peaks were 
annotated to genes playing a role in neuronal processes such as neuronal projection morphogenesis, 
neuron projection regeneration and synaptic transmission. The majority of GR peaks were located 
upstream or downstream of a gene, while GR peaks located within genes were primarily observed 
within intronic regions. RNA-qPCR on a subset of genes revealed significantly upregulated RNA levels 
of 6 genes annotated to GR peaks, and significantly downregulated RNA of one gene annotated to a 
GR peak. GR peaks associated with upregulated RNA were found to contain GREs, while no GREs 










Figure 1.6 A schematic representation of the Illumina next generation sequencing platform 
(A) The DNA library is prepared by random fragmentation of the DNA or cDNA sample and the addition 
of adaptors to the 3’ and 5’ end of the DNA or cDNA fragments. (B) The library is loaded into a flow cell 
containing surface bound oligos complimentary to adaptors added during library preparation and each 
fragment is amplified into distinct, clonal clusters. (C) Sequencing reagents and fluorescently labelled 
nucleotides are added to the flow cell, and the first sequencing primer is extended to produce the first 
read. With each cycle, fluorescently tagged nucleotides compete for addition to the growing chain 
however only one is incorporated, based on the sequence of the template. After the addition of each 
nucleotide, the clusters are excited by a light source and a characteristic fluorescent signal is emitted. 
Hundreds of millions of clusters are sequenced in this massively parallel process, with the read depth 
ranging from 20 to 400 million reads. (D) Once sequencing has been completed, the sequence read 





ChIP-seq of hippocampal tissue of ADX rats supplemented with low or high doses of CORT revealed 
over 2400 significant GR peaks (Polman et al., 2013). These GR peaks were annotated to genes 
playing a role in neurite projection, neuron differentiation and cell survival. Over 99% of these GR peaks 
contained a GRE and the majority were located upstream or downstream of a gene, while GR peaks 
located within genes were primarily observed within intronic regions. ChIP-qPCR was carried out on a 
subset of genes and revealed a differential binding pattern of the MR, particularly with higher CORT 
concentrations. As a follow on from this work (Polman et al., 2013), MR ChIP-seq was conducted on 
hippocampal tissue of ADX rats exposed to both low (300μg/kg) and high (3000μg) doses of CORT. 
The MR peaks were compared with previously identified GR peaks present in ADX rats supplemented 
with high doses of CORT, to identify distinct and overlapping regions of the genome to which MRs and 
GRs bind. Over 1,400 GR-exclusive binding sites were identified, while fewer MR-exclusive (n=918) 
and MR-GR overlapping (n=475) were found. All peaks were found to contain a GRE, while the Atoh1 
motif was reported as the most prominent motif in MR-exclusive binding sites. Biological processes 
associated with specific and overlapping peaks were subsequently identified by pathway analysis, with 
genes annotated to MR-exclusive peaks linked to cell projection and adhesion, genes annotated to 
overlapping peaks associated with synaptic plasticity and GR-exclusive peaks linked to synaptic 
vesicles (van Weert et al., 2017). A recent ChIP-seq study carried out on stressed and non-stressed 
ADX rats supplemented with CORT identified over 7000 GR enrichment sites in the hippocampus 
(Pooley et al., 2017). These GR peaks were annotated to genes involved in neuron development and 
differentiation, synaptogenesis and neuron projection development. Surprisingly, GR binding was not 
shown to be significantly different between stress and non-stressed rats. The majority of GR peaks 
were detected in intergenic regions or within introns. 49% of GR peaks contained a GRE while 61.2% 
of all GR peaks contained a motif resembling a GRE half-site.  
These studies, however, pose many limitations. The lack of biological replicates (n = 1) in these studies 
increases the possibility that the high number of binding peaks reported may not be reproducible. PC12 
cells have been extensively used to study neuronal function in relation to GCs and display properties 
similar to those of sympathetic neurons such as neurite development, and electrical activity (Polman et 
al., 2012). Human A549 lung epithelial carcinoma cells are also widely used in GC hormone research 
(Reddy et al., 2009), however cell lines simply cannot replicate the properties of cells in an intact animal. 





due to the depletion of endogenous CORT and potential effects of ADX on the neurodegeneration of 
hippocampal DG cells (Sloviter et al., 1989). Furthermore, MR ChIP-seq is limited to a single study (van 
Weert et al., 2017), and no study has currently investigated the genome-wide binding of both MRs and 
GRs under physiological conditions to determine how they interact with stress and one another under 
stress or circadian conditions.  
1.2.6 The Krüppel-like factors: MR and GR target genes 
Many members of the Krüppel-like factor (KLF) family of transcription factors have been identified as 
transcriptional targets following elevations in CORT (Datson et al., 2011, Mychasiuk et al., 2016, Reddy 
et al., 2009), therefore may play a role in orchestrating GC-related effects during the acute stress 
response or following circadian input. The KLFs have been named based on their sequence homology 
with the DNA-binding domain of Krüppel protein; an embryonic pattern regulator found in Drosophila 
melanogaster (Yin et al., 2015). All KLF family members contain a characteristic zinc finger domain also 
shared by the Specificity Protein (SP) family of transcription factors (Wimmer et al., 1993). Although 
KLFs are often grouped with the SP family, little homology is observed between the KLFs and SPs 
outside of the characteristic zinc finger domain (Suske et al., 2005). 17 members of the KLF family have 
been characterised to date in humans and are named chronologically; KLF1-17  (Turner and Crossley, 
1999), with 11 of these 17 homologs found in rat (Kaczynski et al., 2003). Many physiological processes 
regulated by GCs are also regulated by the KLFs, such as metabolism, immunity and cardiovascular 
function (McConnell and Yang, 2010). KLFs have been widely implicated in proliferation, differentiation 
and development of many cell types (McConnell and Yang, 2010), and in the brain where KLFs are 
abundantly expressed where they have been shown to influence processes such as neural 
development and response to injury (Yin et al., 2015).  
KLF family members exhibit a characteristic structure (Figure 1.7.a).  Like MRs and GRs, KLFs share 
a highly conserved DNA-binding domain which facilitates their transcriptional effects. Within the DBD, 
three Cys2/His2 zinc fingers allow KLFs to bind CACCC elements and GC-rich regions of DNA and 
regulate transcription (Pearson et al., 2008). Each zinc finger recognizes three base pairs in the DNA 
sequence, interacting with nine base pairs in total (McConnell and Yang, 2010). Similar to MRs and 
GRs, KLFs also contain nuclear localisation sequences, which are found within or in close proximity to 





subtypes and contains domains that mediate transcriptional activation or repression. KLFs also recruit 
co-regulatory proteins such as co-activators, co-repressors and chromatin remodelling factors to 
domains within the N-terminal to exert transcriptional effects (Kaczynski et al., 2003).  
The genes encoding the KLFs are randomly dispersed throughout the genome, which may explain the 
diversity of function observed among the KLF proteins (Kaczynski et al., 2003). KLF1, 2 and 4, however 
are more closely related to one another than to other members of the protein family (Dang et al., 2000) 
and the amino acid sequences of KLF6 and KLF7 show a high degree of homology and almost identical 
NTDs (Laub et al., 2001). Based on the diversity of function observed among the KLF proteins, they 
have been divided into three distinct subgroups according to their transcriptional effects (Figure 1.7.b). 
KLF3, 8 and 12 are classified as “Group 1” KLFs and repress transcription via interactions with C-
terminal binding protein (CtBP) at a CtBP-binding site located in the N-terminal region. Group 2 KLFs 
include KLF 1, 2, 4, 5, 6 and 7 and predominantly activate transcription. Group 3 KLFs such as KLF9, 
10, 11, 13, 14 and 16 interact with Sin3A, a common transcriptional co-repressor, via a Sin3A binding 
site within the N-terminal region to repress transcription. KLF15 and 17 have not been grouped as they 
contain no defined protein interaction motifs. Histone acetyltransferases (HATs) which interact with MRs 
and GRs, such as CBP, p300 and p300/CBP-associated factor (P/CAF) also interact with KLFs to 
facilitate transcriptional repression or activation depending on the KLF subtype. (McConnell and Yang, 
2010). 
A number of KLFs are found in various cell types throughout the nervous system, such as neurons, 
astrocytes, microglia, oligodendrocytes and cerebral vascular cells and many neurobiological 
processes have been shown to be mediated by KLFs (Yin et al., 2015). A role of KLF4 in neurite and 
axon outgrowth has been suggested, and KLF4 was shown to suppress neurite and axon outgrowth of 
optic nerve retinal ganglion cells (RCGs) and increase the regeneration potential of damaged RGCs 
(Moore et al., 2009). Neurogenesis and neuronal migration may also involve KLF4, as constitutive 
expression of KLF4 prevented the migration and development of neural progenitors in the cerebral 
cortex (Qin and Zhang, 2012). Studies investigating the expression pattern of KLF7 during 
embryogenesis and development strongly suggest a role of this gene in neurogenesis (Laub et al., 
2001). KLF7 is also believed to play a role in differentiation, with delayed neuronal differentiation of 





KLF9 expression and neural development has also been shown, with forced expression of the gene 
resulting in increases in cells reflective of neuronal differentiation and maturation (Bonett et al., 2009). 
Many of these effects may be mediated by GC action on KLF gene expression, as many studies have 
identified the KLFs as GC target genes. In the PFC, exposure to chronic stress led to upregulated 
mRNA expression of Klf4 in male rats (Mychasiuk et al., 2016). Expression of the Klf4 protein was 
significantly increased in the hippocampus and cortex of male rats exposed to psychological stress, 
while increased Klf4 mRNA and protein levels were elevated in HT-22 cells following CORT treatment. 
Antagonism of the GR, by treatment with RU486, abolished increases in Klf4 protein levels (Li et al., 
2017). Cardiac expression of Klf13 mRNA and protein was significantly reduced in mice following GR 
KO. Moreover, increased GR binding at a GRE within intron-1 of Klf13 following exposure of HL-1 
cardiac muscle cells to the synthetic GR agonist, DEX (Cruz-Topete et al., 2016). DEX was shown to 
significantly increase the expression of Klf4, Klf5, Klf6 and Klf9 and decrease the expression of Klf10 in 
human A549 lung epithelial cells. Furthermore, GR binding sites harbouring GREs have also been 
found in close proximity to Klf5 and Klf9, indicating that GR transactivation at this site may be inducing 
the expression of these genes (Reddy et al., 2009). In particular, Klf9 has been shown to respond to 
changes in GC levels. In silico GRE prediction identified a GRE within Klf9 and Klf9 mRNA levels have 
been found to be upregulated by CORT in the dentate gyrus of the rat hippocampus (Datson et al., 
2011).  
These findings are supported by the observation of high levels of GR binding in close proximity to Klf9 
within rat hippocampal tissues (Polman et al., 2013). Exposure to acute restraint stress and CORT 
treatment was shown to increase hippocampal Klf9 mRNA levels in mice, while no significant changes 
were detected following exposure to chronic restraint stress (Besnard et al., 2018). Increased Klf9 
mRNA expression was observed in DEX treated mouse liver, an effect which was attenuated following 
antagonism of GR by treatment with RU486 (Cui et al., 2019). A role for signalling between GCs, KLF15 
and branched chain amino acid signalling in spinal muscle atrophy was shown in survival motor neuron 
1 (SMN1) KO mice. The SMN1 gene encodes the survival motor neuron (SMN) protein which maintains 
motor neuron function. Skeletal muscle mRNA expression of Klf15, GRα and GRβ were dysregulated 
in SMN1-KO mice, while treatment with the GR agonist prednisolone significantly enhanced Klf15 





the effects of stress and the circadian drive on Klf expression have not been fully investigated. Presently 
it is also unclear whether genomically acting GC receptors, in particular the MR, are responsible for GC 
regulation of Klf expression.  
1.3 Glucocorticoid hormone action throughout the brain via MRs and GRs 
GC hormones elicit a broad range of physiological responses following acute stress or circadian input 
by acting on the brain. CORT freely passes the rat blood-brain barrier (BBB); a structure which functions 
to regulate the movement of compounds from the plasma circulation to the brain. Once GC hormones 
have dissociated from CBG and are freely available to penetrate tissues, they exert a diverse range of 
effects on a number of brain regions which play a role in memory, anxiety and decision making in 
response to arousing or stressful situations.  
1.3.1 Glucocorticoids and the hippocampus 
The initial discovery of GC hormones in the rodent brain identified the hippocampus, a structure shown 
to play a significant role in learning and memory (Scoville and Milner, 1957), as a GC hormone target 
(McEwen et al., 1968). The hippocampal structure consist of the DG, CA fields which are subdivided 
into four regions; CA1-4, and the subiculum (Wible, 2013). The DG of the hippocampus is of particular 
interest, as it is one of the few brain regions in which the process of “neurogenesis”, involving the 
generation of new-born neurons typically occurring during development, persists throughout adulthood 
(Kaplan and Hinds, 1977). Primarily within the subgranular zone of the DG, granule cells are born and 
migrate into the granule cell layer, where they form synaptic connections and differentiate into glial cells 
or neurons (Cameron et al., 1993). The sensitivity of the hippocampus to stress is not surprising given 
the high degree of MR and GR co localisation in this brain region. The highest concentrations of MRs 
are typically found within the DG, dorsal subiculum, CA1 and CA2 subfields while the highest levels of 
GRs are found in the lateral septum, DG and CA3 (Herman et al., 1989, Reul and de Kloet, 1985, Van 
Eekelen et al., 1988). 
GC hormone action, via hippocampal MRs and GRs, has been shown to regulate hippocampal gene 
expression, development, neurogenesis, morphology and hippocampal-dependent learning and 
memory. Furthermore, hippocampal-dependent learning has been shown to enhance neurogenesis 




















Figure 1.7 Schematic representation of the KLF transcription factor structure (a) and the 
grouping of KLF family members according to phylogeny and functional similarities (b) 
(A) Members of the KLF family exhibit a characteristic structure consisting of an N-terminal 
Activation/Repression domain, three C-terminal Zinc fingers, each chelating a single zinc ion. Each Zinc 
finger is linked by a TGERP-like motif which facilitates DNA binding. Taken from (Pearson et al., 2008). 
(B) KLFs are subdivided into three groups based on their structural characteristics and functional 
effects. Group 1 and 3 KLFs repress transcription while group 2 KLFs activate transcription. Taken from 






GC hormones exert a wide range of genomic affects within the hippocampus via MRs and GRs, with 
genome-wide changes in the transcription of many genes observed following exposure to stress. 
Exposure of rats to an acute FS stressor was shown to significantly upregulate the binding of MRs and 
GRs at responsive elements within 3 well-established GC-inducible genes; FK506 binding protein 51 
(Fkbp5), Period 1 (Per1) and Serum and glucocorticoid-regulated kinase 1 (Sgk1). Increased levels of 
hippocampal heteronuclear RNA (hnRNA) and mRNA levels of Fkbp5, Per1 and Sgk1 were also 
observed at various timepoints following exposure to FS, indicating that the binding of MRs and GRs 
may underlie these transcriptional responses (Mifsud and Reul, 2016). In a microarray study on RNA 
isolated from human hippocampal progenitor cell lines treated with high and low doses of GCs, a 
number of GC responsive genes were identified. These genes were predicted to be associated with 
signalling pathways such as Hedgehog signalling, a pathway involved in neuronal differentiation, and 
Forkhead box (FOX) O3A (FOXO3A) signalling which has been implicated in neurogenesis, depression 
and GC action (Anacker et al., 2013). The effect of chronic stress exposure on gene expression within 
the hippocampal DG was examined in rats using microarray, revealing 90 genes to be significantly 
differentially expressed. These genes were predicted to play a role in long-term potentiation (LTP) and 
long-term depression (LTD) (Datson et al., 2012). RNA-seq identified changes in gene expression within 
the hippocampus of rats exposed to a novel environment stressor daily for 2 weeks, with 15 genes 
differentially expressed in male rats and 16 genes differentially expressed in female rats. Interestingly, 
the mRNA expression of the hsp90 gene, Heat shock protein 90-alpha, was downregulated. These 
genes were predicted, by pathway analysis software, to regulate LTP (Mychasiuk et al., 2016). 
GC hormones play an important role in regulating neurogenesis within the DG, which, unlike other brain 
structures, generates the majority of its cells postnatally (Cameron et al., 1993). The period during which 
cell birth and cell death is maximal in the DG coincides with the early postnatal stress hyporesponsive 
period, which is characterised by naturally low GC levels (Gould et al., 1991a). GCs have been shown 
to regulate the rate and pattern in which granule cells are generated postnatally, with GC administration 
during the first postnatal week shown to inhibit neurogenesis (Bohn, 1980). Furthermore, increased GC 
levels during the first postnatal week was shown to decrease the density of pyknotic cells in the granule 
cell layer (Gould et al., 1991b). The effects of GC hormones on adult neurogenesis have been shown 
to vary depending on the duration and degree of exposure to GC hormones. Enhanced generation of 





(Gould et al., 1992). Exposure to physiological levels of GC hormones imposed by the circadian rhythm, 
however, was reported to have no effect on neurogenesis, while decreased cell proliferation was 
observed following exposure to persistently high GC levels (Ambrogini et al., 2002). Antagonism of the 
GR was shown to rapidly reverse the impairments in neurogenesis seen in adult rats following chronic 
GC exposure (Mayer et al., 2006). The MR and GR may have differential roles in regard to 
neurogenesis, with MR-dependent increases in proliferation and differentiation of NPCs into astrocytes 
and GR-dependent decreases in proliferation and differentiation reported following exposure of 
hippocampal progenitor cells to low and high GC levels, respectively (Anacker et al., 2013). GCs may 
also play a role in the maintenance of hippocampal structure. A steroidogenic disorder characterised 
by GC deficiency has been shown to lead to changes in hippocampal structure. The hippocampi of 
female congenital adrenal hyperplasia (CAH) patients were shown, by functional magnetic resonance 
imaging (fMRI), to exhibit lower fractional anisotropy; a measure of axonal structure integrity in the brain 
influenced by fibre density, myelination and axonal calibre (Webb et al., 2018). MRI showed a significant 
negative correlation between the hippocampal volume and the ratio of serum GC to 
dehydroepiandrosterone (DHEA) and its sulphate ester (DHEAS); hormones thought to antagonise the 
effects of GCs in the central nervous system (CNS). Moreover, in subjects with major depressive 
disorder, a significant positive correlation was observed between DHEAS levels and hippocampal 
volume (Jin et al., 2016). 
An “inverted-U” relationship has been described between GCs and learning and memory, in which low 
to moderate GC levels facilitate, while high GC levels impair learning and memory. LTP, an 
electrophysiological process involving a long-lasting enhancement of synaptic efficacy following high 
frequency stimulation of afferent fibers, is a widely used model of hippocampal memory formation and 
also exhibits an inverted-U relationship with GC levels (Diamond et al., 1992, Yau et al., 1995). This 
inverted-U relationship has led to studies reporting conflicting results regarding the effects of GC in 
tasks involving hippocampal-dependent learning and memory. Many studies have reported enhanced 
hippocampal-dependent learning and memory formation following acute exposure to moderate levels 
of GCs. Enhanced learning and memory formation following acutely stressful challenges which engage 
the hippocampus, such as FS, has been shown to depend on the presence of GC hormones (Jefferys 
and Funder, 1987, Mitchell and Meaney, 1991, Veldhuis et al., 1985, Jefferys et al., 1983). Reduced 





test (Korte et al., 1996), while hippocampal MRs have been shown to significantly increase following 
FS training (Gesing et al., 2001). Blockade of MR action, however, does not affect FS behaviour. 
Following FS, GRs have also been shown to interact with the NMDAR-activated MAPK-ERK pathway, 
allowing consolidation of long-lasting behavioural responses (Gutierrez-Mecinas et al., 2011). GC 
hormones have also been shown to play an important role in tasks involving hippocampal-dependent 
spatial learning and memory formation, including the Morris water maze (MWM) paradigm (Oitzl et al., 
1998). A positive correlation was found between antidepressant induced elevations in MR mRNA 
expression and MWM performance (Yau et al., 1995) while antagonism of MRs has been shown to 
impair spatial learning in the MWM (Yau et al., 1999). Furthermore, ADX experiments have shown that 
GCs are essential for enhancing the acquisition of associative memories following a stressful 
experience. ADX prevented hippocampal-dependent acquisition of trace conditioning and hippocampal-
independent delay conditioning (Beylin and Shors, 2003). Despite the role of GC hormones in 
hippocampal dependent memory has been widely reported, findings vary between studies. Following 
administration of exogenous cortisol, no increase in cerebral blood flow to the hippocampus was 
detected by fMRI during autobiographical memory retrieval; a type of long-term memory involving 
episodic memory and autobiographical knowledge (Fleischer et al., 2019).  
In contrast, negative effects on hippocampal-dependent learning and memory formation have been 
reported by studies examining chronic exposure to high GC levels. Exposure of rats to a potent stressor 
was shown to impair hippocampal LTP and had a negative impact on working memory (Diamond and 
Rose, 1994), while continuous blockade of the GR was shown to enhance hippocampal-dependent 
spatial learning in the MWM (Oitzl et al., 1998). Furthermore, rats exposed to single-prolonged stress  
exhibited decreased levels of hippocampal MRs and GRs, a reduced MR/GR ratio in the hippocampus 
and changes in the distribution of GR among hippocampal subregions (Zhe et al., 2008). The negative 
effects of GC hormones on learning and memory may be influenced by age, as exposure to high social 
stress was shown to induce significant spatial learning impairments in the MWM in middle aged rats, 
while young rats did not display any behavioural deficits following short-term exposure to moderate GC 
levels (Bodnoff et al., 1995). Long-term exposure to high GC hormone levels, however, was reported 
to induce cognitive deficits in young rats (Dachir et al., 1993), indicating that chronic stress may have a 





1.3.2 Glucocorticoids and the amygdala  
The amygdala, a key limbic brain region essential for adaptation to stress, is an important target of GC 
hormone action (Kolber et al., 2008), with high levels of GR expression and to a lesser extent, MR 
expression observed within the central and cortical amygdala (Reul and de Kloet, 1985). Furthermore, 
the amygdala also contains CRH nerve terminals (Uryu et al., 1992), cell bodies (Cummings et al., 
1983) and receptors (De Souza et al., 1985) and stimulation of the amygdala has been shown to 
promote the release of GC hormones, which may enhance the HPA response to behavioural stressors 
(Shepard et al., 2003). To date, no published studies have examined changes in MR and GR binding 
to GREs within the amygdala following exposure to stress, however GC hormone action has been 
shown to regulate gene expression within the amygdala. The nuclear translocation and DNA-binding of 
GRs in the amygdala has been investigated in ADX rats following treatment with low, intermediary and 
high doses of CORT. Intermediate and high doses of CORT significantly increased the nuclear 
translocation of the GR within the amygdala, while DNA binding was significantly increased by a high 
dose of CORT (Spiga and Lightman, 2009). Many studies have reported changes in gene expression 
in the amygdala following exposure to stress. Exposure of rats to a single restraint stress was shown 
to result in the differential mRNA expression of over 600 genes and the differential protein expression 
of over 200 proteins within the basolateral nucleus of the amygdala (BLA), including proteins known to 
regulate intracellular stress responses (Sillivan et al., 2019). Daily chronic restraint stress for 2 weeks 
resulted in the differential expression of 125 genes in the amygdala which were predicted to be 
associated with Huntington’s disease (Andrus et al., 2012). The mRNA expression levels of GABAergic 
marker genes glutamic acid decarboxylase (GAD) 65 and GAD67, neuropeptide Y (NPY), somatostatin 
(SST) and cholecystokinin (CCK) were increased in the BLA of water exposed stress rats compared 
with rats undergoing MWM training. Stress has been shown to modulate GABAergic signalling within 
the BLA, while NPY, SST and CCK encode neuropeptides expressed within hippocampal subregions 
involved hippocampal-dependent spatial learning (Hadad-Ophir et al., 2014). In a mouse model of 
PTSD, induced by chronic foot shock fear conditioning, over 1000 genes were differentially expressed 
in the amygdala, including genes predicted to be related to nervous system development, neurogenesis 





Following a stressful or emotionally arousing experience, GC hormones act on the amygdala to promote 
memory consolidation (Roozendaal et al., 2009) by interacting with the amygdalar noradrenergic 
system (Roozendaal et al., 1999). The memory enhancing effects of GC hormones are believed to 
occur as a result of the amygdala modulating memory storage processes in other brain regions 
(McGaugh et al., 1996). Training known to involve the amygdala induces the expression of 
transcriptionally regulated genes implicated in synaptic plasticity in brain areas including the 
hippocampus, striatum and cortex. (McGaugh, 2004). Furthermore, the amygdala may modulate 
hippocampal function in response to stress (Kim et al., 2001) and has been shown to interact with the 
hippocampus via direct and indirect projections (McGaugh, 2004). The amygdala has been shown to 
play an important role in the regulation of hippocampal LTP, as studies have reported lesions of the 
BLA to attenuate LTP within the DG (Ikegaya et al., 1994). In addition to blocking stress effects on 
hippocampal LTP, amygdalar lesions were also found to block stress effects on hippocampal-
dependent memory formation (Kim et al., 2001). Acute stress has been shown result in changes in the 
functional connectivity within the amygdala. fMRI of stress responsive humans revealed enhanced 
resting state functional connectivity within the amygdala during stress exposure, in addition to increased 
connectivity between the amygdala and the hippocampus during the stress recovery period (Quaedflieg 
et al., 2015).  
Many studies have examined the role of GC hormone action within the BLA which plays a role in the 
acquisition and consolidation of fear memory and the central nucleus of the amygdala (CeA), which 
plays a role in the expression of autonomic and behavioural correlates of conditioned fear (Kolber et 
al., 2008). Administration of a GR agonist to the BLA was shown to enhance memory retention following 
an inhibitory avoidance task, while treatment with a GR antagonist impaired memory within the MWM 
(Roozendaal and McGaugh, 1997). This GC-induced enhancement of memory-consolidation via the 
BLA may also involve GR action within noradrenergic cell groups of the nucleus of the solitary tract 
(NTS) of the brain stem, via noradrenergic projections from the NTS to the amygdala (McGaugh, 2004). 
Administration of a GR agonist to the NTS enhanced retention performance in inhibitory avoidance 
training, an effect which was blocked by, antagonism of β-adrenergic activity within the BLA 
(Roozendaal et al., 1999). Fewer studies have examined GC hormone action on the CeA, however 
conditioned fear (Thompson et al., 2004) and GC treatment (Shepard et al., 2000) have been shown to 





attributed to GRs, as GR deletion in the CeA of mice has been shown to prevent the development of 
fear conditioning behaviour (Kolber et al., 2008). Stereotaxic delivery of GCs to the amygdala was 
shown to enhance GC production in response to a behavioural stressor, without altering plasma GC 
concentrations in non-stressed rats (Shepard et al., 2003). Activation of both the BLA and CeA has 
been demonstrated by fMRI of mice following exposure to learned aversive stimuli. Mice were 
conditioned to associate a conditioned stimulus (flashing light) with foot shock, leading to enhanced 
activation of the amygdala compared with mice receiving unpaired foot shock and flashing light 
exposure (Harris et al., 2015).  
1.3.3 Glucocorticoid and neocortical regions 
GC hormones also act upon neocortical regions via MRs and GRs, such as the PFC and neocortex, 
key brain regions involved in regulating cognition and emotion (Yuen et al., 2009). The PFC plays a role 
in processing of emotional stimuli (Cerqueira et al., 2007) and translating stressful emotional information 
into action (McKlveen et al., 2013) and many studies have demonstrated the region to be strongly 
influenced by stress. The neocortex is critical for cortical memory consolidation (Wiltgen et al., 2004) 
and in contrast to the hippocampus, amygdala and PFC, the effects of GCs on the neocortex have not 
been as extensively studied.  
The PFC comprises several functionally distinct areas, however the mPFC appears to be particularly 
involved in memory retrieval and consolidation (Preston and Eichenbaum, 2013) and MRs and GRs are 
expressed in this region (Diorio et al., 1993). Changes in gene expression within the PFC have been 
observed following exposure to stress, however the binding of MRs and GRs to GREs within the PFC 
has not been extensively examined. One study has, however, investigated the changes in nuclear 
translocation and GRE binding of GRs in the PFC of the rat following stress and circadian influences. 
During the circadian rise and following exposure to acute restraint stress, western blot demonstrated 
increased nuclear GR within the PFC, while a gel shift assay demonstrated increased GR binding to a 
32P-labelled GRE sequence within the PFC (Kitchener et al., 2004). Nuclear translocation and DNA-
binding of the GR in the PFC of ADX rats was also shown to increase following rises in GC levels. 
Intermediate and high doses of CORT significantly increased the nuclear translocation of the GR within 
the PFC, while DNA binding was significantly increased by a high dose of CORT (Spiga and Lightman, 





between GC receptor binding and changes in gene expression has not been evaluated. RNA-seq 
identified changes in gene expression within the mPFC in rats exposed to a novel environment stressor 
daily for 2 weeks, with 8 genes differentially expressed in male rats and 17 genes differentially 
expressed in female rats. These genes were predicted, by pathway analysis software, to upregulate 
processes such as LTP and participate in corticotrophin releasing hormone signalling (Mychasiuk et al., 
2016). Exposure to chronic mild stress was also shown to alter the expression of genes involved in the 
circadian clock, which are collectively termed clock genes, with increased mRNA levels of Brain and 
Muscle ARNT-Like 1 (Bmal1) and decreased mRNA levels of Cryptochrome 2 (Cry2) and Period 2 
(Per2) shown in the PFC of rats exposed to a chronic stress regime for 7 weeks (Calabrese et al., 2016). 
Acute stress has also been shown to mediate the expression of genes involved in synaptic plasticity 
and dendritic spine architecture within the PFC. Rats exposed to acute foot shock for 7 days exhibited 
increased mPFC mRNA levels of SH3 And Multiple Ankyrin Repeat Domains 1 (Shank1), a member of 
the Shank family of scaffolding proteins found at the post-synaptic density of glutamatergic synapses. 
14 days of exposure to foot shock decreased PFC mRNA levels of the scaffolding protein Homer 
Scaffold Protein 3 (Homer3) and Cofilin 1 (CFL1) (Nava et al., 2017).  
Alongside the hippocampus and hypothalamus, the PFC plays a role in the negative feedback of the 
HPA axis (Mizoguchi et al., 2004), and lesions of the cingulate gyrus region of the mPFC have been 
shown to increase plasma levels of ACTH and GCs following restraint stress (Diorio et al., 1993). 
Studies have demonstrated GC action in the PFC to exert both positive and negative influences on 
memory formation, depending on the type of exposure. Exposure to acute stress enhanced 
performance on a behavioural task involving PFC-mediated working memory (Yuen et al., 2009) while 
chronic stress impaired working memory, via a mechanism involving dopaminergic neurotransmission 
in the PFC (Mizoguchi et al., 2004). Some level of GC hormones are required for enhancement of 
memory within the PFC, however, as complete removal of GCs by ADX was been shown to impair 
working memory (Mizoguchi et al., 2004). The effects of GC hormone action on memory consolidation 
via the PFC may be mediated by interactions between the PFC and the hippocampus. The mPFC is 
connected to the hippocampus via axonal projections originating in the hippocampal subiculum and 
ventral CA1 subfields terminating in the pyramidal cells and interneurons of the mPFC (Jay and Witter, 
1991) and synaptic activity within the hippocampal-mPFC circuitry has been shown to regulate learning 





induce LTP within the PFC via glutamatergic projections from the CA1 to the prelimbic area of the PFC. 
Exposure to an acute inescapable stress was shown to completely inhibit hippocampal-PFC LTP within 
the prelimbic PFC, an effect which was abolished by antidepressant pre-treatment (Rocher et al., 2004). 
Within the PFC, acute stress was shown to impair spatial memory in the radial arm water maze, a 
hippocampal-dependent memory task and reduce levels of neural cell adhesion molecule; a cell-surface 
glycoprotein implicated to play a critical role in memory formation and the induction of hippocampal LTP 
(Sandi et al., 2005).  
Acute and chronic stress have been shown to induce changes in the morphology of neurons within the 
mPFC. Daily exposure to a mild stressor for 1 week was sufficient to significantly alter the dendritic 
morphology of layer II-III pyramidal neurons in the mPFC (Brown et al., 2005). Furthermore, exposure 
to daily restraint stress for 3 weeks produced a decrease in branch number and length of the apical 
dendrites of layer II-II pyramidal neurons in the mPFC (Cook and Wellman, 2004). Significant apical 
dendritic retraction and spine loss was reported in callosal neurons of the infralimbic and prelimbic PFC 
following exposure of rats to daily restraint stress for 3 weeks (Luczynski et al., 2015). Exposure to 
changes in cortisol has been shown to result in changes in activity within the anterior mPFC (amPFC). 
Following administration of hydrocortisone, a significant increase in the blood oxygenation level 
dependent (BOLD) response was seen by fMRI within the amPFC during AM retrieval (Fleischer et al., 
2019).   
In contrast with the PFC, very little information is available regarding GC hormone action within the 
neocortex, however evidence suggests MRs and GRs may influence gene expression in this brain 
region following exposure to stress. Microarray analysis of neocortical tissue from mice exposed to 
acute immobilisation stress and treated with a gamma aminobutyric acid (GABA) subunit A (GABAA) 
inhibitor revealed differential RNA expression of 7 genes, including upregulated expression of Fos 
(Kurumaji et al., 2008), a marker of neuronal activation commonly upregulated following exposure to 
stress (Chandramohan et al., 2008). Exposure of rats to immobilisation stress significantly reduced 
mRNA levels of the highly expressed brain neurotrophin, Bdnf, in the rat neocortex. BDNF regulates 
processes such as cell survival and differentiation and decreased expression associated with age-
related memory deficits (Park et al., 2009). Stress may also influence neurogenesis of the neocortex 





within the neocortex, a reduced number of GABAergic progenitors within the neocortex and decreased 
expression of transcription factors which regulate interneuron migration, such as Distal-Less Homeobox 
2 (dlx2), NK2 Homeobox 1 (nkx2.1) and their downstream target Erb-B2 Receptor Tyrosine Kinase 4 
(erbb4). 
 
1.4 Rationale, hypotheses, aims and objectives 
1.4.1 Rationale 
Previous work in the Reul laboratory has shown significantly upregulated binding of MRs and GRs to 
GREs within well-known GC-target genes during the circadian rise in GC levels or following exposure 
to an acute stressor (Mifsud and Reul, 2016). Strong evidence was also provided which supports 
heterodimerisation formation between MRs and GRs at these GREs. Furthermore, hnRNA and mRNA 
levels of these genes are also shown to increase significantly under these conditions, indicating the 
binding of MRs and GRs may be exerting transcriptional activation of the corresponding genes. 
Although the regulation of gene expression by MRs and GRs has been examined within the 
hippocampus, a comprehensive in vivo investigation into the genome-wide binding of both MRs and 
GRs in the brain and associated transcriptional responses remains to be undertaken.  
GC hormones have been associated with a wide range of processes in the brain, including learning and 
memory, neurogenesis, neuronal morphology and the pathophysiology of neuropsychiatric disorders. 
Some studies have established a link between the genomic actions of MRs and GRs with these 
processes in the brain and have identified GC target genes which may be involved; however, these 
studies have been limited to investigating a handful of genes at a time and provide little insight into what 
is happening at the network level. Pathway analysis of the genome wide targets of MRs and GRs and 
the transcriptomic wide responses following acute stress or circadian input may provide insight into how 
networks of GC hormone target genes influence processes such as learning and memory or the 
development of stress related neuropsychiatric disorders such as depression and PTSD.   
Following elevations in GC hormone levels during the acute stress response or by circadian input, MR 
and GR binding to GREs has been associated with changes in RNA expression of nearby genes. It is 





observed in these genes. The effects of suppressing GC hormone action or antagonising GR hormone 
receptors on RNA expression has hardly been examined.   
GC hormones have been shown to act upon many brain regions, such as the amygdala, PFC and 
neocortex, however very few studies have investigated the genomic actions of MRs and GRs in these 
tissues. It is presently unknown whether MRs and GRs regulate gene expression in these brain regions, 
following exposure to acute stress or under circadian conditions, as seen in the hippocampus. The KLFs 
have been identified as GC-target genes and are shown to play important roles in processes such as 
differentiation and development, however their regulation by MRs and GRs has not been studied 
extensively.  
1.4.2 Hypotheses  
Based on the rationale, the hypothesis of this work was that following elevations in levels of circulating 
CORT, MR and GR binding to GREs within the genome will increase significantly. This will be 
accompanied by changes in RNA levels of the corresponding gene. The MR and GR binding pattern 
will differ depending on whether CORT was induced by stress or circadian input and will lead to 
activation or suppression of specific groups of genes with differential functions linked with the stress 
response or the circadian rhythm.  
Based on the overarching hypothesis, the additional sub-hypotheses were formulated: 
1. A subset of regions will show overlapping MR and GR binding supporting heterodimerisation 
formation, while certain regions of the genome will be exclusively bound by the MR or the GR.   
2. Pathway analysis will predict a link between MR and GR bound genes and numerous 
physiological processes in the brain and will reveal distinct signalling pathways, diseases and 
functions associated with either receptor.  
3. Inhibiting the synthesis and secretion of CORT in the rat, pharmacologically with metyrapone 
and surgically by ADX, will prevent the binding of MRs and GRs to GREs and subsequent 
changes in RNA expression.  
4. Antagonising MRs and GRs, with Spironolactone or RU486, will prevent interactions between 






5. MRs and GRs bind to responsive elements within KLF genes under circadian conditions and 
following exposure to acute stress, within the hippocampus, amygdala, PFC and neocortex. 
RNA expression of genes exhibiting significant MR or GR binding will increase significantly. 
 
1.4.3 Aim and objectives 
The overall aim of this thesis was to investigate the genome-wide changes in MR and GR binding and 
the associated transcriptional responses the rat hippocampus under circadian conditions and following 
exposure to acute stress. Furthermore, the binding of MRs and GRs to overlapping or distinct regions 
of the genome was to be examined, to determine whether the receptors act largely in parallel or whether 
they regulate specific subsets of genes alone.  
The main objectives of this PhD study were as follows; 
1. To identify genomic regions which are significantly bound by MRs and GRs following acute 
stress and under circadian rise conditions, and to determine whether this binding is upregulated 
or downregulated in comparison to the circadian trough. 
2. To establish an extensive time course of transcriptome-wide RNA expression following acute 
stress, cross-correlating MR and GR binding at GREs with changes in RNA expression. 
3. To predict downstream pathways, diseases and functions affected by the genes becoming 
bound by MRs and GRs or exhibiting differential RNA expression following acute stress or the 
circadian rise. 
4. To observe the effects of the removal of endogenous CORT, prevention of CORT synthesis 
and the pharmacological antagonism of the MR and GR on the binding of MRs and GRs at 
GREs and the RNA expression of GC target genes. 
5. To investigate the genomic action of MRs and GRs in the hippocampus, amygdala, prefrontal 






Chapter 2 Materials and Methods 
2.1 Animals  
For all animal experiments, adult male Wistar rats (150-200g on arrival) were purchased from Envigo 
(formerly known as Harlan (Oxon, UK)) and group-housed (2-3 per cage). Rats were housed under 
standard lighting (lights on 05:00– 19:00 h, approximately 80-100 Lux) and environmentally controlled 
conditions (temperature 21 ± 1 °C; relative humidity 40–60%) with food and water available ad libitum. 
Rats were randomly assigned to cages and these were labelled randomly to avoid subjective bias. All 
rats were handled daily for at least 5 days prior to experimentation to reduce non-specific handling 
stress on the day of the experiment. All animal work was approved by the University of Bristol Ethical 
Committee and the Home Office of the United Kingdom (Animal Scientific Procedures Act, 1986, UK) 
and under the Project Licences held by Johannes Reul  (Ref: P396EB569), protocol 1: “Molecular and 
cellular changes in stressful behavioural models” and protocol 2: “Elucidation of the mediators involved 
in the molecular and cellular changes in stressful behavioural models”, severity category; moderate.  
 
2.2 Stress procedures 
Stress procedures were carried out with the assistance of Miss Emily Price. Baseline rats were killed 
straight from their home-cages between either 7-9am (circadian trough, ‘baseline AM’ (BLAM)) or 5-
7pm (circadian peak, ‘baseline PM’ (BLPM)). Alternatively, rats were forced to swim for 15 min in 25°C 
(±1) water in individual glass beakers (height 35 cm, diameter 21.7 cm), towel dried, returned to their 
home cage and killed at various timepoints after the start of forced swimming (FS). Rats were 
decapitated following quick isoflurane anaesthesia (<10sec). 
 
2.3 Drug treatment 
All drugs and chemicals were purchased from Sigma (Dorset, UK) unless stated otherwise. To block 
MR- and GR-mediated effects, rats were voluntarily dosed with the MR antagonist spironolactone or 
the GR antagonist RU486 (Mifepristone). All rats underwent a 5-day acclimatisation period in which a 




the home cage bars. Once the rat approached, the experimenter pushed down gently on the syringe, 
allowing the rats to drink the mixture voluntarily. The advantage of this method is that the rat does not 
need be touched or restrained which would cause stress for the animal. On the day of the experiment, 
1ml syringes containing vehicle (50% condensed milk, 50% tap water) or the drug suspended in the 
vehicle were suspended through home cage bars. The rats consumed the contents voluntarily within 5 
minutes. Rats receiving drug suspension either received RU486 alone (30mg/kg), or a combination of 
RU486 (30mg/kg) and Spironolactone (50mg/kg).  
Metyrapone experiments were conducted by Dr Sylvia Carter with the assistance of Dr Karen Mifsud. 
In an alternative approach to block CORT-mediated effects, rats were intraperitoneally (i.p.) injected 
either once or twice at 90-minute intervals with the 11-β-hydroxylase inhibitor metyrapone (75 or 100 
mg/kg). As a control condition, the same amount of vehicle (40% poly-ethylene glycol 300 (PEG), 60% 
0.9%-saline; 1ml/kg i.p.) was injected at corresponding intervals. A full schedule for metyrapone dosing, 
FS and killing can be seen in Table 2.1, Table 2.2 and Table 2.3.  
 
2.4 Surgical procedures 
Surgical procedures were performed by Dr Karen Mifsud. To remove the endogenous source of CORT, 
a cohort of rats underwent adrenalectomy (ADX) or sham surgery. All ADX procedures were performed 
according to the latest guidelines, under aseptic conditions and with appropriate analgesia to relieve 
peri-operative pain (monitored using the rat grimace scale and other subtle pain-related behavioural 
features). All adrenalectomies were done bilaterally through two dorsolateral midflank skin and 
muscular incisions. Sham surgeries were identical to ADX except that the adrenals were not removed. 
Muscle incisions were sutured, and skin incisions were clipped with Michel suture clips. All rats were 
anesthetised with isoflurane gas during surgery. All rats that underwent ADX were allocated 5 days of 
post-surgical recovery, during which time 0.9% saline containing CORT (Sigma, UK) supplementation 
(15 mg/l) was provided in their drinking water to maintain isotonic salt levels and homeostasis of the 






2.5 Tissue dissection and storage 
Tissue dissection was performed by Professor Hans Reul. Following decapitation and removal of the 
brain, the hippocampus, amygdala, neocortex and prefrontal cortex were dissected on an ice-cold steel 
box. All tissues were snap-frozen in liquid N2 and stored at -80 °C. Trunk blood was also collected at 
the point of decapitation and stored on ice in tubes containing EDTA and aprotinin for determination of 
plasma CORT concentration. Blood samples were centrifuged at 1500 × g for 30 min to separate 
plasma, which was collected into fresh tubes and stored at -80°C until analysis. 
2.6 Radioimmunoassay  
The plasma CORT concentration in samples of rat plasma was determined using the commercial 
Corticosterone 125I Double Antibody radioimmunoassay (RIA) kit for rats and mice (MP Biomedicals, 
New York). The RIA was carried out as per the manufacturer’s instructions. Plasma samples were 
diluted using steroid diluent according to the dilution table (Table 2.4). Each sample was run in triplicate 
and standards provided in the kit were used. 50 µl of 125I-labelled corticosterone and 50 µl of anti-
corticosterone were added to 25 µl of each sample and vortexed to mix. The mixture was incubated in 
a lead-lined box for precisely 2 hrs. Once incubation time had elapsed, 125 µl precipitant solution was 
added to each sample and samples were centrifuged at 2500 x g for 15 min at 4 ºC (Eppendorf 
centrifuge, 5417R, Eppendorf, Stevenage, UK). The supernatant was aspirated to leave a precipitate. 
The samples were analysed using a WIZARD automatic gamma counter (2470 model, PerkinElmer, 
London, UK). The detection limits were 0.25 ng/ml. Inter and intra-assay variations are given individually 
in the results chapters. Inter-assay variation was calculated based on the average % coefficient of 
variation for the high standards across 5 assays. Intra-assay variation was calculated based on the 











Table 2.1 The schedule of metyrapone dosing experiments described in Chapter 7.4.3  
Rats were intraperitoneally (i.p.) injected once with metyrapone (75 or 100 mg/kg) or vehicle (40% PEG, 60% 0.9%-saline; 1ml/kg i.p). 90 minutes later, rats 










Chapter 7.4.2 Time of 1st 
injection  
0 5 10 15 20 25 30 35 - 85 90 95 100 105 110 115 120 
No injection N/A FS  Home cage Kill         
Vehicle ~8:15 - 10:45 am Injection (i.p.) FS  Home cage Kill 
Met (75 mg/kg) ~8:30 - 11:15 am Injection (i.p.) FS  Home cage Kill 






Table 2.2 The schedule of metyrapone dosing experiments described in Chapter 7.4.2  
Rats were intraperitoneally (i.p.) injected either once or twice at 90-minute intervals with metyrapone (100 mg/kg) or vehicle (40% PEG, 60% 0.9%-saline; 








Chapter 7.4.2 Time of 1st injection 0 - 50 90 - 115 120 125 - 175 180 - 205 210 
Vehicle BLAM ~8:45 - 11:15 am Injection (i.p.) Home cage Kill 
    
Vehicle FS30 ~8:00 - 11:30 am Injection (i.p.) FS Home cage Kill 
    
Met (100 mg/kg) BLAM ~8:55 – 9:05 am Injection (i.p.) Home cage Kill 
    
Met (100 mg/kg) FS30 ~8:30 - 11:00 am Injection (i.p.) FS Home cage Kill 
    
Met (2*100 mg/kg) BLAM ~9:15 - 9:30 am Injection (i.p.) Injection (i.p.) Home cage Kill 





Experiment Time (min) 
Chapter 7.4.3 Time of 1st injection 0 - 50 90 - 175 180 - 235 240 
Vehicle BLAM ~7:00 - 9:00 am Injection (i.p.) Injection (i.p.) Home cage Kill 
Vehicle FS30 ~8:00 -10:00 am Injection (i.p.) Injection (i.p.) FS  Home cage Kill 
Met (2*100 mg/kg) BLAM ~7:00 - 9:00 am Injection (i.p.) Injection (i.p.) Home cage Kill 
Met (2*100 mg/kg) FS30 ~8:00 -10:00 am Injection (i.p.) Injection (i.p.) FS  Home cage Kill 
 
Table 2.3 The schedule of metyrapone dosing experiments described in Chapter 7.4.3 
Rats were intraperitoneally (i.p.) injected twice at 90-minute intervals with metyrapone (100 mg/kg) or vehicle (40% PEG, 60% 0.9%-saline; 1ml/kg i.p). 90 
















Table 2.4 The dilution of plasma samples with steroid diluent for Corticosterone I125 Double Antibody RIA  









2.7 Chromatin immunoprecipitation 
2.7.1 Buffers for ChIP 
Formaldehyde solution with protease, phosphatase and histone deacetylase inhibitors 
1X PBS (phosphate buffered saline, Sigma-Aldrich) 
1% w/v formaldehyde solution (Sigma-Aldrich) 
0.1 mM PMSF (phenylmethanesulfonylfluoride, Sigma-Aldrich) 
5 mM NaBut (Sodium butyrate, Merck Millipore, Nottingham, UK) 
1 tablet PhosSTOP phosphatase inhibitor cocktail (Roche, West Sussex, UK)/10ml  
PBS with inhibitors 
1X PBS (Sigma-Aldrich) 
5 mM NaBut (Merck Millipore) 
1 mM Na3VO4 (Sodium orthovanadate, Sigma-Aldrich) 
0.1 mM PMSF (Sigma-Aldrich) 
1 tablet PhosSTOP phosphatase inhibitor cocktail (Roche, West Sussex, UK)/10ml 
Lysis buffer 
50 mM Tris-HCL pH 8.0 (Trizma hydrochloride, Sigma-Aldrich) 
150 mM NaCl (Sodium chloride, Sigma Aldrich) 
5 mM EDTA (Ethylenediaminetetraacetic acid, Sigma-Aldrich) 
0.5% w/v Igepal (Sigma-Aldrich) 
0.5% w/v Sodium deoxycholate (Sigma-Aldrich) 
 1% SDS (Sodium dodecyl sulphate, Sigma-Aldrich) 
5 mM NaBut (Merck Millipore) 




1 mM Na3VO4 (Sigma-Aldrich) 
1X dilution of protease inhibitor solution from Complete Ultra EDTA-free protease inhibitor tablets 
(Roche); 1 tablet per 1ml nfH20 
1 tablet PhosSTOP phosphatase inhibitor cocktail (Roche, West Sussex, UK)/10ml 
Dilution buffer with inhibitors 
50 mM Tris-HCL pH 7.4 (Sigma-Aldrich) 
150 mM NaCl (Sigma-Aldrich) 
5 mM EDTA pH 7.5 (Sigma-Aldrich) 
1% Triton (Sigma-Aldrich) 
0.1% w/v Sodium deoxycholate (Sigma-Aldrich) 
5 mM NaBut (Merck Millipore) 
1 mM AEBSF (Sigma-Aldrich) 
1X dilution of protease inhibitor solution from Complete Ultra EDTA-free protease inhibitor tablets 
(Roche) 
1 tablet PhosSTOP phosphatase inhibitor cocktail (Roche, West Sussex, UK)/10ml 
 
Dilution buffer without inhibitors 
50 mM Tris-HCL pH 7.4 (Sigma-Aldrich) 
150 mM NaCl (Sigma-Aldrich) 
5 mM EDTA pH 7.5 (Sigma-Aldrich) 
1% Triton (Sigma-Aldrich) 
0.1% w/v Sodium deoxycholate (Sigma-Aldrich) 




RIPA wash buffer with inhibitors 
10 mM Tris pH 7.5 (Sigma-Aldrich) 
1 mM EDTA pH 7.5 (Sigma-Aldrich) 
0.1% SDS (Sigma-Aldrich) 
0.5 mM EGTA (ethylene glycol tetra-acetic acid, Sigma-Aldrich) 
1% Triton (Sigma-Aldrich) 
140 mM NaCl (Sigma-Aldrich) 
Elution buffer I 
10 mM Tris pH 7.5 (Sigma-Aldrich) 
50 mM NaCl pH 7.5 (Sigma-Aldrich) 
1.5% SDS (Sigma-Aldrich) 
Elution buffer II 
10 mM Tris pH 7.5 (Sigma-Aldrich) 
50 mM NaCl pH 7.5 (Sigma-Aldrich) 
0.5% SDS (Sigma-Aldrich) 
  
2.7.2 Chromatin extraction 
Hippocampal tissue from 2 rats, amygdala tissue from 2 rats, prefrontal cortex tissue from 1 rat or 
neocortex tissue from 1 rat was cross-linked in formaldehyde solution with protease, phosphatase and 
histone deacetylase inhibitors, transferred to DNase/RNase free tubes and rotated at RT for 10 min. 
Cross-linking was terminated by the addition of 1.25 M glycine to a final concentration of 200 mM, and 
the solution was rotated for 5 min at RT and subsequently centrifuged (5 min, 6,000 × g, 4 ºC). The 




4 ºC), with ice cold PBS with inhibitors. The pellet was resuspended in 1 ml ice-cold Lysis buffer and 
rotated at 4 ºC for 15 min.  
 
2.7.3 Chromatin fragmentation 
Chromatin was fragmented by sonication using a Bioruptor (UCD-300 or Picoruptor; Diagenode, Liege, 
Belgium) at 4 °C. Hippocampal chromatin sonicated by the UCD-300 were aliquoted into 200µl aliquots 
and each aliquot was sonicated on high power for three sets of 10 cycles (30s on and 60s off). Samples 
were vortexed between each cycle. Chromatin from the hippocampus, amygdala and prefrontal cortex 
sonicated by the Picoruptor was aliquoted into 300µl aliquots and each aliquot was sonicated on high 
power for one set of 3 cycles (30s on and 30s off). Chromatin from the neocortex sonicated by the 
Picoruptor were aliquoted into 300µl aliquots and each aliquot was sonicated on high power for one set 
of 4 cycles (30s on and 30s off). Following sonication, samples were centrifuged (20,817 × g 10 min, 4 
ºC) and the supernatant containing sheared chromatin was collected. Aliquots of 200 µl were taken 
from each sample for chromatin-immunoprecipitation (ChIP) and two aliquots of 20 µl was taken from 
each sample and diluted in 280 µl of 1X Tris-EDTA (TE) (Sigma-Aldrich); one to be used as Input DNA 
and the other to be used to check the size of the sheared chromatin fragments. To check the size of 
the sheared chromatin fragments, samples were reversed by adding 5 M NaCl to the samples (to a final 
concentration of 200 mM) and incubating at 65 ºC overnight. The following day, ribonuclease A from 
bovine pancreas (Sigma-Aldrich) was added to each sample, to a final concentration of 60 µg/ml and 
incubated for 1 hr at 37 ºC. Subsequently, proteinase K from Tritirachium album (Sigma-Aldrich) was 
added to a final concentration of 250 µg/ml and incubated for 3h at 37 ºC. A QIAquick PCR purification 
kit (Qiagen) was used, as per the manufacturer’s instructions, to purify the DNA. Purified samples were 
run on a 1.5% agarose gel (w/v dissolved in TAE buffer), alongside a 100 base pair DNA ladder (NEB). 
Samples and DNA ladder were made up to a final volume of 24 µl by the addition of 10% loading buffer 
(20% Ficoll (Sigma-Aldrich), 0.1 M EDTA (Sigma-Aldrich), 1% SDS (Sigma-Aldrich), 1.5% Xylene 
Cyanol (Sigma-Aldrich)), 10% Midori green (Midori green Advance DNA stain (Nippon Genetics, 






2.7.4 Chromatin immuno-precipitation (ChIP) 
Each 200 µl aliquot of chromatin was mixed with 1,800 µl of ice-cold dilution buffer, 10 µl of antibody 
(Table 2.5) was added and the solution was rotated overnight at 4ºC. For each sample, an aliquot of 
150 µl of Protein-A coated Dynabeads (Thermo Fisher) magnetic beads was washed with 0.5% BSA in 
1X PBS using a Magna GrIPTM magnetic rack (Merck Millipore) and rotated overnight at 4ºC. The 
following day, the magnetic beads were washed once in ice-cold dilution buffer without inhibitors. 
Dilution buffer was removed from the magnetic beads and the antibody/chromatin mixture was added. 
The resultant mixture was rotated for 3 hours at 4ºC. Using the magnetic rack, the “unbound” fraction 
was separated and discarded. The beads were washed three times with ice-cold RIPA buffer with 
inhibitors and twice with ice cold 1X TE (Sigma-Aldrich). 200 µl of elution buffer I was added to the 
beads at room temperature and the mixture was vortexed for 15 min to elute the antibody-bound 
fraction. The sample was placed on a magnetic rack and the solution was collected and placed in a 
fresh tube. A second elution step was carried out at room temperature by adding 100 µl of elution buffer 
II to the beads and vortexing the mixture for 15 min. The sample was placed on a magnetic rack and 
the solution was collected and pooled with the collected solution from elution buffer I. The protein-DNA 
crosslinks were reversed by adding 5 M NaCl to the bound samples and input samples (to a final 
concentration of 200 mM) and incubating at 65 ºC overnight. The following day, ribonuclease A from 
bovine pancreas (Sigma-Aldrich) was added to each sample, to a final concentration of 60 µg/ml and 
incubated for 1 hr at 37 ºC. Subsequently, proteinase K from Tritirachium album (Sigma-Aldrich) was 
added to a final concentration of 250 µg/ml and incubated for 3h at 37 ºC. A QIAquick PCR purification 
kit (Qiagen) was used, as per the manufacturer’s instructions, to purify the DNA. Total dsDNA content 
of each sample was determined with a High-Sensitivity Qubit DNA Assay Kit (Life Technologies) as per 






 MR ChIP GR ChIP 
Chapter 3 MR H-300, sc11412x, Santa Cruz GR H-300, sc8992x, Santa Cruz 
Chapter 5 MR ab64457, Abcam GR 24050-1-AP, Proteintech 
Chapter 6 MR ab64457, Abcam GR 24050-1-AP, Proteintech 
Chapter 7 MR H-300, sc11412x, Santa Cruz GR H-300, sc8992x, Santa Cruz 
 
Table 2.5 Antibodies used for chromatin-immunoprecipitation  






2.7.5 Primers and probes for ChIP-qPCR  
Primers and dual-labeled probe with 6-Carboxyfluorescein (6-FAM) as the fluorescent dye and 
tetramethylrhodamine (TAMRA) as the quencher were designed using Primer Express software 
(version 3.0.1; Life Technologies).  Primers were designed to cover glucocorticoid responsive elements 
(GREs) identified by ChIP-seq. All primers and probes were ordered from Sigma (Dorset, UK). Primer 
and probe sets used for ChIP-qPCR are shown in Table 2.6.  
Standard curves were performed for each primer pair, and the qPCR efficiency was calculated using 
the equation E = ((10 − 1/slope) − 1) × 100 (where E is qPCR efficiency, and the slope is the gradient 
of the standard curve). Only primer pairs with efficiencies greater that 80% were used.  
 
2.7.6 Real-Time Polymerase chain reaction for DNA 
All bounds and inputs were diluted to a standardised concentration with nuclease-free water (nfH20; 
Promega) and 2 µl was added to 18 µl mastermix in a 96-well plate. Mastermix was prepared containing 
900 nM forward and reverse primers, 250 nM probe, and 1× TaqMan Fast Mastermix (Life 
Technologies) and made up to volume with nfH20 (Promega). Samples were run in duplicate. Plates 
were covered with an adhesive clear seal (Life Technologies) and spun down in a plate mini centrifuge 
prior to qPCR. qPCR was performed using a StepOne Plus Machine (Life Technologies). Taq enzymes 
were activated at 95 °C for 20 s, and then, 40 cycles of 95 °C (1 s) to 60 °C (20 s) were performed to 
amplify samples. 
A standard curve, created from 2-fold serial dilutions of rat brain genomic DNA (Biochain, CA, USA), 
was included in each qPCR run. Data are expressed as quantity of bound DNA divided by the respective 
quantity of input DNA (i.e., B/I), which is a measure of the enrichment of steroid receptor bound to 






Table 2.6 DNA primers and probe sequences used for ChIP-qPCR 
The Ensemble gene ID for each gene is shown, as well as the region where the primers and probes have been designed to span, and the primers and probe 




Ensemble gene ID  Region Forward primer sequence Reverse primer sequence Probe sequence 
Klf2 ENSRNOG00000014205 GRE TCGGGTGAGCACAGTAGTGACT TCAGGCCCCGGGAAAC CAGACTCCCCATGCATCGGTCCA 
Klf9 ENSRNOG00000014215 GRE TGCGGTGCGGACTATGTTTAG ATCCTCGAAGATCAGGAAAACCT TCATCGCGACACCCTCTACTCTGCAG 
Klf15 ENSRNOG00000017808 GRE1 TCAGGGAGGACTCTTATTTTGAAGA CCCCCATTCGCCACCCCC CATTGGGTCAGCGTGCAA 




2.8 ChIP sequencing 
Sequencing, quality control and basic bioinformatic analysis was performed by collaborators at the 
Wellcome Centre for Human Genetics, University of Oxford.  
2.8.1 ChIP seq library construction and sequencing 
DNA was quantified using Qubit (Invitrogen) and the size profile analysed on the 2200 or 4200 
TapeStation (Agilent, dsDNA HS Assay). Input material was normalised to 5 ng prior to library 
preparation. Automated library preparation was performed using the Apollo prep system (Wafergen, 
PrepX ILMN 32i, 96 sample kit) and standard Illumina multiplexing adapters following manufacturer’s 
protocol up to pre-PCR amplification. Libraries were PCR amplified (18 cycles) on a Tetrad (Bio-Rad) 
using the NEBNext® High-Fidelity 2X PCR Master Mix (NEB) and in-house (Wellcome Centre for 
Human Genetics, University of Oxford) single indexing primers (Lamble et al., 2013). Individual libraries 
were normalised using Qubit, and the size profile was analysed on the 2200 or 4200 TapeStation. 
Following normalisation, individual libraries were pooled accordingly. The pooled library was diluted to 
~10 nM for storage. The 10-nM library was denatured and further diluted prior to loading on the 
sequencer. Samples were pooled and multiplexed libraries were sequenced on 5 lanes of an Illumina 
HiSeq4000 System to generate 75 basepair (bp) paired end reads. All samples were assessed for a 
number of QC metrics, including Q30 and acceptable Passing Filter (%PF). 
 
2.8.2 Genome mapping and bioinformatic analysis of ChIP-seq data 
At least 25 million read pairs reads were produced per sample using Illumina’s bcl2fastq2 and trimmed 
to remove any multiplex PCR or index primers using Skewer (Jiang et al., 2014), with settings:  
-f sanger -x 
AGATCGGAAGAGCACACGTCTGAACTCCAGTCACNNNNNNNNATCTCGTATGCCGTCTTCTGCT
TG -y AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGCCGTATCATT -m 
pe -l 25 -r 0.1 
Adapter-trimmed reads were aligned using Burrows-Wheeler Aligner (BWA-MEM) (Li and Durbin, 2009) 




mapping quality < 20, not properly paired, or with insert size > 1000 bp were filtered out using Bamtools 
(Barnett et al., 2011). BAM files from individual sequencing lanes were merged and duplicate reads 
were removed with PICARD (http://broadinstitute.github.io/picard). The degree of enrichment for the 
proteins of interest was evaluated through the Normalised Strand Cross-correlation (NSCC) and the 
Relative Strand Cross-correlation (RSC) coefficients, which were calculated for each ChIP sample; in 
all cases, NSCC and RSC values were > 1.05 and > 0.8, respectively, in agreement with the ENCODE 
guidelines (Landt et al., 2012). To identify significantly enriched regions, the peak caller Model based 
Analysis of ChIP-seq (MACS2) (Zhang et al., 2008) was used with parameters -f BAMPE -g 2.5e9 for 
GR and MR narrow peaks. Peaks with a false discovery rate (FDR) lower than 5% were reported and 
annotated to their nearest genes (Ensembl release 81) using the Bedtools suite (Quinlan, 2014).  
The difference in binding levels between conditions - measured by differences in read densities - was 
performed using the R Bioconductor package DiffBind (version 2.4.8) (Ross-Innes et al., 2012) (Stark 
and Brown, 2011). The significantly differentially bound sites between sample groups resulting from this 
analysis were used as input to carry out known and de novo motif search using FIMO (MEME suite, 
version 4.11.2) (Bailey et al., 2015) and the position weight matrices for vertebrates from the JASPAR 
CORE database (Sandelin et al., 2004). All bioinformatic analyses were executed using in-house scripts 
written in the Python and R programming languages. 
 
2.9 RNA analysis 
2.9.1 RNA extraction  
Brain tissue was homogenised (600 rpm) in ice-cold TRI Reagent (Sigma) using a polymix homogeniser 
(polymix PX-SR 90D, Kinematica Ag, Littau-Luzern, Switzerland). The homogenate was transferred to 
a DNase/RNase-free tube and placed on ice. All samples were centrifuged at 12,000 × g for 10 min at 
4 ºC to remove insoluble material. The supernatant was transferred to a fresh tube and allowed to stand 
for 5 min at room temperature. 100 µl of 1-bromo-3-chloropropane (Sigma-Aldrich) was added to each 
sample and shaken vigorously for 15 seconds before allowing to stand for 15 min at room temperature. 
The resulting mixture was centrifuged at 12,000 × g for 10 min at 4 ºC to separate the mixture into three 
phases; a lower red organic phase (containing protein), an interphase (containing DNA), and a 




to a fresh tube and 500 µl 2-propanol (Sigma-Aldrich) was added. Samples were mixed, allowed to 
stand for 10 min then centrifuged at 12,000 × g for 10 min at 4 ºC. The RNA precipitate formed a pellet 
at the bottom of the tube. The supernatant was removed, and the RNA pellet was washed by adding 1 
ml of 75% ethanol (Sigma-Aldrich) and centrifuging at 12,000 × g for 5 min at 4 ºC. The pellet was 
washed with ethanol once more. The ethanol was then removed, and the pellet left to air dry for 20-30 
min before adding 50 µl 1X TE (Sigma-Aldrich). The sample was then heated at 60 ºC for 10 minutes 
to facilitate dissolution.  
 
2.9.2 Reverse Transcription 
The RNA was quantified using a NanoPhotometer P300 (Implen, Germany). Total RNA (3µg) was 
reverse transcribed into cDNA using the QuantiTect Reverse Transcription Kit (Qiagen, Manchester, 
UK) as per the manufacturer’s instructions. 4 µl of 7 x gDNA wipeout buffer was added to 3 µg of each 
RNA sample in 24 µl nfH20. Samples were placed in a BioRad T1000 Thermal Cycler (Bio-Rad, 
Hercules, CA, USA), incubated at 45 ºC for 2 min and then held at 4 ºC. An RNA reverse-transcription 
reaction mix was made up using 2 µl Quantiscript reverse transcriptase, 8 µl Quantiscript RT buffer 5x, 
2 µl RT primer mix per reaction. 12 µl of the mix was added to each sample, and samples were 
incubated at 42 ºC for 15 min then 95 ºC for 5 min and finally held at 4 ºC. The resultant cDNA was 
diluted fourfold in nfH20 and stored at -20 ºC. 
 
2.9.3 Primers and probes for RNA-qPCR 
Primers and dual-labeled probe with 6-Carboxyfluorescein (6-FAM) as the fluorescent dye and 
tetramethylrhodamine (TAMRA) as the quencher were designed using Primer Express software 
(version 3.0.1; Life Technologies). All primers and probes were ordered from Sigma (Dorset, UK). 
Primer and probe sets used for RNA-qPCR are shown in Table 2.7 for hnRNA and Table 2.8 for mRNA. 
Standard curves, created from 2-fold serial dilutions of rat brain cDNA (BioChain, CA, USA), were 
performed for each primer pair, and the qPCR efficiency was calculated using the equation E = ((10 − 
1/slope) − 1) × 100 (where E is qPCR efficiency, and the slope is the gradient of the standard curve). 






Table 2.7 hnRNA primers and probe sequences for RNA-qPCR 
The Accession number of each gene, the primers and probe sequences and the efficiency of each primer/probe set is shown. Primers were designed to the 









Forward primer sequence Reverse primer sequence Probe sequence Efficiency 
(%) 
CyPA NM_017101.1 AGCATACAGGTCCTGGCATCTT CTTTCAACTGATCCATTCATTTTTTC CATGGCAAATGCTGGACCAAACACAAA 90% 
Hprt1 NM_012583.2 TGTGCTTGCAGACCAAATACTCTTA CGTGGATCAAGACGAGACATTG CCACTGAGTCACCTCCCCAATGCC 90% 
Klf2  NM_001007684.1 ACCAACTGCGGCAAGACCTA CTGAACTCGCTCCCATCCAT CGCCTGGCCTCACTCCCCG 94% 
Klf4 NM_053713.1 GCGGGAAGGGAGAAGACACT CCCCATCTGCAGAAATCTAAAGG CGTCCAGCAGGTGCCCCGA 90% 
Klf9 NM_057211.1 TGTTATGTCCTGGTTTCCTTCTCTT CGAGCGCGAGAACTTTTTAAG TCCCCTGCACGTGGCCAGACT 91% 
Klf15 NM_053536.1 TGGCACTGGCTTTGAAGTCA AACTCATCTGAGCGTGAAAACCT CCCACGATGGCCTGGCTGACC 94% 








Forward primer sequence Reverse primer sequence Probe sequence Efficiency 
(%) 
Gapdh NM_017008.4 AAGAGAGAGGCCCTCAGTTGCT ATTGTGAGGGAGATGCTCAGTGT AGTCCCCATCCCAACTCAGCCCC 90% 
Hprt1 NM_012583.2 CCTCCTCAGACCGCTTTTCC CATAACCTGGTTCATCATCACTAATCA CATGTCGACCCTCAGTCCCAGCG 95% 
Klf2  NM_001007684.1 TGAGAAGCCTTATCATTGCAACTG CCGTGTGCTTGCGGTAGTG CGCGCGCTCTGACGAGCTTACC 93% 
Klf4 NM_053713.1 GGCCCAGCTACCCTCCTTT GGATCCCGGTGGCATGA TGCCAGACCAGATGCAGTCGCAA 98% 
Klf9 NM_057211.1 CCATTACAGAGTGCATACAGGTGAA CGAGCGCGAGAACTTTTTAAG CCTTCCCCTGCACGTGGCCA 100% 
Klf15 NM_053536.1 GCTGCGGCTGGAGGTTTT TTCACACCCGAGTGAGATCGT CGCTCAGATGAGTTGTCACGGCACC 101% 
Rpl10a NM_031065.1 GAAGAACTACGACCCTCAGAAGGA AGGACGCACACGGAGAACTT AAACGCTTCTCGGGCACCGTCA 94% 
Ywhaz NM_013011.3 TGCTGCTGGTGATGACAAGAA CATCTCCTTTTTGCTGATTTCAAA TGGACCAGTCACAGCAAGCATACCAAGAA 99% 
 
Table 2.8 mRNA primers and probe sequences for RNA-qPCR 
The Accession number of each gene, the primers and probe sequences and the efficiency of each primer/probe set is shown. Primers were designed to the 








2.9.4 Real-time polymerase chain reaction for cDNA 
2 µl cDNA was added to 18 µl mastermix in a 96-well plate. Mastermix was prepared containing 900 
nM forward and reverse primers, 250 nM probe, and 1× TaqMan Fast Mastermix (Life Technologies) 
and made up to volume with nfH20 (Promega). Plates were covered with an adhesive clear seal (Life 
Technologies) and spun down in a mini centrifuge prior to qPCR. Samples were run in duplicate and 
expression of RNA was calculated based on the Pfaffl method of relative quantification (Pfaffl, 2001) 
standardised to the expression of housekeeping genes (Table 2.9). qPCR was performed using a 
StepOne Plus Machine (Life Technologies). Taq enzymes were activated at 95 °C for 20 s, and then, 
40 cycles of 95 °C (1 s) to 60 °C (20 s) were performed to amplify samples. 
 
2.9.5 Selection of reference genes 
One or more of the reference genes hypoxanthine phosphoribosyltransferase 1 (Hprt1) and tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein, zeta (Ywhaz), Glyceraldehyde 3-
phosphate dehydrogenase (Gapdh), Ribosomal protein L10a (Rpl10a), Cyclophilin A (CyPA) were used 
to standardise RNA expression within the hippocampus (Figure 2.1), amygdala (Figure 2.2), prefrontal 
cortex (Figure 2.3) and neocortex (Figure 2.4). The data were expressed as fold change over baseline. 















Table 2.9 Reference genes selected to normalise RNA levels within each brain region 





 Brain Region Reference genes 
Chapter 5 
 
Hippocampus Hprt1 and Ywhaz  
Amygdala Hprt1 and Gapdh  
Prefrontal cortex Hprt1 and Ywhaz  
Neocortex Rpl10a and CyPA  
Chapter 6 Hippocampus – RU/SPIRO Hprt1 and Gapdh  
Hippocampus – ADX  Hprt1 and Ywhaz  
Chapter 7 Hippocampus – MET Hprt1 and Ywhaz  





Figure 2.1 Hippocampal and Amygdala RNA CT values of reference genes Hprt1, Ywhaz and 
Gapdh 
CT values from hippocampal (A-B) and amygdala (C-D) RNA samples for housekeeping genes Hprt1, 
Ywhaz and Gapdh. Rats were killed directly from their home cage under early baseline conditions 
((~7:00 am), BLAM), 30 min (FS30), 60 min (FS60) or 120 min (FS120) following forced swimming or 
under late baseline conditions ((~5:00 pm), BLPM). RNA was extracted from the hippocampus and 
amygdala and reverse transcribed to cDNA. qPCR was carried out using dual-labelled primers and 
probes designed to amplify the reference genes shown. CT values of reference genes were used to 
normalise the expression of genes of interest using the Pfaffl method. Statistical analysis; One-way 
ANOVA (A) F (4, 39) = 0.8285, p = 0.5152, (B) F (4, 39) = 0.3995, p = 0.8106, (C) F (4, 40) = 2.285, p = 0.0769, 










Figure 2.2 PFC and Neocortex RNA CT values of reference genes Hprt1, Ywhaz, Rpl10a and 
CyPA  
CT values from PFC and neocortex RNA samples for housekeeping genes Hprt1, Ywhaz, Rpl10a and 
CyPA. Rats were killed directly from their home cage under early baseline conditions ((~7:00 am), 
BLAM), 30 min (FS30), 60 min (FS60) or 120 min (FS120) following forced swimming or under late 
baseline conditions ((~5:00 pm), BLPM). RNA was extracted from the PFC and neocortex and reverse 
transcribed to cDNA. qPCR was carried out using dual-labelled primers and probes designed to amplify 
the reference genes shown. CT values of reference genes were used to normalise the expression of 
genes of interest using the Pfaffl method. Statistical analysis; One-way ANOVA (A) F (4, 40) = 1.442, p = 












Figure 2.3 Hippocampal RNA CT values of reference genes Hprt1 and Gapdh of rats treated with 
SP and RU 
CT values from hippocampal RNA samples for housekeeping genes Hprt1 (A) and Gapdh (B). Rats 
were voluntarily dosed with vehicle, a combination of SP (50 mg/kg) and RU (30mg/kg) or RU only 
(30mg/kg). Baseline rats were killed 120 minutes after voluntary dosing under early baseline conditions 
(~7:00 am (BL)). Stressed rats were voluntarily dosed 60 minutes before the onset of FS and killed 60 
min after the start of FS (15 min, 25 °C water). RNA was extracted from the hippocampus and reverse 
transcribed to cDNA. qPCR was carried out using dual-labelled primers and probes designed to amplify 
the reference genes shown. CT values of reference genes were used to normalise the expression of 
genes of interest using the Pfaffl method. Statistical analysis; One-way ANOVA (A) F (5, 41) = 0.8563, p 
















Figure 2.4 Hippocampal RNA CT values of reference genes Hprt1 and Ywhaz of rats undergoing 
sham or ADX surgery 
CT values from hippocampal RNA samples for housekeeping genes Hprt1 (A and D) and Ywhaz (B and 
C). Rats underwent sham surgery or ADX and 1 week later, alongside an intact group, were killed under 
early baseline conditions (~7:00 am (BL)) or 60 min after the onset of FS (15 min, 25 °C water). RNA 
was extracted from the hippocampus and reverse transcribed to cDNA. qPCR was carried out using 
dual-labelled primers and probes designed to amplify the reference genes shown. CT values of 
reference genes were used to normalise the expression of genes of interest using the Pfaffl method. 
Statistical analysis; One-way ANOVA (A) F (5, 29) = 2.243, p = 0.0767, (B) F (5, 29) = 1.683, p = 0.1702, 











Figure 2.5 Hippocampal RNA CT values of reference genes Hprt1 and Ywhaz of rats injected with 
vehicle or metyrapone 
CT values from hippocampal RNA samples for housekeeping genes Hprt1 (A and D) and Ywhaz (B and 
C). Rats were injected twice with vehicle or MET (100mg/kg) 90 minutes before the onset of FS, with a 
90-minute interval between injections. Rats were killed 60 min after the start of FS (15 min, 25 °C water). 
RNA was extracted from the hippocampus and reverse transcribed to cDNA. qPCR was carried out 
using dual-labelled primers and probes designed to amplify the reference genes shown. CT values of 
reference genes were used to normalise the expression of genes of interest using the Pfaffl method. 
Statistical analysis; One-way ANOVA (A) F (3, 20) = 1.544, p = 0.2342, (B) F (3, 20) = 1.26, p = 0.3148, (C) 








2.10 RNA sequencing 
2.10.1 RNA-seq library construction and sequencing 
RNA was quantified using RiboGreen (Invitrogen) on the FLUOstar OPTIMA plate reader (BMG 
Labtech) and the size profile and integrity analysed on the 2200 or 4200 TapeStation (Agilent, RNA 
ScreenTape). RIN (RNA integrity number) estimates for all samples were between 7.4 and 8.5. Input 
material was normalised to 1 g prior to library preparation. Total RNA was depleted of ribosomal RNA 
using Ribo-Zero rRNA Removal Kit (Epicentre/Illumina, Human/Mouse/Rat) following manufacturer’s 
instructions. Library preparation was completed using TruSeq Stranded Total RNA kit (Illumina) 
following manufacturer’s instructions. Libraries were amplified (15 cycles) on a Tetrad (Bio-Rad) using 
in-house unique dual indexing primers (Lamble et al., 2013). Individual libraries were normalised using 
Qubit, and the size profile was analysed on the 2200 or 4200 TapeStation. Individual libraries were 
normalised and pooled together accordingly. The pooled library was diluted to ~10 nM for storage. The 
10 nM library was denatured and further diluted prior to loading on the sequencer. Paired-end 
sequencing was performed using a HiSeq4000 75bp platform (Illumina, HiSeq 3000/4000 PE Cluster 
Kit and 150 cycle SBS Kit), generating a raw read count of >45 million reads per sample. 
 
2.10.2 Genome mapping and bioinformatic analysis of RNA-seq data  
Quality control analysis was performed on data generated from individual samples as per ChIP (see 
above). RNA-Seq read pairs were aligned to Rattus norvegicus reference genome, Rnor_6.0 using a 
splice-aware aligner, Hisat2 version-2.0.4 (Kim et al., 2015). Gene annotation files were downloaded in 
GTF format from Ensembl, release 81 (Cunningham et al., 2015). GTF files with intron coordinates were 
prepared by subtracting annotated exon features from full-length transcripts using subtractBed 
implemented in Bedtools suite v2.26.0. Read fragments mapping to annotated exon features, or intron 
features were separately quantified to obtain exon, or intron count tables, respectively.  All reads were 
counted with featureCounts (Liao et al., 2014), part of subread-v1.5.0 (Liao et al., 2013), using the 
specified parameters ("-M" "-O" "--fraction" "-p"). Values for duplication rates and median 3’ bias were 




(https://broadinstitute.github.io/picard/), respectively. Normalised read counts and count based metrics 
were obtained using in-house R scripts (Team, 2014), R core tools, v 3.1.0.  
Differentially expressed genes were identified for each comparison using edgeR v3.20.4 (McCarthy et 
al., 2012, Robinson et al., 2010), R core tools, v3.4.2. Each comparison was analysed separately using 
subsets of the exon and intron count tables. First, the count tables were selected to samples of interest 
and expressed genes, keeping genes with greater than 10 reads in each biological replicate in a group. 
Then, count table subsets were normalised, and data were fit using generalised linear models as 
implemented in edgeR. Normalised fitted expression values were tested for differential expression 
between groups using likelihood ratio tests, and finally corrected for multiple comparisons using 
Benjamini-Hochberg correction to control the FDR; the probability of type II error (Benjamini and 
Hochberg, 1995). One biological replicate from the BLAM group, RN067, showed a different gene 
expression profile as compared to other samples in the experiment. We excluded this potential outlier 
from all downstream analysis as this sample consistently separated from the data and especially the 
BLAM group in hierarchical clustering as well as principal component analysis (PCA).  
 
2.11 Pathway Analysis 
Ingenuity Pathway Analysis (IPA) software was used to interpret data from ChIP-seq and RNA-seq 
experiments (QIAGEN Inc.,) (Kramer et al., 2014). A “Core Analysis” was performed on datasets 
included to predict diseases and functions associated with genes becoming bound by MRs or GRs or 
exhibiting differential RNA expression after acute stress and during the circadian rise. 
2.11.1 ChIP-seq dataset preparation 
A ChIP-seq dataset comprising all genes annotated to an MR or GR peak included in DiffBind analysis 
was uploaded to IPA. For each gene, the fold change in receptor binding, p-value and false discovery 
rate (FDR) was included. In instances where multiple peaks of the same category were annotated to a 
single gene, the largest fold change value was included in the dataset. A total of 1996 genes were 
included in the dataset, with IPA mapping 1495 gene IDs and 501 gene IDs left unmapped. 1303 genes 





2.11.2 RNA-seq dataset preparation 
An RNA-seq dataset comprising all genes with significant (FDR<0.05) differential intronic RNA (inRNA) 
or exonic RNA (exRNA) expression following acute stress or the circadian rise was uploaded to IPA. 
For each gene, the fold change in RNA expression, p-value and FDR was included. CON genes were 
not included in the dataset as the number of CON genes exceeded the limit possible to upload to IPA. 
For genes responding at multiple timepoints during the acute stress time course, the maximal fold 
change expression value was included in the dataset. Data concerning 2238 genes were uploaded, 
with IPA mapping 2056 gene IDs and 182 IDs left unmapped.  
2.11.3 Core Analysis 
A core analysis was performed on each dataset by IPA which identified canonical pathways, upstream 
regulators, diseases and functions and networks predicted to be associated with genes present in the 
dataset. The settings for all core analyses were as follows; the reference set of genes was taken from 
the Ingenuity Knowledge base, interaction networks were considered, all node types and data sources 
were included, experimentally observed predictions were considered, all species were considered, 
nervous tissues and neuroblastoma cell lines were considered, and all mutations were considered. An 
FDR cut off of 1.0 was used to include constitutively bound genes. 
Core Analysis identified canonical pathways predicted to be influenced by the genes in the datasets 
based on the directional changes in receptor binding or gene expression. Upstream regulators of the 
genes in the reference datasets were also predicted based on published experimental molecular 
interactions by correlating literature-reported effects with observed gene expression. Core analysis also 
identified diseases and functions predicted to be influenced by genes in the reference datasets. A 
directional change was also predicted on cellular processes and biological functions by correlating 
observed expression with reported experimental gene effects. Networks were predicted involving non-
directional gene interactions. 
An “overlap p-value” was calculated using a Right-Tailed Fisher’s Exact Test and reflects the likelihood 
that the association or overlap between the set of significant molecules from the datasets and a given 
pathway/interaction/network is due to random chance. The smaller the p-value the less likely that the 
association is random. The p-value does not consider the directional effect of one molecule on another, 




A “z-score” was applied in some analysis types and provided predictions about upstream or downstream 
processes, considering the directional effect of one molecule on another molecule or on a process, and 
the direction of change of molecules in the dataset. 
An additional analysis was performed where genes were separated based on the category of their 
respective peak or RNA response i.e. stress and circadian responsive (SR&CR), stress exclusive (SE), 
circadian exclusive (CE) and constitutive (CON). For the ChIP-seq dataset, there were too few peaks 
in the SE category for the MR (n=50) and in the SE (n=23), CE (n=6) and CON (28) category for GR, 
therefore, results of this analysis were difficult to interpret. Based on these observations, pathway 
analysis findings of ChIP-seq and RNA-seq datasets are presented as a whole in this thesis. 
 
2.12 Statistical Analysis  
The statistical and graphical package GraphPad Prism 7 (GraphPad Software, San Diego, CA, USA) 
was used to generate figures and perform statistical analysis. Results are presented as group means ± 
SEM; sample sizes are indicated in the figures. Data was tested for normality and homogeneity of 
variance using Shapiro-Wilk test. Statistical comparisons were conducted on normally distributed data 
with one- or two-way ANOVA. If significant, a Dunnett’s or Sidak post hoc test was performed for one- 
or two-way ANOVA respectively. Non-parametric data were tested using Kruskal-Wallis and if 
significant, a Dunn’s posthoc test was performed. Correlation analysis was performed using 
Spearman’s or Pearson’s correlation test on parametric or non-parametric data respectfully. P<0.05 










Chapter 3 MR and GR genomic activity investigated by hippocampal genome-
wide ChIP-sequencing and RNA-sequencing following acute stress and during 
the circadian rise  
3.1 Abstract 
GC hormones are of critical importance for physiological regulation across the circadian cycle and 
behavioural adaptation following stressful experiences. In the rat hippocampus, GCs act via MRs and 
GRs, which bind to responsive elements within the DNA and regulate the expression of GC target 
genes. MR and GR binding to GREs within promoter and intronic regions and corresponding 
transcriptional responses of GC target genes have been observed in the rat hippocampus following 
elevations in GC levels; however how GCs act to regulate gene transcription within the hippocampus 
at a genome-wide level is still largely unknown.  
This study integrated ChIP- and RNA-seq in order to investigate the genome-wide binding of MRs and 
GRs and the associated transcriptional responses in the rat hippocampus under physiological 
conditions with differing GC secretion patterns (circadian variation and acute stress). Genome-wide 
binding peaks of MRs and GRs were identified primarily within distal intergenic, promoter and intronic 
regions of the DNA under all physiological conditions. In the majority of loci, acute stress and/or the 
circadian rise resulted in enhanced MR and/or GR binding, while a subset of loci exhibited constitutive 
binding of MRs or GRs. Moreover, the transcription factor recognition site composition within MR and 
GR binding peaks showed marked differences depending whether the site was constitutively or 
dynamically bound by either receptor. This binding motif analysis revealed that MR and GR bind to GC 
responsive elements (GREs) but also, most likely via intrinsic transcription factors, to many other motifs. 
In a subset of genes, MR and GR binding was accompanied by associated gene transcriptional 
changes. A positive correlation was found between changes in MR binding and the corresponding RNA 
responses, while changes in GR binding correlated with RNA responses to a lesser extent. These 
results show that hippocampal MRs and GRs, constitutively and dynamically, regulate hippocampal 







GC hormones are of critical importance for central nervous system functioning during daily activities 
and following a stressful challenge. They play a pivotal role in stress resilience and behavioural 
adaptation (Oitzl and de Kloet, 1992, Roozendaal et al., 1996, Reul et al., 2015, Reul, 2014, McEwen, 
2012). Impaired GC secretion and function has been associated with stress-related disorders like major 
depression, schizophrenia and post-traumatic stress disorder (de Kloet et al., 2005, McEwen, 2012, 
Reul et al., 2015). The link between GC hormone activity and the manifestation of these disorders 
remains yet to be elucidated.  
GC secretion from the adrenal glands varies over the circadian cycle peaking at the onset of the active 
phase. Exposure to a stressful event results in a transient surge of GC secretion that is superimposed 
on the circadian rhythm. In the brain, GCs bind to two types of receptors, the MR and the GR (Reul and 
de Kloet, 1985), which co-localize in hippocampal neurons (Reul and de Kloet, 1986, van Steensel et 
al., 1996). Once bound and activated by GCs, MRs and GRs translocate to the cell nucleus where they 
behave as ligand-dependent transcription factors. MRs and GRs recognise and bind to GREs within 
the DNA, where they recruit coregulators to initiate or repress the transcription of GC target genes. It is 
thought that genomic actions in the hippocampus underlie the distinct roles of MR and GR in the control 
of circadian and stress-related physiology, cognition and behaviour, however, the molecular 
underpinnings of these receptor-mediated actions are still largely unresolved (Mifsud and Reul, 2018, 
Oster et al., 2017).   
Comprehensive knowledge about genome-wide MR and GR interactions within the hippocampus under 
physiological conditions is currently lacking. Specifically, many of the genes affected by MR and/or GR 
across the circadian cycle or following stress are yet to be identified. Recently, chromatin 
immunoprecipitation (ChIP) analysis has been used to investigate the binding of MR and GR to well-
known GC-target genes in the hippocampus (Mifsud and Reul, 2016). Although these experiments have 
demonstrated MR and GR binding to GREs within these genes and associated transcriptional 
responses, they do not provide a genome-wide insight into GC receptor interaction with DNA and largely 





The combination of ChIP with NGS technology provides the opportunity to sequence regions of the 
entire genome bound by MRs and GRs. Although a handful of ChIP-seq studies have been performed 
to elucidate the genomic actions of MRs and/or GRs in the rat hippocampus, they pose many limitations. 
So far, ChIP-seq studies have failed to represent physiological conditions of GC secretion, as they have 
been carried out in cell lines (Polman et al., 2012) or the hippocampus of ADX rats supplemented with 
CORT (Polman et al., 2013b, Pooley et al., 2017, van Weert et al., 2017). In particular, the existence of 
selectively MR- or GR-regulated genes within the genome has remained elusive, as parallel MR and 
GR ChIP-seq is limited to a single study (van Weert et al., 2017). Presently, MR and GR ChIP-seq has 
not been integrated with RNA-seq to determine the transcriptomic responses following transcription 
factor binding. Technically, these sequencing studies have been carried out with a low number of 
biological replicates and annotated to outdated versions of the rat genome. As long as the identity of all 
MR- and GR-targeted genes is undetermined, comprehensive insight into the function of these 
corticosteroid receptors in the hippocampus will be lacking. 
Therefore, in this chapter, MR and GR binding is examined throughout the entire rat hippocampal 
genome under early morning baseline (BLAM) and late afternoon baseline (BLPM) conditions, 
representing the circadian trough and peak, and after exposure to an acute stressor (forced swimming 
(FS)). Moreover, this data is integrated with genome-wide transcriptional responses occurring in the rat 
hippocampus under the same conditions. This approach revealed comprehensive insight into the 
genomic loci bound by MR and/or GR and the transcription factor binding motifs involved. Motif analysis 
suggests alternative motifs to which MRs and GRs may indirectly bind, in the absence of a classical 
GRE. Furthermore, a subset of genomic loci constitutively bound my MRs and GRs are characterised, 
and changes in MR and GR binding are correlated with transcriptional responses in the target gene. 
Overall, this study offers the most detailed investigation to date into the genomic actions of MRs and 





3.3 Materials and Methods 
3.3.1 Animals  
Male Wistar rats (150-175g) were purchased from Envigo (Oxon, UK) and group housed (two to three 
animals per cage). Animals were kept under standard light (lights on 5:00–19:00; 80–100 Lux) and 
environmentally controlled conditions (temperature 21 ± 1 °C; relative humidity 40–60%) with food and 
water available ad libitum. Until the day of the experiment all rats were handled (2 min per rat per day; 
min. 5 days) to reduce any nonspecific stress effects. 
3.3.2 Stress Procedures 
Rats were killed under early or late baseline conditions or following forced swimming (FS) as described 
in Chapter 2. Rats undergoing FS were killed at a number of timepoints following FS; timepoints are 
described in the text and figure legends and in each case refer to the amount of time from the start of 
FS.  
3.3.3 Tissue Collection 
Following quick isoflurane anaesthesia (<10sec) and decapitation, the brain was removed, and 
hippocampus dissected on an ice-cold steel box. Hippocampus tissues were snap-frozen in liquid N2 
and stored at -80 °C.  
3.3.4 Radioimmunoassay 
Trunk blood was collected at the point of decapitation and stored on ice in tubes containing EDTA and 
aprotinin for determination of plasma corticosterone concentration. Blood samples were prepared, and 
Corticosterone 125I Double Antibody radioimmunoassay was carried out as described in Chapter 2.  
3.3.5 ChIP-Seq sample preparation 
Four independent biological replicates were sequenced per condition (BLAM, FS30, BLPM), each 
replicate consisting of the dissected hippocampi from two animals. Frozen hippocampus tissues were 
cross-linked in a buffered 1% formaldehyde solution, sonicated (Bioruptor (UC 300; Diagenode) (high 
power; 3 x 10 cycles, 30s on, 60s off) and chromatin prepared as previously described in Chapter 2. 




sc11412x, Santa Cruz) or GR (GR H-300, sc8992x, Santa Cruz) with 200 µl chromatin as previously 
described in Chapter 2. Corresponding input samples were prepared as described in Chapter 2.  
3.3.6 ChIP-seq library construction, sequencing, genome mapping and bioinformatic analysis 
ChIP-seq library construction, sequencing, genome mapping and bioinformatic analysis was performed 
as previously described in Chapter 2. 
3.3.7 RNA sample preparation 
RNA was extracted from 9 independent biological samples per group (BLAM, FS30, FS60, FS120, 
FS180, FS360 and BLPM) as previously described in Chapter 2. Each biological sample comprised 
RNA from hippocampi of one rat. Three biological samples were randomly selected from the FS60 and 
FS120 groups to send for initial sequencing to confirm the possibility of conducting Ribo-Zero RNA-
Seq. Following the success of this initial test, a further three randomly chosen samples from these 
groups (FS60 & FS120), along with 5 randomly selected samples from each of the other condition 
(BLAM, FS30, FS180, FS360 and BLPM) were subjected to RNA-seq.    
3.3.8 RNA-seq library construction and sequencing 
RNA-seq library construction, sequencing, genome mapping and bioinformatic analysis of RNA-seq 
data was performed as previously described in Chapter 2.  
3.3.9 Statistical Analysis  
The statistical and graphical package GraphPad Prism 7.04 was used to generate figures and perform 
Spearman rank correlation and other statistical analyses on the ChIP-qPCR and RNA RT-qPCR data 
(GraphPad Software, San Diego, CA, USA). The independent biological sample sizes (n-values) are 
indicated in the legends to the figures. Data were analysed with students t-test or one-way ANOVA 
followed by the post-hoc Dunnett’s multiple comparison test, as appropriate. P-values <0.05 were 




3.4 Results  
3.4.1 Characterization of MR and GR binding peaks throughout the rat hippocampal genome  
Genome-wide changes in hippocampal MR and GR binding following acute stress, or in response to 
the circadian rise in corticosterone levels, were quantified by ChIP-seq. MR and GR ChIP-seq was 
performed on hippocampal chromatin samples from rats killed under baseline conditions (BLAM, 7am-
9am; BLPM, 5.30-7.00 pm, representing the trough and peak of circadian GC secretion in the rat, 
respectively), or 30 min after the start of an acute 15 min FS challenge, i.e. at the peak of the stress-
evoked plasma corticosterone rise (FS30). Changes in plasma corticosterone levels (Figure 3.1) 
following acute stress and the circadian rise were examined. Compared with BLAM conditions, plasma 
corticosterone levels increased significantly following acute stress (> 64-fold) or in response to the 
circadian rise (> 17-fold).  
Areas of the genome with significant peaks of MR or GR binding (Figure 3.2) under baseline conditions 
and following acute stress were identified. Under BLAM conditions, MRs (Figure 3.2.a) bound to >300 
sites on average which increased significantly following acute stress (>5-fold) or in response to the 
circadian rise (>7-fold). GRs (Figure 3.2.b) bound to <100 sites on average under BLAM condition, 
however this number increased significantly following acute stress (~20-fold) and in response to the 
circadian rise (>8-fold).  
The genomic location of MR and GR binding peaks was analysed (Figure 3.3). The highest levels of 
binding were seen within distal intergenic regions (A – MR, 40-50% of peaks; B – GR, 50-70% of peaks, 
depending on the experimental condition). The remaining peaks were predominantly located in the 
promoter or intronic regions. Acute stress and circadian influences led to increases in the number of 
both MR (Figure 3.3.a) and GR (Figure 3.3.b) peaks within exonic, intronic and 3’-untranslated regions 
(3’UTR) and a corresponding relative reduction of peaks at promoter (MR) or intergenic regions (GR), 
representing a shift in the genomic distribution of peaks due to the experimental condition.  
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Figure 3.1 Plasma corticosterone levels in rats under early morning baseline conditions, 
following acute stress or under late afternoon baseline conditions  
Rats were killed under early morning baseline conditions (~7:00 hrs (BLAM)), 30 min (FS30) after the 
start of FS (15 min, 25ºC water) or under late afternoon baseline conditions (~17:00 hrs (BLPM)). 
Plasma corticosterone levels are expressed as ng/ml (mean ± SEM, n=12 per group). Average 
concentration at BLAM, 15.20 ng/ml. Statistical analysis: one-way ANOVA, F(2, 33) = 85.07, p<0.0001, 
Dunnett’s post hoc test, **P<0.01, ****P<0.0001 significantly different from BLAM. Inter-assay 
coefficient of variation, , intra-assay coefficient of variation, 2.57%. 
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Figure 3.2 Identification of significant MR and GR binding peaks under early morning baseline 
conditions, following acute stress and under late afternoon baseline conditions  
Rats were killed under early morning baseline conditions (~7:00 hrs (BLAM)), 30 min (FS30) after the 
start of FS (15 min, 25ºC water) or under late baseline conditions (~17:00 hrs (BLPM)). MR and GR 
binding peaks in the hippocampus were determined by ChIP-seq. Data is presented as number of MR 
peaks (A) and GR peaks (B) under each biological condition (mean ± SEM, n=4 per group). Statistical 
analysis: one-way ANOVA, MR: F(2, 9) =10.06, p<0.01, GR: F(2, 9)=59.01, p<0.0001, Dunnett’s post hoc 
test, *P<0.05, **P<0.01, ****P<0.0001 significantly different from BLAM. 
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Figure 3.3 Genomic distribution of MR and GR binding peaks under early baseline conditions, 
following acute stress and under late baseline conditions  
Rats were killed under early morning baseline conditions (~7:00 hrs (BLAM)), 30 min (FS30) after the 
start of FS (15 min, 25ºC water) or under late baseline conditions (~17:00 hrs (BLPM)). Data is 
presented as % of MR peaks (A) and % of GR peaks (B) under each physiological condition (mean, n 
= 4 per group). Untranslated region, (UTR). Absence of bars indicate peaks were not detected in the 
genomic region under the corresponding physiological condition.  
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3.4.2 Genome-wide MR and GR binding is regulated by acute stress and circadian influences 
To determine whether genome-wide binding of MRs and GRs changed following acute stress and 
during the circadian rise, differential binding analysis was carried out, which identified genomic regions 
in which MR binding and GR binding was significantly upregulated or downregulated at FS30 or BLPM 
compared with BLAM. A correlation heat map of the read count data shows a robust clustering of 
biological replicates within each experimental condition and shows a clear differentiation between 
samples collected under BLAM, FS30 and BLPM conditions for the MR ChIP (Figure 3.4.a) and GR 
ChIP (Figure 3.4.b).  
A total of 1753 MR peaks (Figure 3.5.a) and 1066 GR peaks (Figure 3.5.b) were selected for differential 
binding analysis by the computational package, “DiffBind”. The majority of genomic locations identified 
by DiffBind analysis were stress- and circadian-responsive (SR&CR) i.e. became differentially bound 
under both physiological conditions (MR: 60%; GR: 92%). In contrast, only a very limited number of 
binding sites were stress exclusive (SE) i.e. became differentially bound solely in response to acute 
stress (MR: 3%; GR: 2%). A higher percentage of MR peaks (9%) were circadian exclusive (CE) i.e. 
showed differential binding selectively in response to the circadian drive, when compared with GR 
peaks (1%). The percentage of genomic loci which showed constitutive (CON) binding, i.e. the level of 
binding did not change between conditions, was also substantially higher for MR (28%) than GR (5%). 
Almost all differentially bound MR peaks and GR peaks were upregulated following acute stress (MR, 
Figure 3.6.a; GR, Figure 3.6.b) and the circadian rise (MR, Figure 3.7.a; GR, Figure 3.7.b). The 
magnitude of change in MR binding (Figure 3.8.a) was also significantly larger following acute stress 
(2.489 ± 0.034, mean ± SEM, n=4; Log2FC). compared with the circadian rise (2.24 ± 0.028, mean ± 
SEM, n=4; Log2FC). Similarly, for the GR (Figure 3.8.b), acute stress induced a significantly larger 
change in binding (4.063 ± 0.041, mean ± SEM, n=4; Log2FC) compared with the circadian rise (3.37 ± 


















Figure 3.4 Quality control heat maps of MR peaks and GR peaks from each biological replicate 
undergoing differential binding analysis  
Significant (A) MR peaks and (B) GR peaks from each biological replicate underwent differential binding 





Figure 3.5 Categorisation of MR and GR peaks based on the physiological condition(s) in which 
binding significantly changed  
Pie charts display the proportion of (A) MR peaks and (B) GR peaks becoming differentially bound in 
response to both stress and the circadian rise (Stress-responsive and circadian-responsive - SR&CR), 
exclusively following stress (Stress exclusive – SE), exclusively under the circadian rise (Circadian 
exclusive – CE), or peaks in which the binding of the receptor remains unchanged between conditions 
(Constitutively bound - CON). 
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Figure 3.6 Acute stress results in genome-wide changes in the binding of MRs and GRs 
DiffBind analysis identified MR and GR peaks which were differentially bound following acute stress. 
Scatterplots exhibit the fold change in binding (log2 FC) of the (A) MR and (B) GR versus the significance 
of the change (-log10FDR) following acute stress (FS30 vs BLAM). SE; stress exclusive, SR; stress 
responsive, CON; constitutive.  
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Figure 3.7 The circadian rise results in genome-wide changes in the binding of MRs and GRs 
DiffBind analysis identified MR and GR peaks which were differentially bound during the circadian rise. 
Scatterplots exhibit the fold change in binding (log2 FC) of the (A) MR and (B) GR versus the significance 
of the change (-log10FDR) following the circadian rise (BLPM vs BLAM). CE; circadian exclusive, CR; 
circadian responsive, CON; constitutive.  
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Figure 3.8 Acute stress induces a larger change in MR and GR binding compared with the 
circadian rise  
Following acute stress, the average fold change in binding, as calculated by DiffBind, for the MR (A) 
and the GR (B) was significantly higher compared with the average fold change in binding during the 
circadian rise. Binding levels are expressed as log2 fold change in binding vs levels under BLAM 




3.4.3 MR and GR peaks are associated with distinct transcription factor binding motif 
patterns, depending on the physiological condition 
The top-500 peaks, based on statistical significance (false discovery rate, FDR) from the MR and GR 
datasets were subject to de novo motif analysis, identifying the binding motif with the highest occurrence 
and statistical significance. The most prevalent motif was matched to a palindromic GRE for both MR 
(Figure 3.9.a) and GR (Figure 3.9.b) binding datasets. Whilst a GRE was present in 100% of the top-
500 GR peaks, only ∼67% of the top-500 MR peaks contained a GRE. Find Individual Motif 
Occurrences (FIMO) software was used to identify motifs present in the 1753 MR and 1066 GR peaks 
included in the DiffBind analysis. The 5 most prominent motifs within each peakset were identified. 
Overall, GREs were the most prominent motif found within each peakset, with this response element 
observed in 77% of all MR peaks (Figure 3.10) and 93% of all GR peaks (Figure 3.11). A similar 
incidence of Zinc Finger (ZNF), Specificity Protein (SP) and Krüppel-like Factor (KLF) motifs within MR 
peaks (70-76%) and GR peaks (68-74%) was observed. Early Growth Response (EGR) motifs were 
found in 64% of MR peaks (Figure 3.10), while 44% of GR peaks (Figure 3.11) contained EWS RNA 
Binding Protein 1-Fli-1 Proto-Oncogene, ETS transcription factor (EWSR1-FLI1) motifs. 
The top-5 most prominent motifs were subsequently identified according to peak category. The GRE 
was no longer one of the top-5 motifs in CON MR peaks (Figure 3.10) or in CON and CE GR peaks 
(Figure 3.11). ZNF, SP and EGR motifs remained in the top-5 among all MR peak categories, while 
KLF motifs were present in the top-5 for CON and SE peaks (Figure 3.10). Regulatory Factor X (RFX), 
Atonal BHLH Transcription Factor (ATOH1) and EWSR1-FLI1 motifs entered the top-5 for CON, CE 
and SR&CR MR peaks, respectively (Figure 3.10). For the GR (Figure 3.11), SP motifs remained in the 
top-5 among CE, SE and SR&CR peaks, while ZNF motifs remained in the top-5 among SE and SR&CR 
peaks. KLF and EWSR1-FLI1 motifs remained in the top-5 among SR&CR peaks only. A number of 
motifs entered the top-5 list, including Nuclear Receptor (NR), NKX Homeobox (NKX), Signal 
Transducer and Activator of Transcription (STAT), Paired Box (PAX), ATOH1 and Estrogen Receptor 
(ESR) motifs. Caution is required when interpreting the top-5 motifs in the CE GR binding peaks, due 
to the low number of peaks. Ten motifs were selected based on the top-5 among all peak categories 
and their incidence among peak categories are presented as stacked bars for the MR (Figure 3.12.a) 
and GR (Figure 3.12.b). This view clearly displays the higher percentage of MR peaks showing CON 














Figure 3.9 MEME analysis of the top 500 MR and GR binding peaks across all biological 
conditions reveals the motif with the highest occurrence and statistical significance  
The top-500 MR and GR binding peaks across all biological conditions underwent MEME analysis to 
identify the motif with the highest occurrence and statistical significance. (A) MR peaks were associated 
with a motif matching the palindromic GRE (E = 1.2e-157). The motif was present in 67% of the top 500 
MR peaks. (B) GR peaks were associated with a motif matching the palindromic GRE (E = 8.7e-668). 










Figure 3.10 FIMO analysis reveals the top 5 transcription factor binding site motifs predicted 
within all MR peaks and each MR peak subcategory 
A flowchart displays the top-5 motifs found within MR peaks. The first level of the flowchart shows the 
top-5 motifs within all MR peaks. The second level of the flowchart shows the top-5 motifs within CON 
(constitutive), CE (circadian exclusive), SE (stress exclusive) and SR&CR (stress & circadian 
responsive) peaks for the MR. Motifs underlined and highlighted in red are only found in the top 5 within 
that peak category. The percentage of peaks containing the respective motif is indicated between 
brackets. Glucocorticoid Response Element (GRE), Zinc Finger (ZNF), Specificity Protein (SP), Early 
Growth Response (EGR), Krüppel-like Factor (KLF), Regulatory Factor X (RFX), Atonal BHLH 




Figure 3.11 FIMO analysis reveals the top 5 transcription factor binding site motifs predicted 
within all GR peaks and each GR peak subcategory  
A flowchart displays the top-5 motifs found within GR peaks. The first level of the flowchart shows the 
top-5 motifs within all GR peaks. The second level of the flowchart shows the top-5 motifs within CON 
(constitutive), CE (circadian exclusive), SE (stress exclusive) and SR&CR (stress & circadian 
responsive) peaks for the GR. Motifs underlined and highlighted in red are only found in the top 5 within 
that peak category. The percentage of peaks containing the respective motif is indicated between 
brackets. Glucocorticoid Response Element (GRE), Zinc Finger (ZNF), Specificity Protein (SP), 
Krüppel-like Factor (KLF), EWS RNA Binding Protein 1-Fli-1 Proto-Oncogene, ETS transcription factor 
(EWSR1-FLI1), Nuclear Receptor (NR), NKX Homeobox (NKX), Signal Transducer and Activator of 
Transcription (STAT), Paired Box (PAX), RELA Proto-Oncogene, NF-KB Subunit (RELA), Forkhead 
Box (FOX), Con-Rod Homeobox (CRX), Atonal BHLH Transcription Factor (ATOH1), Estrogen 
Receptor (ESR).  
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Figure 3.12 Top motifs predicted within MR and GR peak subcategories 
10 motifs were selected for further analysis based on identification of the top motifs within each peak 
category. Stacked bar charts show the percentage of SR&CR (stress and circadian responsive), SE 
(stress exclusive), CE (circadian exclusive) and CON (constitutive) (A) MR peaks and (B) GR peaks 
containing a top-10 motif. Glucocorticoid Response Element (GRE), Zinc Finger (ZNF), Specificity 
Protein (SP), Nuclear Receptor (NR), Krüppel-like Factor (KLF), Forkhead Box (FOX), Early Growth 
Response (EGR), EWS RNA Binding Protein 1-Fli-1 Proto-Oncogene ETS transcription factor (EWSR1-
FLI1) Regulatory Factor X (RFX), Atonal BHLH Transcription Factor (ATOH).  
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3.4.4 In the absence of a GRE, MR and GR peaks are associated with distinct transcription 
factor binding motif patterns 
MR peaks (n = 401) and GR peaks (n = 74) that did not encompass a GRE motif were analysed to 
determine alternative motifs to which MRs and GRs may be binding. FIMO analysis identified the SP, 
ZNF, KLF, EGR and RFX motifs as the predominant motifs within the non-GRE-containing MR peaks 
(Figure 3.13.a). Strikingly, apart from the RFX motif which is only found within the top-5 of CON MR 
peaks, these motifs are also amongst the most prominently present motifs if all MR peaks were 
considered (Figure 3.10) indicating that MRs may interact with such motifs in the presence or absence 
of a GRE. Within the non-GRE-containing GR peaks, the most frequently observed motifs were NR, 
STAT, PAX, EGR and Retinoic Acid Receptor Gamma (RARG) (Figure 3.13.a). Interestingly, these 
motifs were not present among the top-5 motifs after FIMO analysis on all GR peaks (Figure 3.11). 
They were also absent among the top-5 motifs within GR peaks associated with the SR&CR and SE 
groups whereas NR, STAT and/or PAX were present within GR peaks of the CE and CON groups. 
Stacked bars (Figure 3.13.b) present the relative percentage of MR and GR peaks associated with the 
different physiological conditions and depending on whether peaks contained a GRE motif or not. The 
presence of a GRE is strongly associated with MR and GR binding after acute stress or at the circadian 
rise (SR&CR). Conversely, the majority of MR (n = 407) and GR (n = 74) peaks lacking a consensus 




Figure 3.13 FIMO analysis reveals the top 5 transcription factor binding site motifs predicted 
within MR and GR peaks lacking a GRE  
A flowchart shows the top-5 motifs (A) within MR and GR peaks lacking a GRE. A stacked bar chart (B) 
shows the percentage of SR&CR (stress and circadian responsive), SE (stress exclusive), CE 
(circadian exclusive) and CON (constitutive) peaks predicted to contain a GRE (+GRE) or not predicted 
to contain any GREs (-GRE). 
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3.4.5 Acute stress impacts hippocampal gene transcription more greatly than the circadian 
drive 
Transcriptome-wide changes in hippocampal gene expression following acute stress, or in response to 
the circadian rise in corticosterone levels, were quantified by RNA-seq. RNA extracted from the 
hippocampi of rats killed under baseline conditions (BLAM or BLPM) or at various time points after 
acute FS stress was sequenced following ribosomal RNA (rRNA) depletion (Ribo-Zero RNA-seq). 
inRNA reads were an approximation of hnRNA, while exRNA reads were representative of mRNA. 
Changes in plasma CORT levels (Figure 3.14) following acute stress and the circadian rise were 
examined. Compared with BLAM conditions, plasma CORT increased following acute stress (> 90-fold, 
FS30; > 10-fold, FS60; >15-fold, FS360) and in response to the circadian rise (> 20-fold).  
To investigate the effects of acute stress and the circadian drive on hippocampal gene transcription, 
differential expression analysis was carried out which compared the expression levels of inRNA and 
exRNA at each time point after stress or at the circadian rise with expression levels at BLAM (Figure 
3.15). This analysis measured the highest number of changes in inRNA expression at FS60 and the 
highest number of exRNA changes at FS120. Genes were subsequently categorised based on the 
physiological conditions under which a transcriptional response was elicited (Figure 3.16). To collate 
the stress-responsive genes in terms of transcriptional responses, the maximal fold change in intronic 
and exonic reads (regardless of time point and direction) was determined for each gene along with its 
relative significance value. A higher percentage of genes responded with inRNA changes (13%; Figure 
3.16.a) compared with exRNA changes (3%; Figure 3.16.b), however the majority of inRNA (87%) and 
exRNA (97%) were expressed CON. Of the 13% of genes exhibiting differential inRNA expression, 9% 
exhibited a SE response, 1% were CE and 3% responded to both (SR&CR). Of the 3% of genes 
exhibiting differential exRNA expression, 1% were SE, 1% were CE and 1% were SR&CR. The 
magnitude of differential expression for genes in terms of inRNA (Figure 3.17.a) and exRNA (Figure 
3.17.b) is illustrated by volcano plots. SR&CR genes were examined to determine whether the inRNA 
and exRNA responses were occurring in the same direction. A highly significant positive correlation 
was observed between the magnitude of the stress-induced versus circadian rise-associated changes 
in intronic (Figure 3.18.a) and exonic (Figure 3.18.b) RNA expression, strongly indicative of a shared 
regulatory mechanism for SR&CR genes. Very few genes showed opposing inRNA responses (n = 5) 
or opposing exRNA responses (n = 4) to acute stress and the circadian drive. 
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Figure 3.14 Plasma corticosterone levels of rats under early morning baseline conditions, at 
various timepoints following acute stress or under late afternoon baseline conditions  
Rats were killed under early morning baseline conditions (~7:00 hrs (BLAM)), 30 min (FS30), 60 min 
(FS60), 120 min (FS120), 180 min (FS180), or 360 min (FS360) after the start of FS (15 min, 25 ºC 
water) or under late afternoon baseline conditions (~17:00 hrs (BLPM)). Plasma corticosterone levels 
are expressed as ng/ml (mean ± SEM, n=9 per group). Average concentration at BLAM, 9.84 ng/ml. 
Statistical analysis: one-way ANOVA, F(6, 56)=185.9, p<0.0001, Dunnett’s post-hoc test, *P<0.05, 
**P<0.01, ***P<0.001, ****P<0.0001 significantly different from BLAM. Inter-assay coefficient of 
variation, , intra-assay coefficient of variation, 2.43%. 
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Figure 3.15 RNA-seq reveals genes responding with changes in inRNA and exRNA transcripts 
following acute stress or during the circadian rise  
RNA-seq was carried out on hippocampal tissue from rats under early morning baseline conditions 
(BLAM), killed at various timepoints (30-360 min) following exposure to FS (15 min, 25 ºC water) or 
under late afternoon baseline conditions (BLPM). Differential expression analysis identified changes in 
the inRNA or exRNA expression of genes following FS or at BLPM compared with BLAM conditions. 
The number of genes exhibiting significant changes in the expression of inRNA and exRNA transcripts 




















Figure 3.16 Differential expression analysis of inRNA and exRNA following acute stress or 
during the circadian rise compared with early morning baseline conditions  
Differential expression analysis identified genes of which the intronic or exonic expression was 
upregulated, downregulated or remained stable following acute stress or the circadian rise. Pie charts 
display the proportion of genes of which the (A) intronic and (B) exonic RNA expression is significantly 
altered in response to both stress and the circadian rise (Stress-responsive and circadian-responsive - 
SR&CR), exclusively following stress (Stress exclusive – SE), exclusively under the circadian rise 
(Circadian exclusive – CE), or genes in which RNA expression remains unchanged between conditions 






















Figure 3.17 Acute stress and the circadian rise result in differential intronic RNA (inRNA) and 
exonic RNA (exRNA) expression  
Differential expression analysis identified genes of which the intronic or exonic expression was 
upregulated, downregulated or remained stable following acute stress or the circadian rise. Volcano 
plots show the fold change in (A) intronic RNA and (B) exonic RNA expression (log2 FC) versus the 
statistical significance of the change (-log10 FDR). Stress and circadian-responsive (SR&CR), Stress 






















Figure 3.18 Genes exhibiting changes in RNA expression following acute stress and during the 
circadian rise  
Correlation analysis was carried out to determine the relationship between changes in gene expression 
following stress (FS) or during the circadian rise (BLPM). A Scatterplot displays the magnitude of stress-
induced and circadian-induced changes in (A) intronic RNA (n=470) and (B) exonic RNA (n=171) 
expression for SR&CR genes. Genes in which the change of expression correlated between stress and 
circadian conditions are depicted in red circles. Genes in which the change of inRNA and exRNA 
expression did not correlate between stress and circadian conditions are depicted in red triangles. 





3.4.6 Integration of ChIP-seq and RNA-seq data 
The extent to which MR or GR binding was associated with an RNA response of the corresponding 
genes was subsequently addressed. Peaks were annotated to the gene in closest proximity (Figure 
3.19.a); MR peaks, 1505 genes; GR peaks, 932 genes. 662 genes (48%) were distinctly associated 
with MR binding while 182 genes (13%) were specifically annotated to GR peaks. 536 genes (39%) 
were associated with both MR and GR binding. The transcription factor binding profile of the distinct 
and overlapping genes was examined. Almost 50% of “MR only” genes were constitutively bound by 
the MR, while the majority of “MR/GR” and “GR only” genes exhibited SR&CR binding. Of the 1505 
genes annotated to MR peaks and the 932 genes annotated to GR peaks across all conditions, the 
expression of 1198 (∼80%) and 718 (77%) genes, respectively, could be detected based on intronic 
and/or exonic RNA count data. The differential expression patterns for the top-5 upregulated and 
downregulated genes with the largest changes in inRNA (Figure 3.20.a) or exRNA (Figure 3.20.b) 
expression following acute stress or the circadian rise and showing significant MR and/or GR binding 
are presented as heatmaps. Whilst all of the top-5 upregulated genes based on inRNA expression have 
SR&CR binding of MR and/or GR, four of the top-5 downregulated genes show CON binding of MR 
and/or GR and only one gene in the top-5 downregulated genes, Cd180, shows SR&CR binding of GR 
(Figure 3.20.a). All of the top-5 upregulated and downregulated genes based on exonic expression 
have SR&CR or SE binding of MR and/or GR (Figure 3.20.b).  
Correlation analysis was performed to determine whether changes in MR or GR binding were correlated 
with the transcriptional RNA responses in the respective gene. A positive correlation was found between 
the fold change in MR binding and changes in associated inRNA (Figure 3.21.a) and exRNA (Figure 
3.21.b). These correlations persisted when the data was split, according to physiological condition i.e. 
acute stress or circadian rise. When the data was split according to the RNA response i.e. SR&CR, SE 
or CE, changes in MR binding correlated with changes in inRNA levels within the SR subset and with 
changes in exRNA levels within the SR and CE subsets. Regarding the GR, a positive correlation was 
found between the fold change in binding and changes in associated inRNA (Figure 3.22.a) only. When 
the data was split, according to physiological condition, these correlations did not persist, however when 
the data was split according to the RNA response, changes in GR binding correlated with changes in 
inRNA levels within the SE subset. No correlation between changes in GR binding and changes in 




















Figure 3.19 Genes annotated to MR peaks only, GR peaks only or both MR and GR peaks 
Identification of genes showing MR and/or GR binding following acute stress or the circadian rise. (A) 
MR and GR peaks were annotated to the gene in closest proximity. These genes were examined to 
identify genes exclusively bound by MRs or GRs, and genes bound by both MRs and GRs. (B) “MR 
only”, “GR only” and “MR/GR” genes were subsequently examined to determine the category of binding 
associated with these genes.  
 
 

























Figure 3.20 Genes exhibiting changes in RNA expression and significant MR or GR binding 
following acute stress and during the circadian rise  
Identification of genes showing MR and/or GR binding and differential RNA expression following acute 
stress or the circadian rise. MR and GR peaks were annotated to the closest gene, with 1753 MR peaks 
annotated to 1505 genes and 1066 GR peaks annotated to 932 genes. Heatmaps based on the 
differential expression (log2 fold change) of (A) intronic and (B) exonic RNA show the top-5 upregulated 



















Figure 3.21 Genes exhibiting changes in MR binding and intronic RNA or exonic RNA expression 
following acute stress and during the circadian rise  
Correlation analysis was carried out to determine the relationship between changes in gene expression 
and changes in MR binding following acute stress or during the circadian rise. A scatterplot displays the 
magnitude of change in MR binding vs the magnitude of change in (A) intronic RNA (log2 FC inRNA) 
expression or (B) exonic RNA (log2 FC inRNA) expression. Spearman correlation analysis: (A) All data 
rs(311)=0.2061, p<0.001; Acute stress rs(202)=0.2014, p<0.01; Circadian rise rs(109)=0.2139, p<0.05; 
Circadian Exclusive rs(21)=0.1364, p=0.555; Stress Exclusive rs(111)=0.1188, p=0.2142; Circadian 
Responsive rs(88)=0.2026, p=0.0583; Stress Responsive rs(91)=0.2082, p=0.0477. (B) All data 
rs(105)=0.2884, p=0.0028; Acute stress rs(51)=0.3081, p<0.05; Circadian rise rs(54)=0.2854, p<0.05; 
Circadian Exclusive rs(19)=0.5526, p=0.0141; Stress Exclusive rs(14)=0.3187, p=0.2666; Circadian 



















Figure 3.22 Genes exhibiting changes in GR binding and intronic RNA or exonic RNA expression 
following acute stress and during the circadian rise 
Correlation analysis was carried out to determine the relationship between changes in gene expression 
and changes in GR binding following acute stress or during the circadian rise. A scatterplot displays the 
magnitude of change in GR binding vs the magnitude of change in (A) intronic RNA (log2 FC inRNA) 
expression or (B) exonic RNA (log2 FC inRNA) expression. Spearman correlation analysis: (A) All data 
rs(248)=0.1314, p=0.0387; Acute stress rs(155)=0.1102, p=0.1721; Circadian rise rs(93)=0.1436, 
p=0.1696; Circadian Exclusive rs(17)=0.2745, p=0.2853; Stress Exclusive rs(79)=0.2288, p=0.0426; 
Circadian Responsive rs(76)=0.09541, p=0.4123; Stress Responsive rs(76)=0.005332, p=0.9635. (B) 
All data rs(152)=0.09917, p=0.2242; Acute stress rs(74)=0.03677, p=0.7558; Circadian rise 
rs(78)=0.07245, p=0.5285; Circadian Exclusive rs(23)=0.09125, p=0.6788; Stress Exclusive 





3.5 Discussion  
Integrated ChIP- and RNA-seq has revealed the complexity of GC action in the hippocampus under 
physiological conditions which are of significance for GC secretion, i.e. during the circadian rise and 
trough and following acute stress. The MR/GR ChIP studies show that binding can be constitutive or 
responsive to stress and circadian influences and mediated by classical GREs or many alternative TF 
binding motifs. Cross-correlation of the ChIP- and RNA-seq datasets shows that changes in receptor 
binding to the genome impacts on gene transcriptional activities. These data significantly expand our 
knowledge of GC-controlled genes under baseline and stress conditions, how these genes are 
controlled and what their putative functions are. The purely physiological approach adopted in this study 
differs substantially from earlier genome-wide MR and GR binding studies that used hippocampal 
tissues of corticosterone-injected ADX rats (Polman et al., 2013a, van Weert et al., 2017, Pooley et al., 
2017). The present results are not affected by any influences of ADX, directly on MR and/or GR binding 
characteristics and indirectly because of loss of dentate gyrus neurons due to lack of endogenous 
corticosterone (Sloviter et al., 1993). Furthermore, ADX may influence hippocampal RNA responses, 
as Gray et al. (2014) found relatively little overlap in hippocampal RNA responses of mice subjected to 
FS or corticosterone injection (Gray et al., 2014). Also technically, it is difficult to compare this present 
study with previous studies, as this analysis is based on 4 independent biological samples (cf. n=1 in 
earlier studies), the ChIP-seq was performed at a much higher depth and these sequencing results 
were aligned to the latest rat genome version (Rnor_6.0; cf. Rnor_4 (Polman et al., 2013b, van Weert 
et al., 2017)).  
 
ChIP-seq identified MR and GR binding peaks throughout various genomic regions under all 
physiological conditions. Although it is generally accepted promoter regions are the primary site of 
transcription factor binding (Finsterwald and Alberini, 2014), the majority of MR and GR peaks identified 
in this study were located in distal intergenic regions under all physiological conditions. Little is presently 
known regarding the functions of intergenic DNA; however accumulating evidence suggests that 
genome architecture may be regulated by intergenic regions that influence the spacing of neighbouring 
genes. Interestingly, genes with more complex functions were shown to be flanked by significantly more 
intergenic DNA compared with genes with simple or housekeeping functions (Nelson et al., 2004). As 




possible that intergenic regions facilitate the assembly of large regulatory complexes which may be 
recruited by genes with more complex functions. Under circadian trough conditions, a considerable 
proportion of MR peaks were detected within promoter regions, while only a modest fraction of GR 
peaks was observed. Interestingly, following acute stress and the circadian rise, MR binding within 
promoter regions decreased by almost 50%, while a small increase in the proportion of GR peaks was 
seen. Under GC-elevated conditions, MR and GR binding increased substantially within intronic 
regions. Although intronic regions were initially believed to represent non-functional “junk-DNA” (Li et 
al., 2012), they have been found to contain DNA elements that regulate transcription initiation (Chorev 
and Carmel, 2012) which may be recognised by MRs and GRs. These observations indicate the 
presence of a distinct binding pattern of MRs and GRs which may be important in the regulation of GC 
target genes. It also challenges the previous belief that MR and GR binding predominantly occurs in 
promoter regions and indicates that more work needs to be done on elucidating the regulatory roles of 
intergenic and intronic DNA regions. 
 
Upon differential binding analysis, regions of the genome were identified in which the binding of MRs 
and GRs was upregulated or downregulated following acute stress and/or the circadian rise. A 
considerable number of loci were also identified which showed no changes in MR or GR binding 
between these physiological conditions (i.e. constitutive binding). MR peaks (1753) and GR peaks 
(1066) diverged considerably regarding their distribution across the CON, CE, SE and SR&CR 
categories. While more than 90% of GR peaks were SR&CR, fewer MR peaks (60%) exhibited this type 
of binding. This disparity is largely due to the much greater relative (and absolute) number of CON MR 
peaks (28%) than CON GR peaks (5%). A reason for the high number of CON MR peaks may be due 
to the high degree of MR occupancy by endogenous corticosterone under all physiological conditions 
(Reul and de Kloet, 1985, Reul et al., 1987) rendering these receptors in a constantly activated state. 
Although a recent study has reported relatively low binding of occupied MRs at GREs of stress 
responsive genes under BLAM conditions (Mifsud and Reul, 2016), it is possible that in the case of 
CON MR binding, MRs are selectively recruited by transcription factors at distinct genomic loci, which 
are not responsive to stress or circadian conditions. GRs only become occupied under GC-elevating 
conditions, such as stress and the circadian rise (Reul and de Kloet, 1985, Reul et al., 1987),  therefore 




the fraction of CE MR peaks was much higher, approximately 9-fold, than the fraction of CE GR peaks. 
It appears that MR-selective circadian factors may play a decisive role in the CE binding and the nature 
of these factors needs to be delineated in future studies.  
 
Based on MEME analysis of the top-500 MR and GR peaks, the GRE consensus sequence was, with 
very high statistical significance, the predominant recognition site for MR and GR binding underscoring 
the high specificity of this ChIP analyses. Further examination of all 1753 MR and 1066 GR peaks 
revealed alternative motifs to which MRs and GRs may be binding. To a certain degree, these motifs 
overlap with those reported by previous studies, such as EGR and ATOH1 (van Weert et al., 2017), 
however FIMO analysis on this data discovered many additional motifs in substantial numbers of peaks 
including KLF, SP, FOX, STAT and RFX motifs which had not been revealed previously. It is possible 
that ADX conditions in the study by van Weert and colleagues may restrict the access of MRs and GRs 
to these motifs. Access to binding motifs is controlled by local epigenetic modifications and changes in 
chromatin architecture. It has previously been reported that acute FS stress indeed results in distinct 
epigenetic changes including histone modifications (Gutierrez-Mecinas et al., 2011) and DNA 
demethylation (Saunderson et al., 2016). Thus, under changing physiological (environmental) 
conditions, access to the chromatin landscape is likely to alter, shaping accessibly of binding motifs and 
thereby MR and GR binding patterns. 
 
A number of MR and GR peaks were shown to lack a GRE motif, the majority of which were bound 
constitutively under all physiological conditions. The most prominent motifs present within loci lacking 
a GRE differed substantially for the MR and the GR. For the MR, apart from RFX which is only found 
within the top-5 of CON MR peaks, the motifs associated with non-GRE-containing loci overlapped with 
the top-5 motifs within all MR peaks, indicating that MR can bind these motifs in the presence or 
absence of a GRE. GR binding to non-GRE-containing loci was associated with a very different motif 
profile compared with the top-5 most prominent motifs within all GR peaks. It seems, that in the absence 
of a GRE, GRs may bind NR, STAT, PAX, EGR and RARG motifs. The high incidence of MR and GR 
binding to loci that do not contain a GRE element prompts the question whether these receptors bind 
directly or indirectly to such non-GRE motifs. An indirect action of MR and/or GR at a non-GRE motif 




analyses revealed the induction of the respective transcription factor RNAs for members of the EGR 
and KLF superfamilies of transcription factors following acute stress and/or circadian influences. 
Constitutive RNA expression of a number of members of the SP, RFX, ZNF and NR, PAX and RARG 
superfamilies was also observed. Strikingly, we found that a number of genes (i.e. Klf2, Klf7, Klf9, Klf13, 
Klf15) showed increased MR and GR binding after stress or at the circadian rise. Previously, FS was 
shown to induce EGR1 in distinct hippocampal neurons; a process requiring a convergence of NMDAR-
mediated MAPK/ERK and (non-genomic) GR signalling, formation of the dual histone mark H3K14ac-
S10p at the gene promoter, as well as DNA demethylation of the promoter and 5’-UTR of the Egr1 gene 
(Saunderson et al., 2016, Gutierrez-Mecinas et al., 2011, Chandramohan et al., 2008). Moreover, Chen 
et al. recently provided evidence that GR and EGR1 interact at the EGR motif within the Bdnf gene 
(Chen et al., 2019). Such interactions have also been reported for GR and STAT3/STAT5b, and GR 
and KLF2/KLF4/KLF9 at STAT and KLF/GRE binding motifs, respectively, in various cell types 
(Engblom et al., 2007, Petta et al., 2016, Chinenov et al., 2014, Sevilla et al., 2015). Thus, it may be 
that corticosteroid receptor action involves direct interaction with GRE motifs and indirect interactions 
via other transcription factors with their intrinsic binding motifs, whereby GCs can enhance the latter 
mode of interaction through induction of the respective transcription factor.  
  
The Ribo-Zero RNA sequencing method detected more than 3-times the number of responsive genes 
when considering intronic versus exonic expression. Thus, this data supports that assessment of 
intronic expression is a much more sensitive approach to detect changes in gene transcription due to 
acutely changing physiological conditions. This notion is reflected in the numbers of responsive intronic 
vs exonic RNAs in the sub-divided data sets CE, SE and SR&CR. There were more than 6-times as 
many genes with SE differential inRNA expression than there were genes with SE differential exRNA 
expression. In contrast, the number of genes with CE inRNA and exRNA responses were similar, 
possibly because the circadian rise targets less acutely changing RNAs. Correlation analysis between 
ChIP- and RNA-Seq datasets indicated that in particular changes in MR binding were significantly 
correlated with associated intronic and exonic RNA responses under both stress and circadian 
conditions. Changes in GR binding were only correlated with inRNA responses when data from both 
physiological conditions were considered. It was surprising that more significant positive correlations 




responsive to stress- and circadian-induced changes than MR (Reul and de Kloet, 1985, De Kloet and 
Reul, 1987). Furthermore, in early work in vitro, GR has been shown to have much stronger 
transactivation potency than MR (Rupprecht et al., 1993). Presently, the exact reason for the relative 
deficiency of correlation between GR binding and corresponding RNA responses is unclear. An 
additional factor affecting the relationship between MR/GR binding and gene transcription is the 
phenomenon of chromatin looping enabling transcription factor-bound enhancers to interact with gene 
promoters across substantial distances within the genome and affect transcriptional activities (Rajarajan 
et al., 2016, Matharu and Ahituv, 2015). Accordingly, MR/GR binding may not necessarily impact on 
transcription of the nearest gene to which it has been annotated. As a consequence, chromatin looping 
may have contributed to a certain level of ‘fuzziness’ in the cross-correlation of MR/GR binding and 
gene transcriptional responses. The contribution of this phenomenon will need to be clarified by future 
chromatin conformation capture (3C) analyses. Furthermore, epigenetic factors determining MR/GR 
binding as well as binding of and interaction with other transcription factors may have influenced MR/GR 
binding and associated transcriptional responses. The identification of multiple recognition sites other 
than GREs underline such putative involvement. Future studies involving comprehensive transcription 
factor (co-)binding and epigenomic analysis in combination with whole-genome 3C (Hi-C) and intron-
transcriptomics will shed further light on the relationship between MR/GR binding and gene 
transcriptional responses. 
 
The data presented in this Chapter shows that the interaction of MRs and GRs with the hippocampus 
genome in vivo is highly complex, involving interactions with GREs and possibly other transcription 
factors. These interactions can be constitutive and, depending on the environmental circumstances 
(stress, active phase of circadian cycle), can be enhanced resulting in gene transcriptional changes. 
The main physiological effector is CORT whose increased secretion after stress and during the 
circadian rise is key to the activation of GR in particular. In addition, however, there are countless co-
regulators, (GC-inducible and constitutively expressed) transcription factors, and epigenetic modulators 
requiring further examination to fully elucidate MR’s and GR’s interaction with the genome, and how, 





Chapter 4 Pathway analysis of hippocampal genome-wide ChIP-seq and RNA- 
seq following acute stress and during the circadian rise  
4.1  Abstract 
GC hormones are critical regulators of many vital physiological processes and the genomic actions of 
GCs, via hippocampal MRs and GRs, are essential for adaptation to external stressors. Despite the 
importance of hippocampal GC hormone action in adaptation and survival, the genomic actions of MRs 
and GRs within the hippocampus at a genome-wide level remains yet to be fully elucidated. For the first 
time, MR and GR ChIP-seq has been integrated with RNA-seq, providing a comprehensive insight into 
the genomic actions of MRs and GRs in the rat hippocampus under physiological conditions of 
relevance for GC secretion. These ChIP- and RNA-seq analyses have revealed over 1,000 genome-
wide loci to which MRs and/or GRs bind and many more genes exhibiting transcriptional responses 
under acute stress and circadian peak and trough conditions. Though the findings of ChIP- and RNA-
seq have provided an unprecedented insight into the genomic actions of MRs and GRs in the 
hippocampus, the biological relevance of these findings require interpretation.  
Ingenuity Pathway Analysis (IPA), a highly sophisticated pathway analysis programme, was used to 
analyse MR and GR ChIP-seq and RNA-seq datasets of rat hippocampus following acute stress and 
circadian conditions. Genes exhibiting MR and/or GR binding and/or changes in RNA expression were 
linked to signalling pathways such as circadian rhythm signalling and glucocorticoid receptor signalling, 
and upstream regulators such as heat shock proteins, circadian enzymes and circadian transcriptional 
regulators, underscoring the high specificity of the analyses. Biological processes involved in 
neurodevelopment, hippocampal functions and synaptic functions were predicted to be affected by 
genes in the target datasets, demonstrating the diversity of important neurobiological functions under 
GC hormone regulation. Moreover, neurological diseases such as Alzheimer’s disease, epilepsy and 
Parkinson’s disease were all predicted to be linked to genes in the target datasets, indicating a 
relevance for GC hormone action in these poorly understood diseases. The output of these pathway 
analyses provides a valuable resource in understanding how the genomic targets of MRs and GRs may 





4.2  Introduction 
Decades of research and thousands of publications have established the importance of GC hormone 
action in maintaining homeostasis, facilitating adaptation to external stressors and developing resilience 
to promote survival (Reul et al., 2015). A number of vital physiological processes are under GC 
regulation, while genomic GC hormone action in the hippocampus via MRs and GRs influences learning 
and memory formation and facilitates behavioural changes that allow adaptation following stressful 
events. Furthermore, GC hormones have been implicated in a wide range of devastating 
neuropsychiatric disorders that demonstrate hippocampal pathologies, such as depression (Sheline et 
al., 1996), post-traumatic stress disorder (Maes et al., 1998) and schizophrenia (Seo et al., 2018, 
Sinclair et al., 2011), however the link between GC hormone action in the hippocampus and the 
development of these disorders remains yet to be elucidated. In Chapter 3, genome wide ChIP- and 
RNA-seq has provided unprecedented insight into the genomic actions of MRs and GRs in the rat 
hippocampus under stress and circadian conditions. In this chapter, datasets generated in these studies 
were further examined to determine the biological relevance of these findings and to establish links 
between GC hormone action, biological processes and disease pathophysiology.  
Pathway analysis has been developed to facilitate the meaningful biological interpretation of data arising 
from high throughput next generation sequencing experiments, that often generate an output of 
thousands of genes whose functions are unknown at a network level. A number of pathway analysis 
programmes are freely available, including Database for Annotation, Visualization and Integrated 
Discovery (DAVID), Gene Ontology (GO), Kyoto Encyclopaedia of Genes and Genomes (KEGG) and 
Protein Analysis Through Evolutionary Relationships (PANTHER). These programmes have offered 
insight when interpreting data from sequencing experiments, however they fail to provide detailed and 
directional molecular information regarding genomic targets. Ingenuity pathway analysis (IPA) “Core 
Analysis”, however, offers a far more comprehensive analysis and integration of sequencing data. From 
the reference dataset, IPA can identify upstream regulators, predicting downstream effects on biological 
and disease processes and generating networks of genes in the reference dataset. Pathway analysis 
performed on MR/GR ChIP-seq and RNA-seq data has so far been underwhelming, offering very limited 
insight to the consequences of GC hormone action at a network level. DAVID has been used to analyse 
GR ChIP-seq data derived from neuronal PC12 cells (Polman et al., 2012) and hippocampus of ADX 




genes arising from in vitro GR ChIP-seq included “metal ion binding” and “protein tyrosine kinase 
activity” (Polman et al., 2012), while pathway analysis of in vivo GR hippocampal ChIP-seq highlighted 
processes such as “enzyme binding”, “apoptosis” and “positive regulation of transcription” (Polman et 
al., 2013). GC hormones may be relevant for these processes; however, it is unclear how these results 
contribute to and improve our wider understanding of GC hormone action in the hippocampus. DAVID 
was also used to analyse the 7,000 enrichment sites found in rat hippocampus (Pooley et al., 2017), 
however the high number of peaks and low replicate number in the study causes concern regarding the 
interpretation of the pathway analysis. Many of these peaks may simply be artefacts as these 7,000 
comprise the top 20% of each group, indicating that many more peaks were identified. The peaks were 
also aligned to Rnor_5.0, an outdated version of the rat genome, therefore it is possible that certain 
genes have moved location thus the annotations are not the most up to date possible. Pathway analysis 
of MR and GR ChIP-seq datasets of ADX rats by DAVID did enable the identification of pathways 
specific to or shared between both receptors, however terms were yet again quite general, such as “cell 
adhesion” and “sodium channel activity” (van Weert et al., 2017). Moreover, none of these studies have 
integrated ChIP-seq with RNA-seq and are based on the assumption that MR/GR bound genes are 
regulated by the receptor. Binding of MR and/or GR, however, does not always lead to a transcriptional 
response of the gene in closest proximity, therefore pathway analysis of genes annotated to MR/GR 
peaks is liable to misinterpretation. Clearly, current pathway analysis of hippocampal ChIP-seq and 
RNA-seq under physiological conditions of relevance for GC-secretion is lacking.  
Datasets from our ChIP- and RNA-seq experiments described in Chapter 3 underwent “Core Analysis” 
by IPA software, which predicted canonical pathways, upstream regulators and diseases and functions 
associated with the genes in these datasets. Many predictions made by IPA validated the high 
specificity of our ChIP- and RNA-seq experiments, as the genes in these datasets were predicted to 
participate in well-established GC-regulated signalling pathways and biological processes including 
glucocorticoid receptor signalling, learning and memory. In addition to highlighting well known upstream 
regulators, such as heat shock proteins, IPA emphasised previously reported links between several 
transcription factor families, like the KLFs, and genes in our datasets. The analyses also highlighted 
neurodevelopmental processes such as neuritogenesis, development of neurons and differentiation of 
the nervous system, of which GC hormones have been shown to play a role in, however the molecular 




and neurological diseases and neuropsychiatric disorders not yet strongly linked to GC hormone action, 
such as epilepsy and schizophrenia. Although HPA-axis irregularities and stressful experiences have 
been implicated in these disorders (Wolff and Huston, 1959, Nakken et al., 2005), it is unclear whether 
genomically acting MRs and GRs are involved in their aetiology. These data provide so far, the most in 
depth pathway analysis of the genes targeted following hippocampal stress or circadian input, and the 
biological process and diseases potentially influenced consequently. Many novel targets for further 
exploration have been highlighted and these data shall certainly provide a resource for future studies 




















4.3  Materials and Methods 
4.3.1 Ingenuity Pathway Analysis 
Ingenuity Pathway Analysis (IPA) software (QIAGEN Inc.,) was used to perform a “Core Analysis” on 
datasets from ChIP-seq and RNA-seq experiments to predict diseases and functions associated with 
genes becoming bound by MRs or GRs or exhibiting differential RNA expression after acute stress and 
during the circadian rise. Details regarding Core Analysis are described in Chapter 2.  
4.3.2 ChIP-seq dataset preparation 
ChIP-seq datasets comprising all genes annotated to an MR or GR peak included in DiffBind analysis 
were uploaded to IPA, as described in Chapter 2.  
4.3.3 RNA-seq dataset preparation 
RNA-seq datasets comprising all genes with significant (FDR<0.05) differential intronic RNA (inRNA) 
or exonic RNA (exRNA) expression following acute stress or the circadian rise was uploaded to IPA, as 
described in Chapter 2.  
4.3.4 Core Analysis 
A core analysis was performed on each dataset by IPA which identified canonical pathways, upstream 
regulators, diseases and functions and networks predicted to be associated with genes present in the 
dataset. The settings for all core analyses are described in Chapter 2. Core Analysis predicted canonical 
pathways, upstream regulators, diseases and functions and networks to be influenced by genes in our 
ChIP- and RNA-seq datasets. An “overlap p-value” and “z-score” were calculated as described in 










4.4.1 Canonical pathways influenced by genes annotated to MR and GR peaks or differentially 
expressed genes following acute stress or during the circadian rise 
Datasets comprising of genes annotated to MR and GR peaks or exhibiting differential inRNA or exRNA 
expression following acute stress and during the circadian rise were uploaded to IPA and a core 
analysis was performed. We found that a number of canonical pathways were predicted to be influenced 
by genes in these datasets.  
Following acute stress and during the circadian rise, genes annotated to MR and GR peaks were 
predicted (p<0.05) to influence 118 and 92 canonical pathways, respectively, while genes exhibiting 
differential inRNA and exRNA expression were predicted to be influence 266 and 181 canonical 
pathways, respectively.  
Canonical pathways associated with each dataset were examined to identify relevant pathways 
associated with our experimental model. As expected, genes present in MR ChIP, GR ChIP, inRNA 
and exRNA sequencing datasets following both acute stress and the circadian rise (Figure 4.1) were 
linked to glucocorticoid receptor signalling, circadian rhythm signalling and corticotropin releasing 
hormone signalling. The statistical significance (p-value), predicted activation state, activation z-score 
and number of genes associated with each canonical pathway and the corresponding dataset are 





















Figure 4.1 Canonical pathways predicted to be related to genes present in ChIP-seq and RNA-
seq datasets 
IPA Core analysis identified canonical pathways associated with genes present in MR and GR ChIP-
seq datasets and inRNA and exRNA RNA-seq datasets. Among these signalling pathways were 
glucocorticoid receptor signalling, circadian rhythm signalling and corticotropin releasing hormone 



























MR   0.0148 29 
GR   0.0234 18 
inRNA   0.030 35 





MR   0.0389 5 
GR   0.0219 4 
inRNA   2.089e-06 15 
exRNA   2.239e-07 7 
CRH signalling MR Activated 3.000 0.050 8 
inRNA  -0.688  21 
exRNA  0.447  7 
 
Table 4.1.  GC-hormone associated signalling pathways influenced by genes annotated to MR 
and GR peaks and genes exhibiting differential RNA expression following acute stress or during 
the circadian rise  
MR and GR ChIP-seq datasets and intronic and exonic RNA-seq datasets underwent “Core Analysis” 
by IPA. GC-hormone associated signalling pathways, such as glucocorticoid receptor signalling, 
circadian rhythm signalling and corticotropin releasing hormone (CRH) signalling pathways were 
predicted to be influenced by genes in these datasets. Activation z-scores ≥ +2 significantly predict 
pathway activation, while z-scores of ≤ -2 significantly predict pathway inhibition. Activation z-scores < 
+2 or > -2 indicate a trend towards activation or inhibition, however the prediction is not statistically 









4.4.2 Upstream Regulators of genes annotated to MR and GR peaks or genes exhibiting 
differential expression following acute stress or during the circadian rise 
IPA predicted 915 upstream regulators of MR- and GR-annotated genes, while 3323 upstream 
regulators were predicted for genes exhibiting differential inRNA and/or exRNA expression.  
Molecules previously known to be associated with GC-hormone signalling were identified among the 
predicted upstream regulators of genes present in ChIP- and RNA-seq datasets, such as GC 
cochaperones and receptors (Table 4.2), circadian enzymes and circadian transcriptional regulators 
(Table 4.3).  
Findings of upstream regulator prediction were examined for the corresponding transcription factors of 
the top transcription factor binding motifs present in MR and/or GR binding sites, as discussed in 
Chapter 3. Notably, EGR family members (Table 4.4), KLF family members (Table 4.5) SP family 
members (Table 4.6), ZNF family members (Table 4.7) were predicted as upstream regulators of genes 
in the ChIP-seq and RNA-seq datasets.  
Based on experimental evidence of an interaction between GR and the NMDA-R activated MAPK-ERK 
pathway as reported previously by this lab group (Chandramohan et al., 2008, Gutierrez-Mecinas et al., 
2011), results of upstream regulator prediction were searched for glutamate receptor family members, 
as shown in Table 4.8.  
The statistical significance (p-value), predicted activation state, activation z-score and number of genes 



























MR  1.715 0.0377 4 
GR   0.0358 3 
inRNA  1.067 0.0228 5 
Hsp27 inRNA   0.0476 7 
exRNA  0.365 4.33e-04 5 
GR 
 
MR Activated 2.604 1.01e-06 69 
GR Activated 3.84 2.08e-11 57 
inRNA Activated 2.534 4.18e-07 97 





1.046 5.27e-03 14 
GR Activated 2.359 3.98e-06 15 
inRNA Activated 2.404 4.05e-03 17 
exRNA Activated 3.396 3.02e-05 16 
 
Table 4.2 Molecules associated with GC-hormone signalling are predicted upstream regulators 
of genes annotated to MR and/or GR peaks and genes exhibiting differential RNA expression 
following acute stress or during the circadian rise 
IPA Core analysis was performed on ChIP-seq and RNA-seq datasets comprising genes annotated to 
MR and/or GR peaks and genes exhibiting differential RNA expression following acute stress or during 
the circadian rise. Molecules known to interact with MRs and GRs, such as heat shock proteins and 
glucocorticoid receptors themselves were predicted as upstream regulators of genes in these datasets. 
Heat shock protein 27 (Hsp27), heat shock protein 70 (Hsp70), Glucocorticoid receptor (GR), 
Mineralocorticoid receptor (MR). Activation z-scores ≥ +2 significantly predict pathway activation, while 
z-scores of ≤ -2 significantly predict pathway inhibition. Activation z-scores < +2 or > -2 indicate a trend 
towards activation or inhibition, however the prediction is not statistically significant. Statistical analysis: 



















CLOCK MR  1.925 9.98e-03 16 
GR  1.925 08.50e-03 11 
inRNA Activated 3.185 7.51e-10 49 
exRNA  1.421 4.17e-09 21 
CRY1 MR 
 
 0.0334 3 
GR   7.32e-03 3 
inRNA  -1.205 0.0118 4 
exRNA  -1.000 5.54e-07 6 
CRY2 MR 
 
 0.0334 3 
GR   7.32e-03 3 
inRNA  -0.152 0.0118 5 
exRNA  -0.124 1.09e-08 6 
 
Table 4.3 Circadian associated enzymes and transcriptional regulators are predicted upstream 
regulators of genes annotated to MR and GR peaks and genes exhibiting differential RNA 
expression following acute stress or during the circadian rise 
Datasets comprising genes annotated to significant MR and GR peaks and genes exhibiting differential 
RNA expression following acute stress or during the circadian rise were analysed by IPA. Core analysis 
predicted circadian enzymes and circadian transcriptional regulators as upstream regulators of genes 
in these datasets. Clock circadian regulator (CLOCK), cryptochrome circadian regulator 1 (CRY1), 
cryptochrome circadian regulator (CRY2). Activation z-scores ≥ +2 significantly predict pathway 
activation, while z-scores of ≤ -2 significantly predict pathway inhibition. Activation z-scores < +2 or > -
2 indicate a trend towards activation or inhibition, however the prediction is not statistically significant. 



















EGR1 inRNA  0.923 9.15e-05 29 
 exRNA  1.979 1.71e-11 19 
EGR2 
 
MR Activated 3.203 2.31e-03 18 
GR Activated 3.274 3.6e-03 12 
inRNA  0.793 8.51e-05 26 
 exRNA  1.094 3.7e-07 13 
EGR3 GR  -1.000 0.0297 4 
inRNA  -1.091 0.0132 8 
 exRNA   0.0232 3 
 
Table 4.4 EGR transcription factor family members are predicted upstream regulators of genes 
present in datasets produced by MR/GR ChIP-seq and intronic/exonic RNA-seq  
EGR transcription factor family members were predicted, by IPA core analysis, as upstream regulators 
of genes annotated to MR and GR peaks and genes exhibiting differential RNA expression following 
acute stress or during the circadian rise. Early growth response (EGR). Activation z-scores ≥ +2 
significantly predict pathway activation, while z-scores of ≤ -2 significantly predict pathway inhibition. 
Activation z-scores < +2 or > -2 indicate a trend towards activation or inhibition, however the prediction 























KLF1 inRNA   0.0476 7 
KLF2 inRNA  1.219 0.018 19 
exRNA  -0.831 2.57e-07 13 
KLF3 GR    -1.739 0.043 17 
exRNA Inhibited -2.345 0.0455 9 
KLF4 inRNA  -1.366 6.62e-03 31 
exRNA  1.639 5.27e-06 15 
KLF5 GR  1.070 7.34e-03 6 
exRNA   0.049 3 
KLF6 MR   -0.392 0.0491 8 
GR  0.513 0.0275 6 
inRNA  -0.417 4.99e-03 12 
exRNA  -0.77 6.05e-07 9 
KLF10 exRNA   0.0228 2 
KLF15 exRNA   0.0232 3 
KLF16 exRNA   0.0411 1 
 
Table 4.5 KLF transcription factor family members are predicted upstream regulators of genes 
annotated to MR and GR peaks and genes exhibiting differential RNA expression following acute 
stress or during the circadian rise 
Datasets comprising genes annotated to MR and GR peaks and genes exhibiting differential RNA 
expression following acute stress or during the circadian rise were analysed by IPA. Core analysis 
predicted KLFs as upstream regulators of genes in these datasets. Krüppel-like factor (KLF). Activation 
z-scores ≥ +2 significantly predict pathway activation, while z-scores of ≤ -2 significantly predict pathway 
inhibition. Activation z-scores < +2 or > -2 indicate a trend towards activation or inhibition, however the 
















SP1 MR  Activated 3.182 0.0448 41 
inRNA  -0.14 1.10e-05 70 
exRNA  0.641 3.18e-08 27 
SP2 exRNA   1.07e-03 
 
3 
SP3 inRNA  1.299 0.0272 24 
exRNA  1.404 2.3e-06 14 
SP4 exRNA   7.45e-03 3 
SP6 inRNA   0.0289 2 
 
Table 4.6 SP transcription factor family members are predicted upstream regulators of genes 
annotated to MR peaks and genes exhibiting differential RNA expression following acute stress 
or during the circadian rise 
Datasets comprising genes annotated to MR peaks and genes exhibiting differential RNA expression 
following acute stress or during the circadian rise were analysed by IPA. Core analysis predicted SP 
transcription factors as upstream regulators of genes in these datasets. Specificity Protein (SP). 
Activation z-scores ≥ +2 significantly predict pathway activation, while z-scores of ≤ -2 significantly 
predict pathway inhibition. Activation z-scores < +2 or > -2 indicate a trend towards activation or 
inhibition, however the prediction is not statistically significant. Statistical analysis: Right-tailed Fisher’s 























ZNF43 inRNA   8.25e-04 4 
ZNF148 MR   8.31e-03 4 
 GR   0.0111 3 
ZNF503 inRNA   0.0233 3 
exRNA   6.51e-03 2 
 
Table 4.7 ZNF transcription factor family members are predicted upstream regulators of genes 
annotated to MR and GR peaks and genes exhibiting differential RNA expression following acute 
stress or during the circadian rise 
Upstream regulators of genes in MR and GR ChIP-seq datasets and intronic/exonic RNA-seq datasets 
were predicted by IPA Core analysis. ZNF transcription factors were identified as upstream regulators 
of genes in these datasets. Zinc finger protein (ZNF). Activation z-scores ≥ +2 significantly predict 
pathway activation, while z-scores of ≤ -2 significantly predict pathway inhibition. Activation z-scores < 
+2 or > -2 indicate a trend towards activation or inhibition, however the prediction is not statistically 




























NMDAR MR Activated 2.425 3.24e-04 6 
GR  1.982 2.23e-03 4 
GRIA2  MR    6.84e-04  3  
GR   5.87e-03 2 
GRIN1  MR    0.021 3  
GR   0.0464 2 
GRIN2B  MR    0.0283 2  
 
Table 4.8 Glutamate receptor family members are predicted upstream regulators of genes 
annotated to MR and GR peaks following acute stress or during the circadian rise 
Genes annotated to MR and GR peaks following acute stress or during the circadian rise were analysed 
by IPA. Core analysis predicted members of the glutamate receptor family as upstream regulators of 
genes in these datasets. N-methyl-D-aspartate receptor (NMDAR), Glutamate ionotropic receptor 
AMPA type subunit 2 (GRIA2), glutamate ionotropic receptor NMDA type subunit 1 (GRIN1), glutamate 
ionotropic receptor NMDA type subunit 2B (GRIN2B). Activation z-scores ≥ +2 significantly predict 
pathway activation, while z-scores of ≤ -2 significantly predict pathway inhibition. Activation z-scores < 
+2 or > -2 indicate a trend towards activation or inhibition, however the prediction is not statistically 













4.4.3 Biological functions influenced by genes annotated to MR and GR peaks or differentially 
expressed genes following acute stress or during the circadian rise 
IPA made significant predictions between biological functions and genes in our MR, GR, inRNA and 
exRNA datasets. Biological processes of relevance to GC hormone action in the brain were selected 
for further examination and categorised into subgroups. The statistical significance (p-value), predicted 
activation state, activation z-score and number of genes associated with each category of biological 
functions and the corresponding dataset are depicted in Tables 4.9 – 4.11. 
Many hippocampal dependent processes (Figure 4.2) were associated with genes in our ChIP- and 
RNA-seq datasets including memory, spatial memory, conditioning, learning and cognition. The 
hippocampal dependent function predicted with the highest statistical significance to be associated with 
genes in our datasets; Cognition, is depicted in Figure 4.3. The subcellular localisation of MR and/or 
GR annotated genes related to cognition are shown.   
Genes present in our ChIP- and RNA-seq datasets were linked to a number of neurodevelopmental 
processes (Figure 4.4) such as neuronal maturation, branching of neurites, branching of neurons, 
neuronal morphology, nervous system differentiation, nervous system morphology, neurite growth, 
neuritogenesis, neuronal cell proliferation and neuronal development. Neuronal development was the 
most significantly predicted neurodevelopmental process associated with genes in our dataset and the 
subcellular localisation of MR and/or GR annotated genes related to this pathway can be seen in Figure 
4.5.  
Synaptic signalling processes (Figure 4.6) were shown to be linked with genes annotated to MR and/or 
GR peaks or genes exhibiting differential inRNA expression following elevations in GC hormones. Such 
processes included NMDA-mediated synaptic current, long-term depression, synaptic depression, 
synaptic plasticity, long-term potentiation and synaptic transmission. The most significant prediction 
was made between genes in our datasets and synaptic transmission, therefore Figure 4.7 shows the 






Figure 4.2 Hippocampal-dependent processes influenced by genes bound by MRs and/or GRs 
or exhibiting differential RNA expression following acute stress or during the circadian rise  
Hippocampal-dependent processes were predicted, by IPA, to be associated with genes in our ChIP- 
and RNA-seq datasets. Such processes included hippocampal dependent processes, such as memory, 
spatial memory, conditioning, learning and cognition, and genes in our ChIP- and RNA-seq datasets. 























Memory MR Activated 2.012 1.06e-05 40 
GR Activated 2.149 1.2e-04 25 
Spatial 
memory 
MR   1.706 2.41e-07 23 
GR   3.24e-05 14 
Conditioning MR Activated 3.515 6.51e-05 31 
GR Activated 3.365 3.39e-05 22 




MR Activated 2.817 2.91e-08 66 
GR Activated 3.088 2.10e-05 38 
inRNA   0.718 2.23e-10 87 
exRNA  1.622 1.80e-07 26 
Cognition MR Activated 2.525 8.99e-09 72 
GR Activated 2.969 6.67e-06 42 
inRNA  0.224 3.13e-12 98 
exRNA  1.721 2.32e-08 29 
 
Table 4.9 Genes associated with MR and/or GR binding or exhibiting differential RNA expression 
following acute stress or during the circadian rise are associated with hippocampal dependent 
processes  
Datasets comprising genes annotated to significant MR and GR peaks and genes exhibiting differential 
RNA expression following acute stress or during the circadian rise were predicted by IPA Core analysis 
to be linked to hippocampal dependent processes. Activation z-scores ≥ +2 significantly predict pathway 
activation, while z-scores of ≤ -2 significantly predict pathway inhibition. Activation z-scores < +2 or > -
2 indicate a trend towards activation or inhibition, however the prediction is not statistically significant. 























Figure 4.3 The hippocampal dependent process “Cognition” is strongly linked with genes 
exhibiting MR and/or GR binding following acute stress or during the circadian rise 
A highly significant prediction was made by IPA Core analysis between cognition and genes annotated 
to significant MR and/or GR binding peaks following acute stress or during the circadian rise. The 
subcellular localisation of 72 MR- and/or GR-annotated genes associated with the hippocampal 
dependent process; cognition, are shown. Genes highlighted in red indicate increased MR and/or GR 
binding, while genes highlighted in green indicate decreased MR and/or GR binding, with the intensity 
of the shade corresponding to the fold change in binding. Orange connections represent a significant 
prediction of enhanced cognition. Yellow connections indicate that experimental findings are 











Figure 4.4 Neurodevelopmental processes associated with genes annotated to MR and GR 
peaks or genes exhibiting differential RNA expression following acute stress or during the 
circadian rise  
Genes bound by MRs and/or GRs or exhibiting differential RNA expression following acute stress or 
during the circadian rise were linked, by IPA, to neurodevelopmental processes. These processes 
included neuronal maturation, branching of neurites, branching of neurons, neuronal morphology, 
nervous system differentiation, nervous system morphology, neurite growth, neuritogenesis, neuronal 
cell proliferation and neuronal development, and genes in our datasets. Data is expressed as the antilog 
























MR Activated 2.137 1.42e-04 14 
GR Activated 2.236 1.04e-03 9 
Branching of 
neurites 
MR Activated 2.792 5.84e-06 45 
GR Activated 2.568 4.47e-04 26 
Branching of 
neurons 
MR Activated 2.300 2.33e-06 47 
GR Activated 1.756 5.18e-05 29 
Neuronal 
morphology 
MR   3.70e-06 73 
GR   4.29e-05 45 





MR Activated 4.265 2.06e-03 
 
57 
GR Activated 3.646 1.38e-03 37 
inRNA  0.753 7.42e-11 100 
 
Table 4.10.a Neurodevelopmental functions influenced by genes annotated to MR and GR peaks 
or genes differentially expressed following acute stress or during the circadian rise 
IPA Core analysis highlighted a relationship between genes in our ChIP-seq and RNA-seq datasets 
and many neurodevelopmental functions. Neuronal maturation, branching of neurites, branching of 
neurons, neuronal morphology and nervous system differentiation were among these functions. 
Activation z-scores ≥ +2 significantly predict pathway activation, while z-scores of ≤ -2 significantly 
predict pathway inhibition. Activation z-scores < +2 or > -2 indicate a trend towards activation or 
inhibition, however the prediction is not statistically significant. Statistical analysis: Right-tailed Fisher’s 






















MR   2.59e-06 114 
GR   1.59e-06 74 
inRNA   1.60e-12 177 
Neurite growth MR Activated 3.638 3.78e-05 61 
GR Activated 2.397 6.59e-07 45 
inRNA  0.848 7.71e-14 103 
Neuritogenesis MR Activated 3.411 1.01e-10 95 
GR Activated 2.457 1.23e-09 62 
inRNA  0.656 4.59e-15 130 
Neuronal cell 
proliferation 
MR Activated 3.779 1.48e-05 71 
GR Activated 2.443 2.21e-06 49 
inRNA  0.239 3.51e-18 127 
exRNA  0.077 1.07e-06 29 
Neuronal 
development 
MR Activated 4.239 2.49e-10 117 
GR Activated 3.270 1.66e-11 81 
inRNA  0.396 2.63e-22 181 
exRNA  0.077 1.07e-06 29 
 
Table 4.10.b Neurodevelopmental functions influenced by genes annotated to MR and GR peaks 
or genes differentially expressed following acute stress or during the circadian rise 
IPA Core analysis highlighted a relationship between genes in our ChIP-seq and RNA-seq datasets 
and many neurodevelopmental functions. Nervous system morphology, neurite growth, neuritogenesis, 
neuronal cell proliferation, neuronal development. Activation z-scores ≥ +2 significantly predict pathway 
activation, while z-scores of ≤ -2 significantly predict pathway inhibition. Activation z-scores < +2 or > -
2 indicate a trend towards activation or inhibition, however the prediction is not statistically significant. 
























Figure 4.5 Neuronal development is strongly linked to genes bound by MRs and/or GRs 
following acute stress or during the circadian rise 
IPA Core analysis predicted, with high statistical significance, an association between neuronal 
development and genes annotated to MR and/or GR peaks following elevations in GC hormones. The 
subcellular localisation of these 117 MR- and/or GR-annotated genes linked to neuronal development 
can be seen. Genes highlighted in red indicate increased MR and/or GR binding, while genes 
highlighted in green indicate decreased MR and/or GR binding, with the intensity of the shade 
corresponding to the fold change in binding. Orange connections represent a significant prediction of 
enhanced neuronal development. Dashed lines represent predicted enhanced neuronal development 
of all genes within the boxed region. Yellow connections indicate that experimental findings are 












Figure 4.6 Genes bound by MRs and/or GRs or differentially expressed genes following acute 
stress and during the circadian rise are linked to synaptic functions  
Several synaptic functions were highlighted by IPA core analysis to be associated with genes in our 
ChIP-seq and RNA-seq datasets. Among the synaptic related functions were NMDA-mediated synaptic 
current, long-term depression, synaptic depression, synaptic plasticity, long-term potentiation and 
























MR   2.49e-03 5 
GR   2.14e-03 4 
Long-term 
depression 
MR Activated 2.512 1.82e-03 23 
GR Activated 3.037 1.62e-06 17 
Synaptic 
depression 
MR Activated 1.674 5.22e-08 29 
GR Activated 2.410 8.68e-08 21 
Synaptic plasticity MR  1.756 4.18e-04 19 
GR  1.982 2.13e-04 12 
inRNA  -0.488 9.98e-08 31 
Long-term 
potentiation 
MR Activated 3.287 1.84e-06 41 
GR Activated 2.984 2.35e-03 21 
inRNA  -0.260 3.48e-08 53 
Synaptic 
transmission 
MR Activated 1.389 4.65e-11 60 
GR Activated 2.342 1.01e-06 34 
inRNA Activated 2.412 4.26e-11 74 
 
Table 4.11 Synaptic functions influenced by genes annotated to MR and GR peaks or genes 
exhibiting differential inRNA expression following acute stress or during the circadian rise  
IPA predicted an association between a number of synaptic functions and genes annotated to significant 
MR and GR binding peaks or exhibiting differential inRNA expression following elevations in GC 
hormones. Synaptic functions included NMDA-mediated synaptic current, long-term depression, 
synaptic depression, synaptic plasticity, long-term potentiation and synaptic transmission. Activation z-
scores ≥ +2 significantly predict pathway activation, while z-scores of ≤ -2 significantly predict pathway 
inhibition. Activation z-scores < +2 or > -2 indicate a trend towards activation or inhibition, however the 







Figure 4.7 Synaptic transmission is strongly linked to genes bound by MRs and/or GRs following 
stress or circadian driven elevations in GC hormone secretion   
A strong significant association was made, by IPA, between synaptic transmission and genes bound by 
MRs and/or GRs following acute stress or during the circadian rise. The subcellular localisation of the 
60 MR and/or GR bound genes associated with synaptic transmission is shown. Genes highlighted in 
red indicate increased MR and/or GR binding, while genes highlighted in green indicate decreased MR 
and/or GR binding, with the intensity of the shade corresponding to the fold change in binding. Orange 
connections represent a significant prediction of enhanced synaptic transmission. Yellow connections 
indicate that experimental findings are inconsistent with the state of the downstream molecule, therefore 










4.4.4 Neurological diseases and psychological disorders influenced by MR and/or GR bound 
genes and differentially expressed genes following acute stress or during the circadian rise 
IPA made significant predictions between diseases and genes in the reference MR, GR, inRNA and 
exRNA datasets. Diseases of relevance to GC hormone action in the brain were examined further and 
were categorised into neurological diseases and psychological disorders. The statistical significance 
(p-value), predicted activation state, activation z-score and number of genes associated with each 
category of neurological disease or psychological disorder and the corresponding dataset are depicted 
in Table 4.12 and Table 4.13. 
Neurological diseases (Figure 4.10) linked to genes in our ChIP- and RNA-seq datasets included 
Huntington’s disease, epilepsy, Parkinson’s disease, cognitive impairment and Alzheimer’s disease. A 
strong association was made between genes in our ChIP- and RNA-seq datasets and epilepsy, thus 
the subcellular localisation of MR- and/or GR-annotated genes predicted to be involved in this 
neurological disease can be seen in Figure 4.9.  
Genes in our ChIP- and RNA-seq datasets were associated with psychological disorders (Figure 4.12) 
such as anxiety, depressive disorder and schizophrenia spectrum disorder. Schizophrenia spectrum 
disorder was predicted with the highest statistical significance to be linked with genes in our ChIP- and 
RNA-seq datasets, therefore the subcellular localisation of MR and/or GR annotated genes associated 
















Figure 4.8 Neurological diseases are linked to genes bound by MRs and/or GRs or genes 
exhibiting differential expression following stress or circadian driven elevations in GC hormone 
secretion  
A number of neurological diseases were shown to be related to genes annotated to MR and GR peaks 
and differentially expressed genes following acute stress or during the circadian rise. Such diseases 
included Alzheimer’s disease, Parkinson’s disease, cognitive impairment, Huntington’s disease and 


























MR   4.76e-04 69 
GR   2.94e-03 41 
Parkinson’s 
disease 
MR   2.50e-05 38 
GR   1.77e-04 37 
Cognitive 
impairment 
MR  -0.365 4.13e-04 56 
GR  1.342 1.25e-04 38 
inRNA  0.283 3.28e-09 112 
Huntington’s 
disease 
MR   8.56e-09 83 
GR   4.87e-10 59 
inRNA   7.13e-19 127 
exRNA   9.81e-11 36 
Epilepsy MR  0.194 3.30e-08 54 
GR  0.218 1.80e-07 36 
inRNA  -1.599 6.44e-21 97 
 exRNA   9.52e-18 37 
 
Table 4.12 Genes annotated to MR and/or GR peaks or genes differentially expressed following 
acute stress or during the circadian rise are associated with neurological diseases  
A relationship was shown by IPA between genes in our ChIP- and RNA-seq datasets and neurological 
diseases such as Alzheimer’s disease, Parkinson’s disease, cognitive impairment, Huntington’s 
disease and epilepsy. Activation z-scores ≥ +2 significantly predict pathway activation, while z-scores 
of ≤ -2 significantly predict pathway inhibition. Activation z-scores < +2 or > -2 indicate a trend towards 
activation or inhibition, however the prediction is not statistically significant. Statistical analysis: Right-







Figure 4.9 Epilepsy is highly associated with genes bound by MRs and/or GRs and genes 
exhibiting differential RNA expression following acute stress or during the circadian rise 
A strong link was predicted by IPA between epilepsy and genes in our ChIP-seq and RNA-seq datasets. 
The subcellular localisation of 54 genes bound by MRs and/or GRs following stress or circadian driven 
elevations in GC hormone secretion is depicted. Genes highlighted in red indicate increased Mr and/or 
GR binding, while genes highlighted in green indicate decreased Mr and/or GR binding, with the 
intensity of the shade corresponding to the fold change in binding. Orange connections represent 
activation of epilepsy. Yellow connections indicate that experimental findings are inconsistent with the 










Figure 4.10 Psychological disorders are linked to genes annotated to MR and GR peaks and 
differentially expressed genes following acute stress or during the circadian rise 
Psychological disorders, such as anxiety, depressive disorder and Schizophrenia spectrum disorder 
are associated with and genes bound by MRs and/or GRs and genes exhibiting differential inRNA 
expression following stress or circadian driven elevations in GC hormone secretion. Data is expressed 

























Anxiety MR  0.465 3.33e-05 31 
GR  0.492 1.73e-04 20 
inRNA  1.425 1.22e-07 44 
Depressive 
disorder 
MR  -0.987 1.33e-04 39 
GR   1.99 e-03 23 
inRNA  0.769 4.32e-08 58 
Schizophrenia 
spectrum disorder 
MR   4.91 e-06 66 
GR   3.99e-04 38 
 inRNA   4.34e-12 100 
 
Table 4.13 Psychological disorders related to genes bound by MRs and/or GRs or genes 
exhibiting differential inRNA expression following stress or circadian driven elevations in GC 
hormone secretion 
IPA highlighted a relationship between the psychological disorders; anxiety, depressive disorder and 
schizophrenia spectrum disorder and genes in our ChIP- and RNA-seq datasets. Activation z-scores ≥ 
+2 significantly predict pathway activation, while z-scores of ≤ -2 significantly predict pathway inhibition. 
Activation z-scores < +2 or > -2 indicate a trend towards activation or inhibition, however the prediction 






























Figure 4.11 Schizophrenia spectrum disorder is strongly linked to genes bound by MRs and/or 
GRs and genes exhibiting differential inRNA expression following acute stress or during the 
circadian rise  
A highly significant association was made by IPA between schizophrenia spectrum disorder and genes 
in our ChIP- and RNA-seq datasets. The subcellular localisation of 64 genes annotated to MR and/or 
GR peaks following stress and circadian driven elevations in GC hormone secretion is shown. Genes 
highlighted in red indicate increased MR and/or GR binding, with the intensity of the shade 
corresponding to the magnitude of increased binding. Blue connections represent a significant 














“Core analysis” of ChIP- and RNA-seq datasets by IPA has provided a detailed, comprehensive insight 
into the biological processes and diseases which may be under GC hormone regulation in the 
hippocampus under stress and circadian conditions. Several upstream regulators of genes within the 
reference datasets were also predicted by IPA, allowing for the identification of molecules potentially 
acting as coregulators of MRs and GRs in orchestrating the genomic response to stress and the 
circadian rise. Furthermore, numerous biological processes and diseases not specifically associated 
with the hippocampus have been highlighted, enabling the extrapolation of these predictions to GC 
hormone action throughout the brain. These findings have confirmed the high specificity of the ChIP- 
and RNA-seq analyses, while highlighting previously unknown genes and molecular targets for further 
exploration and validation. 
The significant associations made between the genes in all four datasets with glucocorticoid receptor 
signalling, circadian rhythm signalling and CRH signalling highlights the specificity of the ChIP- and 
RNA-seq analyses under both stress and circadian conditions. Glucocorticoid receptor signalling is 
logical when looking at MR and GR. Nevertheless, inRNA and exRNA are also linked with this pathway, 
underlining an overall importance of GCs in the RNA response to stress. Our experimental model is 
consistent with circadian rhythm signalling, while CRH signalling is noteworthy as this hormone is the 
central stress mediator in the brain (Gjerstad et al., 2018). Moreover, the MR and GR were predicted 
as upstream regulators of genes in our datasets, and for both ChIP datasets, the GR was the most 
highly significant upstream regulator predicted by IPA. Well established GC receptor cochaperones 
were also identified as upstream regulators of genes in the target datasets, such as heat-shock proteins 
Hsp70 and Hsp90. These proteins play an essential regulatory role in the assembly and activity of MRs 
and GRs. Hsp70 regulates the folding of de novo synthesised GR, while Hsp90 is essential for the 
processing of GR to its mature form capable of binding GC hormones (Grad and Picard, 2007). Hsp90 
also regulates GRs affinity for ligand (Nemoto et al., 1990) and the interactions between GR and DNA 
(Cadepond et al., 1991).  
Regarding the circadian rhythm, IPA predicted the circadian transcriptional regulators CLOCK, CRY1 
and CRY2 as upstream regulators of genes in our ChIP- and RNA-seq datasets. CLOCK is a key TF 




regulation of GC action at local target tissues by increasing the sensitivity of target tissues to GC 
hormones in the active phase and decreasing tissue sensitivity to GCs during the inactive phase 
(Nicolaides et al., 2014). CLOCK has been demonstrated to reduce the ability of human GR (hGR) to 
influence target gene expression by inducing post-translational modifications within the hGR hinge 
region, thus attenuating hGR binding to GREs. GC-target gene expression was shown to fluctuate in a 
circadian fashion, mirroring in reverse phase the Clock/Bmal1 expression (Nader et al., 2009). CLOCK 
and BMAL1 have also been shown to induce the expression of the circadian co-regulators, Cry1 and 
Cry2 (Oster et al., 2017), which can interact with the GR resulting in genome wide transcriptional 
responses, including the induction of Per1 and Sgk1 (Lamia et al., 2011). 
As previously discussed in Chapter 3, genome-wide MR and GR peaks were highly associated with TF 
binding motifs other than the classical GRE. Interestingly, a number of the corresponding TFs 
associated with these motifs, specifically EGRs, KLFs, SPs and ZNFs, were predicted as upstream 
regulators of genes in the reference datasets. Thus, these TFs share many downstream genomic 
targets with MRs and GRs. The observations from the motif analyses and pathway analyses suggest 
that MRs and GRs may interact with these TFs, thereby indirectly binding to the corresponding motif in 
order to coregulate the transcription of shared target genes. Many findings of in vitro experiments 
support these observations as: 1. The GR has been shown to physically interact with EGR1 at an EGR 
response element (Chen et al., 2019); 2. Co-localisation of GR and ZNF764 binding sites (Fadda et al., 
2017) and KLF binding sites (Chinenov et al., 2014) has been reported; and 3. An indirect interaction 
between GRs and SP1 at Sp-1 binding sites has been demonstrated (Ou et al., 2006).  
Downstream biological processes highlighted by IPA were examined for TFs predicted as upstream 
regulators of genes in our ChIP- and RNA-seq datasets. Although EGR and SP genes were not found 
to be associated with a biological pathway of interest, a number of KLF and ZNF genes were. Klf9 and 
Klf15 were highlighted in neurodevelopmental processes, synaptic plasticity, anxiety, learning, and 
cognition. Klf9 homozygous knockout mice have been found to show impaired differentiation of dendritic 
spines in the DG, impaired maturation of adult-born DG neurons, reduced synaptic plasticity and 
impairments in anxiety-like behaviours and contextual fear discrimination learning (Scobie et al., 2009). 
KLF15 has been implicated in the regulation of glial development, with an overexpression of the protein 
resulting in the induction of Glial fibrillary acidic protein (GFAP) expression in astrocytes of mouse spinal 




ZFP191 protein, which is encoded by the Znf24 gene, was shown to play a critical regulatory role in the 
myelination of CNS oligodendrocytes in mice (Howng et al., 2010), while the absence of DISC1-binding 
zinc finger protein encoded by the Znf365 gene resulted in an irregular morphology of cortical basket 
cells (Koyama et al., 2013). 
Glutamate receptor family members were predicted as upstream regulators of the genes in the 
reference datasets. Their corresponding ligand, glutamate, is the primary excitatory neurotransmitter 
found in the brain. It is likely that a finely tuned balance of glutamatergic and GABAergic signalling may 
serve to potentiate and dampen neuronal activity following the stress response or the circadian drive. 
IPA made a prediction between the upstream regulator, NMDAR, and downstream Fos activation. This 
prediction agrees with previous work of our research group, which has demonstrated an interaction 
between activated GRs and the NMDAR-activated MAPK-ERK pathway, resulting in induction of Fos 
expression within the DG  and the consolidation of long-lasting behavioural responses in response to 
an acutely stressful challenge (Chandramohan et al., 2007, Gutierrez-Mecinas et al., 2011). Glutamate 
receptor genes, including Gria1, Gria2, Grin2a and Grin2b were linked to downstream biological 
processes enriched for genes in our ChIP- and RNA-seq datasets, such as synaptic transmission and 
LTP, which have been strongly linked with GC hormone activity (Diamond et al., 1992). The strong 
electrophysiological effects of GC hormones are well-established, yet the underpinning mechanisms 
are unclear. One mechanism is via rapidly acting membrane GC receptors (Hua and Chen, 1989, 
Tasker et al., 2005) while the other is via slower genomically mediated effects. The latter are still poorly 
characterised; however, our work contributes to the elucidation of electrophysiological activities of 
genomically acting GC receptors, by identifying GC target genes potentially participating in LTP and 
synaptic transmission. 
Gria1 and Gria2 genes encode for AMPA receptor subunits GluR1 and GluR2, respectively, that form 
heterocomplexes in the hippocampus and mediate synaptic transmission (Shi et al., 2001). GluR1 (also 
known as GluA1) has been implicated in LTP and memory formation, and was shown to regulate the 
activity pattern of LTP in CA1 pyramidal neurons (Frey et al., 2009). Grin2a and Grin2b genes encode 
for the GluN2A and GluN2B proteins, respectively, which have been shown to play a role in 
hippocampal LTP and LTD, while GluN2B may regulate spatial memory consolidation (Ge et al., 2010).  
A number of neurological diseases and psychological disorders were also associated with these genes, 




Decreased anxiety-like behaviour has been observed in Grin2a homozygous KO mice (Ryan et al., 
2013). The link between Gria1 and anxiety is unclear, however, as homozygous KO mice have exhibited 
both increased (Fitzgerald et al., 2010) and decreased anxiety-like behaviours (Vekovischeva et al., 
2004). Impairments in spatial learning were observed in homozygous KO Grin2a mice (Sakimura et al., 
1995). Alzheimer’s disease in humans has been associated with a downregulation of Grin2a mRNA 
and GRIN2A protein levels in the hippocampus, motor cortex and cingulate gyrus (Hynd et al., 2004) 
and upregulated Gria2 mRNA in the PFC (Williams et al., 2009). Downregulated levels of Gria1 and 
Grin2a mRNA have been observed in the PFC and perirhinal cortex, respectively, in humans suffering 
with major depression (Beneyto and Meador-Woodruff, 2008).  
A number of genes encoding for synapse-related proteins, such as Syn1, Syn2, Synj1 and Synpo were 
also among genes enriched for biological processes such as synaptic transmission and LTP, and 
neurological diseases such as Alzheimer’s disease. Exposure to chronically high GC levels led to 
significantly lower hippocampal levels of synaptopodin, the protein product of Synpo in the mouse brain 
(Cohen et al., 2011). Chronically stressed rats show decreased hippocampal expression of synapsin, 
the protein product of Syn1 (Schmidt et al., 2015). As GCs strongly regulate LTP, it is possible that 
these synapse-related proteins may be genomic targets participating in this regulation. Syn2 plays a 
critical role in maintaining a balance between synaptic excitation and inhibition, as homozygous KO of 
this gene results in an over-excitable phenotype, with increased spontaneous synaptic activity in the 
hippocampal CA1 region (Feliciano et al., 2013). Expression of synaptopodin, the protein encoded by 
Synpo was shown to be critical for hippocampal LTP in the developing mouse (Zhang et al., 2013) and 
Synpo KO mice demonstrated impaired LTP and spatial learning (Deller et al., 2003). In a mouse model 
of Alzheimer’s disease, heterozygous KO of Synj1 has been shown to decrease cognitive impairment 
(Zhu et al., 2013) and suppress the inhibitory effect of amyloid-β (Aβ), a peptide linked to cognitive 
defects in Alzheimer’s disease, on hippocampal LTP (Berman et al., 2008). Chronic stress exposure 
has also been linked to increased expression of Bace1, which produces a protein involved in Aβ 
cleavage (Cordner and Tamashiro, 2016). 
The potent brain neurotrophin, Bdnf, was also amongst the genes in the target datasets predicted to 
play a role in biological process such as synaptic transmission and learning and memory formation. 
Bdnf expression has been implicated in both short- and long-term memory (Suzuki et al., 2011), and 




Alberini, 2014). Moreover, interactions between GR and EGR1 have been shown to critically regulate 
the expression of the Bdnf isoform Bdnf4 (Chen et al., 2019). BDNF has also been shown to play a role 
in synaptic transmission (Pattwell et al., 2012) and dendritic development (Martin and Finsterwald, 
2011). In the hippocampus, GRs were shown to mediate memory consolidation via neural plasticity 
pathways activated by BDNF (Chen et al., 2012). These findings suggest that MRs and GRs may 
regulate hippocampal memory formation via targeting Bdnf, and the signalling pathways regulated by 
BDNF. 
An association was made by IPA between genes in the reference datasets and neurological disorders 
which have not (yet) been directly linked to GC hormone action, such as epilepsy and schizophrenia. 
Among the genes predicted to play a role in epilepsy were synaptic protein coding genes Syn2 and 
Synj1, the neurotrophin Bdnf and glutamate receptor subunit gene Gria2. GC hormones are not widely 
implicated in the aetiology of epilepsy, however the observation that MRs and GRs target epilepsy-
related genes suggests a potential link. Moreover, the frequent co-occurrence of depression, a disorder 
strongly associated with HPA axis activity, alongside epilepsy has initiated exploration of the role GCs 
may play in this disorder. In rat models of epilepsy, plasma CORT levels were elevated during the period 
between seizures (Mazarati et al., 2009) and in humans experiencing stress-sensitive seizures, levels 
of cortisol were shown to correlate positively with the incidence of epileptiform discharges (van Campen 
et al., 2016). Epilepsy in humans has been associated with increases in neocortical Bdnf mRNA 
(Beaumont et al., 2012) and genetic mutations in Gria2 (Lesca et al., 2013), Synj1 (Hardies et al., 2016) 
and Syn2 (Lakhan et al., 2010). 
A prediction was also made between schizophrenia and genes in our ChIP- and RNA-seq datasets by 
IPA, including Bdnf, Grin2a, Syn2, Syn3 and most notably the Disrupted-In-Schizophrenia 1 (Disc1) 
gene. At present it is unclear whether a link between schizophrenia and HPA activity exists, however a 
number of observations support the possibility. In particular, changes in neuronal morphology (Brown 
et al., 2005, Cook and Wellman, 2004, Luczynski et al., 2015) and reductions in hippocampal volumes 
(Starkman et al., 1992) reported following exposure to elevated GC levels, following chronic stress 
exposure or in disorders such as Cushing’s disease, have also been observed in schizophrenia (Nelson 
et al., 1998). Changes in the mRNA expression of Bdnf (Paz et al., 2006, Pillai, 2008, Wong et al., 2010) 
and Grin2a (Beneyto and Meador-Woodruff, 2008, Dracheva et al., 2001) have been reported in many 




(Hurko and Ryan, 2005) and hippocampal expression of the Syn3 protein (Vawter et al., 2002) have 
been associated with schizophrenia in humans.  
Interactions between the DISC1 scaffold protein and several proteins involved in dopaminergic 
signalling is thought to underlie the role of the Disc1 gene in schizophrenia, as dopamine has been 
widely implicated in the aetiology of psychotic disorders (Dahoun et al., 2017). Mutations in the Disc1 
gene have been strongly associated with schizophrenia in humans (Ayala et al., 2007, Callicott et al., 
2005, Hurko and Ryan, 2005) and the gene has been used as a biomarker in the diagnosis of 
schizophrenia (Pangalos et al., 2007). The neurodevelopmental hypothesis of schizophrenia proposes 
that a disruption of brain development during early life underlies the manifestation of the disorder in 
early adulthood (McGrath et al., 2003), and, interestingly, IPA predicted a relationship between Disc1 
and many other GC target genes with neurodevelopmental processes. In particular, Disc1 was shown 
to play a central role in adult hippocampal neurogenesis (Duan et al., 2007), a process also strongly 
influenced by GC hormone action (Anacker et al., 2013).  
In conclusion, the results of these pathway analyses by IPA has contributed to filling an enormous gap 
in our knowledge regarding the consequences of GC hormone genomic activity in the brain. This 
analysis has highlighted many promising MR and GR target genes for further exploration, including the 
KLFs, synaptic-related genes and neurotrophins such as Bdnf. Several neurological diseases and 
psychological disorders have also been highlighted by these analyses, which is in agreement with the 
importance of HPA axis regulation in the maintenance of brain health and mental well-being. Many 
genes, pathways and putative disease relationships were unknown until this point. It must be 
emphasised, however, that these links are purely predictive and require extensive validation in animal 










Chapter 5 The genomic regulation of the Krüppel-like factors by MRs and GRs 
throughout the brain following acute stress or circadian influences  
 5.1 Abstract 
Our genome-wide hippocampal ChIP- and RNA-sequencing experiments described in Chapter 3 
identified a number of KLF family members as targets of GC hormone action. KLFs comprise a family 
of transcription factors that play a role in various neurobiological processes, such as neurogenesis, 
neuronal migration and neuronal differentiation. Following elevations in GC hormones increased 
binding of MRs and GRs to responsive elements within KLF genes was accompanied by elevated 
intronic RNA (inRNA) and exonic RNA (exRNA) expression. Transcription factor-binding motif analysis 
showed a high prevalence of KLF motifs within genomic loci bound by MRs and GRs, while pathway 
analysis predicted a number of KLF family members as upstream regulators of MR and GR target 
genes. These observations strongly indicate that KLFs may be important GC hormone target genes 
and potential coregulators of MR and GR genomic action in the hippocampus.  
Previous studies showed that the hippocampus is a principal region of MR and GR co-expression in the 
brain and that MR expression is barely detectable in neocortical regions. Consequently, the majority of 
studies investigating the genomic actions of MRs and GRs have centred upon the hippocampus and 
neglected many other brain regions. GC hormones, however, have been shown to act upon brain 
regions such as the amygdala, PFC and neocortex and changes in gene expression have been 
observed in these regions following exposure to stress. In this chapter, studies are reported describing 
MR and GR binding to GREs within Klf2, Klf9 and Klf15 in the hippocampus, amygdala, PFC and 
neocortex under acute stress and circadian conditions. Changes in the expression of the respective 
hnRNAs and mRNAs are also examined under these conditions. These experiments validated results 
of our sequencing experiments while demonstrating increased MR and GR binding to GREs within the 
Klfs accompanied by changes in RNA expression throughout all brain regions following stress and 
circadian input. Our observations suggest that MRs may play a greater role in GC action in extra-
hippocampal brain regions than previously thought. Overall, these observations have highlighted the 






A number of KLF family members have been identified, by genome-wide hippocampal ChIP- and RNA-
seq studies, as targets of MR and GR genomic activity during the acute stress response and the 
circadian rise. The KLFs comprise a family of transcription factors characterised by their zinc finger 
containing DNA-binding domain (Pearson et al., 2008) of which 11 genes can be found in the rat 
(Kaczynski et al., 2003). Family members are categorised into three distinct subgroups according to 
homology and transcriptional activity (McConnell and Yang, 2010) and are abundantly expressed in the 
brain where they have been shown to regulate processes such as neural development and repair in 
response to brain injury (Yin et al., 2015). Our MR and GR ChIP-seq studies (Chapter 3) detected MR- 
and GR-binding peaks in the promoter regions of Krüppel-like factor 2 (Klf2), Krüppel-like factor 9 (Klf9) 
and Krüppel-like factor 15 (Klf15), with binding of both receptors significantly increasing following both 
acute stress and the circadian rise. Differential RNA expression of Klf2, Klf9 and Klf15 was also 
observed under these conditions. Furthermore, many other KLFs, including Klf4, Klf7 and Klf13 
exhibited differential RNA expression following acute stress and the circadian rise, however in the 
absence of MR or GR binding within these genes. Transcription factor-binding motif analysis revealed 
that within the entire hippocampal genome, a high proportion of MR and GR bound loci contain KLF 
motifs. Moreover, pathway analysis by IPA (see Chapter 4) predicted a number of KLF genes as 
upstream regulators of genes present in the ChIP- and RNA-seq datasets and also predicted a 
relationship between Klf9 and Klf15 and biological functions such as neurodevelopment, synaptic 
plasticity, learning and cognition. These observations indicate that KLFs are important MR and GR 
target genes during the acute stress response and circadian rise, and that KLFs may act as coregulators 
of MR and GR genomic actions in the hippocampus.  
The actions of MRs and GRs within the hippocampus have undergone extensive investigation; however, 
it is presently unknown whether they regulate gene expression in a similar manner throughout the brain. 
According to early radioligand binding studies, the hippocampus is the primary site of MR and GR co-
expression. Moreover, MR expression was reported as very low within cortical regions and the (central) 
amygdala, while GR expression was shown throughout the brain (Reul and de Kloet, 1985, Reul and 
de Kloet, 1986). Following these initial findings, very few studies have examined the binding of MRs 
and GRs to DNA in regions such as the amygdala, PFC and neocortex, despite GC hormones exerting 




potentiating the stress response (Shepard et al., 2003), the prefrontal cortex has been suggested to 
play a role in negative feedback of the HPA-axis (Diorio et al., 1993) and differential gene expression 
has been reported in both regions following exposure to acute (Sillivan et al., 2019) and chronic (Andrus 
et al., 2012, Calabrese et al., 2016, Nava et al., 2017) stress. The role of the neocortex in the stress 
response is poorly characterised, however immobilisation stress has been shown to elicit changes in 
gene expression in this brain region (Kurumaji et al., 2008, Park et al., 2009). Clearly, further studies 
are required to expand our knowledge of genomic GC hormone action beyond the hippocampus.  
Therefore, the aims of the following experiments were to validate the findings of genome-wide 
hippocampal ChIP- and RNA-seq regarding the Klfs and to extend this investigation to other brain 
regions influenced by HPA-axis activation, such as the amygdala, prefrontal cortex and neocortex. The 
expression of the MR in neocortical brain regions was of interest, in view of early experiments reporting 
a localised expression of the receptor to hippocampal and amygdalar areas. Rats were killed following 
acute stress or under circadian peak or trough conditions and the binding of MRs and GRs and 
transcriptional responses were examined in the hippocampus, amygdala, prefrontal cortex and 
neocortex. Findings of hippocampal ChIP- and RNA-qPCR validated results of our hippocampal ChIP- 
and RNA- seq, while our observations of increased MR and GR binding to Klf GREs in the amygdala, 
PFC and neocortex following elevations in GCs indicated that co-expression of both receptors is not 
limited to the hippocampus. Changes in receptor binding were accompanied by increased expression 
of hnRNA and mRNA at various timepoints after FS or during the circadian rise in GC secretion. These 
findings indicate that MRs and GRs regulate the expression of KLF genes throughout the brain following 
elevations in GC hormones, and suggest that the KLF family of transcription factors may be of 










5.3 Materials and Methods 
5.3.1 Animals 
A separate cohort of male Wistar rats (150-175g) were purchased from Envigo (Oxon, UK) and group 
housed (two to three animals per cage). Animals were kept under standard light (lights on 5:00–19:00; 
80–100 Lux) and environmentally controlled conditions (temperature 21 ± 1 °C; relative humidity 40–
60%) with food and water available ad libitum. Until the day of the experiment all rats were handled (2 
min per rat per day; min. 5 days) to reduce any nonspecific stress effects. A separate cohort of rats 
were used for sequencing and validation studies. 
5.3.2 Animal Experiments 
Baseline rats were killed straight from their home-cages between either 7-9am (circadian trough, 
baseline AM (BLAM)) or 5-7pm (circadian peak, baseline PM (BLPM)). Alternatively, rats were killed 30 
min (FS30), 60 min (FS60) or 120 min (FS120) after the start of a FS challenge (15 min at 25 ± 1 °C).  
5.3.3 Measurement of corticosterone by Radioimmunoassay (RIA) 
Plasma CORT concentrations were measured using a commercial CORT RIA Kit (MP Biomedicals) as 
described previously in Chapter 2. 
5.3.4 ChIP-seq and RNA-seq 
Data from ChIP-seq and RNA-seq experiments described in Chapter 3 are presented in this Chapter. 
Experimental methods and statistical analysis pertaining to these data are found in Chapter 2.  
5.3.5 ChIP-qPCR 
Standard ChIP was performed as described in Chapter 2. The following antibodies were used: MR (MR 
ab64457; Abcam, Cambridge, UK) or GR (GR 24050-1-AP antibody; Proteintech, Manchester, UK). All 
samples (bounds and inputs) were diluted to a standardized concentration with nuclease-free water for 
analysis by qPCR using primers/probes listed in Table 2.6. Data (i.e. enrichment) are expressed as 
quantity of bound DNA divided by the respective quantity of input DNA (i.e., B/I), which is a measure of 






RNA was extracted and RNA-qPCR was performed as described in Chapter 2 using primers and probes 
listed in Table 2.7 (hnRNA) and Table 2.8 (mRNA). Expression of hnRNA and mRNA in each sample 
was calculated based on the Pfaffl method of relative quantification (Pfaffl, 2001) and standardized to 
the expression of house- keeping genes listed in Table 2.9.  
5.3.7 Statistical Analysis 
ChIP-qPCR and RNA-qPCR data were statistically analysed using GraphPad Prism software 7.04. 
Results are presented as group means ± SEM; sample sizes are indicated in the figures. Multiple 
statistical comparisons were conducted with one-way ANOVA or Kruskal-Wallis, and if significant, a 
Dunnett’s or Dunn’s post hoc test was performed. Statistical results are provided in the figures. P<0.05 


















5.4.1 Acute stress and the circadian rise evoke enhanced MR and GR to KLF GRE binding and 
RNA transcription, as revealed by ChIP- and RNA-seq 
To determine the binding of MRs and GRs to GREs within Klfs, rats were killed under early morning 
baseline conditions (BLAM), 30 min (FS30) after the start of an acute 15 min FS challenge or under late 
afternoon baseline conditions (BLPM). Previous work of our group had shown that MR and GR binding 
at GREs is maximal at 30 min post-stress (Mifsud and Reul, 2016).  
As described in Chapter 3, MR and GR ChIP-seq on hippocampal tissue was followed by Peak calling 
(PeakAnalyser) and differential binding (DiffBind) analysis (see Chapters 2 and 3). Significant MR and 
GR binding peaks were identified within Klf2, Klf9 and Klf15 at FS30 and BLPM (Figure 5.1). Following 
acute stress, the enrichment of MR and GR was increased at GREs within Klf2, Klf9, Klf15 GRE1 and 
Klf15 GRE2 in the hippocampus (Figure 5.2). Under late afternoon baseline conditions, MR enrichment 
was elevated at GREs within Klf2, Klf9 and Klf15 GRE2, while GR binding was increased at GREs 
within Klf2, Klf9, Klf15 GRE1 and Klf15 GRE2.  
To assess changes in hippocampal RNA expression of Klf genes under stress and circadian conditions, 
rats were killed under BLAM conditions, 30 min (FS30), 60 min (FS60), 120 min (FS120), 180 min 
(FS180) or 360 min (FS360) after the start of an acute 15 min FS challenge or under BLPM conditions. 
RNA-seq on hippocampal tissue was followed by differential expression (EdgeR) analysis. Following 
FS stress, a time-dependent increase in the transcription of Klf2, Klf4, Klf9 and Klf15 was observed in 
the hippocampus (Figure 5.3). At FS30, increased inRNA levels of Klf2, Klf4, Klf9 and Klf15 were 
observed. Klf9 inRNA remained elevated at FS60, rising again at FS180 and FS360, while Klf15 inRNA 
was increased at all timepoints following FS.  
exRNA transcripts of Klf2 and Klf4 rose at FS30, remaining elevated at FS60. At FS360, inRNA levels 
of Klf4 decreased. Klf9 exRNA levels rose at FS60 and remained higher throughout the remainder of 
the timecourse. Klf15 exRNA levels were elevated at all timepoints following FS. Under BLPM 




























Figure 5.1 MR and GR peaks within Klf2, Klf9 and Klf15 under baseline and stress conditions 
Rats were killed under early morning (BLAM) or late afternoon (BLPM) baseline conditions or 30 min 
(FS30) after the start of FS (15 min, 25 ºC water). Peak calling identified genomic loci bound by MRs 
and GRs. IG Viewer images show MR and GR peaks within Klf2 (A), Klf9 (B) and Klf15 (C) at BLAM, 
FS30 and BLPM. Significant peaks (i.e. above input level) are indicated by the presence of a horizontal 
red (FS30) or blue (BLPM) bar. Note that there are no significant peaks within these genes under BLAM 
conditions. Numbers between square brackets indicate the y-axis range. Rnor_6.0, Rattus norvegicus 
genome version 6.0. These images represent data from experiments carried out in Chapter 3. 
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Figure 5.2 Hippocampal MR and GR ChIP-seq shows binding of MRs and GRs at GREs within 
Klf2, Klf9 and Klf15 under baseline and stressed conditions 
Rats were killed under early morning (BLAM) or late afternoon (BLPM) baseline conditions or 30 min 
(FS30) after the start of FS (15 min, 25 ºC water). Graphs show enrichment of MR and GR at GREs 
within Klf2 (A and B), Klf9 (C and D) and Klf15 GRE1 (E – H) was calculated by Differential binding 





Figure 5.3 Hippocampal inRNA and exRNA transcript counts of KLFs under baseline conditions 
and following stress  
Rats were killed under early morning (BLAM) or late afternoon (BLPM) baseline conditions, or 30 min 
(FS30), 60 min (FS60), 120 min (FS120), 180 min (FS180) or 360 min (FS360) after the start of FS (15 
min, 25 ºC water. Graphs show inRNA (blue bars) and exRNA (red bars) counts of Klf2 (A), Klf4 (B) 
Klf9 (C) and Klf15 (D). Data are shown as percentage of transcripts per million at BLAM. Differential 
expression analysis, corrected for multiple comparisons with Benjamini-Hochberg procedure, * P<0.05, 










5.4.2 Validation of hippocampal ChIP- and RNA-seq findings regarding KLF-genes in a 
separate cohort of rats with hippocampal ChIP- and RNA-qPCR 
To validate findings of the ChIP- and RNA-seq experiments described in Chapter 3, a separate cohort 
of rats were killed under BLAM conditions, at FS30, FS60, FS120 or under BLPM conditions. Plasma 
CORT levels were examined to determine the similarity of the plasma CORT profile between the 
validation cohort and the sequencing cohort used in experiments described in Chapter 3. The plasma 
CORT profile of the validation cohorts (Figure 5.4) was very similar to that of the sequencing cohort, 
with plasma CORT levels elevated at FS30 and under BLPM conditions. 
The binding of hippocampal MRs and GRs to GREs within Klf genes was subsequently examined in 
the validation cohort of rats under BLAM, FS30 and BLPM conditions. Results of ChIP-qPCR closely 
mirrored that of ChIP-seq. Following FS and under BLPM conditions, MR and GR enrichment increased 
at GREs within Klf2, Klf9, Klf15 GRE1 and Klf15 GRE2 (Figure 5.5).  
Hippocampal transcriptional responses of Klf genes were examined under BLAM conditions, at FS30, 
FS60, FS120 or under BLPM conditions. Similar to results shown by RNA-seq, FS resulted in 
hippocampal transcriptional activation of Klf2, Klf4, Klf9 and Klf15 (Figure 5.6). Klf2 hnRNA levels were 
elevated at FS30, while mRNA levels increased at FS30 and FS60. Klf4 hnRNA levels did not change, 
while mRNA levels rose at FS30 and FS60. Klf9 hnRNA levels were elevated at FS30 and at FS60, 
while mRNA levels rose at FS60 and FS120. Klf15 hnRNA levels were increased at FS30, FS60 and 
FS120, while mRNA levels were elevated at FS120. Under late baseline conditions, hnRNA and mRNA 

























Figure 5.4 Plasma corticosterone levels under baseline and stressed conditions 
Rats were killed under early morning (BLAM) or late afternoon (BLPM) baseline conditions or 30 min 
(FS30), 60 min (FS60) or 120 min (FS120) after the start of FS (15 min, 25ºC water). Plasma CORT 
levels for ChIP (A) and RNA (B) are expressed as ng/ml (mean ± SEM, n=8 per group). Average CORT 
concentration at BLAM for ChIP animals, 8.86 ng/ml (A) and for RNA animals, 10.32 ng/ml (B). 
Statistical analysis: one-way ANOVA, (A) F(2, 21)=19.87, p<0.0001, (B) F(2, 37)=51.12, p<0.0001, 
Dunnett’s post hoc test, *P<0.05, ***P<0.001,  ****P<0.0001 significantly different from BLAM. Inter-

























Figure 5.5 Hippocampal MR and GR binding at GREs within Klf2 Klf9 and Klf15 under baseline 
and stressed conditions  
Rats were killed under early morning (BLAM) or late afternoon (BLPM) baseline conditions or 30 min 
(FS30) after the start of FS (15 min, 25 ºC water). Graphs show enrichment of MR and GR, expressed 
as bound/input (mean ± SEM, n = 4 per group), at GREs within Klf2 (A and B), Klf9 (C and D), Klf15 (E-
H) as determined by MR and GR ChIP-qPCR. Statistical analysis; One-way ANOVA (A) F(2, 9)=17.14, 
p=0.0009, (B) F(2, 9)=55.18, p<0.0001, (C) F(2, 9)=30.22, p<0.001, (D) F(2, 9)=28.05, p<0.001, (E) F(2, 
9)=19.62, p=0.0005, (F) F(2, 9)=52.65, p<0.0001, (G) F(2, 9)=50.43, p<0.0001, (H) F(2, 9)=31.39, p<0.0001. 





Figure 5.6 Hippocampal hnRNA and mRNA of KLF genes under baseline conditions and 
following stress 
Rats were killed under early morning (BLAM) or late afternoon (BLPM) baseline conditions or 30 min 
(FS30), 60 min (FS60) or 120 min (FS120) min after the start of FS (15 min, 25 ºC water). Graphs show 
hnRNA (blue bars) and mRNA (red bars) levels of Klf2 (A), Klf4 (B) Klf9 (C) and Klf15 (D). Data are 
shown as relative RNA copy number calculated using the Pfaffl method of analysis, standardised to the 
expression of the house keeping genes Hprt1 and Ywhaz (mean ± SEM, n = 8-9 per group). Statistical 
analysis: one-way ANOVA; (A) Klf2 hnRNA F(4, 39)=21.91, p<0.0001, Klf2 mRNA F(4, 39)=81.88, 
p<0.0001, (B) Klf4 hnRNA F(4, 39)=2.178, p=0.0895, Klf4 mRNA F(4, 39)=41.14, p<0.0001, (C) Klf9 hnRNA 
F(4, 39)=21.38, p <0.0001, Klf9 mRNA F(4, 39)=16.7, p<0.0001, (D) Klf15 hnRNA F(4, 39)=31.41, p<0.0001. 
Dunnett’s post hoc test, *P<0.05, **P<0.01, ***P< 0.001, compared with BLAM group. Kruskal-Wallis; 
(D) Klf15 mRNA χ2 (4) = 27.72, p<0.0001. Dunn’s post hoc test, **P<0.01, ***P<0.001 significantly 







5.4.3 Brain-region investigation into MR and GR binding at GREs within KLFs and associated 
transcriptional responses following acute stress and during the circadian rise 
The binding of MRs and GRs within Klf genes and the associated transcriptional responses of these 
genes was subsequently investigated in the amygdala, PFC and neocortex under identical experimental 
conditions (BLAM, FS30 and BLPM).  
Following FS and under BLPM conditions, MR and GR enrichment was increased in the amygdala 
(Figure 5.7) and PFC (Figure 5.8) at GREs within Klf2, Klf9, Klf15 GRE1 and Klf15 GRE2. Within the 
neocortex (Figure 5.9), MR and enrichment was elevated at GREs within Klf2, Klf9 and Klf15 GRE2, 
while GR enrichment was also increased Klf15 GRE2 (Figure 5.9.h). Under BLPM conditions, MR 
enrichment was higher at GREs within Klf2 (Figure 5.9.a). 
FS led to the transactivation of Klf2, Klf4 and Klf15 in the amygdala (Figure 5.10), PFC (Figure 5.11) 
and neocortex (Figure 5.12). Klf2 hnRNA and mRNA levels were increased at FS30 in the amygdala 
(Figure 5.10.a), while mRNA was remained higher at FS60. In the PFC (Figure 5.11.a) and neocortex 
(Figure 5.12.a), Klf2 hnRNA and mRNA rose at FS30 and remained elevated at FS60. hnRNA levels of 
Klf4 did not significantly change within the amygdala (Figure 5.10.b) or neocortex (Figure 5.12.b), 
however within the PFC (Figure 5.11.b), Klf4 hnRNA rose at FS30. Klf4 mRNA levels were significantly 
increased at FS30 and FS60 within the amygdala (Figure 5.10.b), PFC (Figure 5.11.b) and neocortex 
(Figure 5.12.b). Klf9 hnRNA were higher at FS30 and FS60 in the amygdala (Figure 5.10.c), PFC 
(Figure 5.11.c) and neocortex (Figure 5.12.c). mRNA of Klf9 was increased at FS30-120 in the 
amygdala (Figure 5.10.c), while mRNA levels were higher at FS60 and FS120 in the PFC (Figure 
5.11.c) and neocortex (Figure 5.12.c). Levels of Klf15 hnRNA were elevated at FS30-FS120 in the 
amygdala (Figure 5.10.d) and increased at FS30 and FS60 in the neocortex (Figure 5.11.d) and PFC 
(Figure 5.12.d). Klf15 mRNA was increased at FS120 in the amygdala (Figure 5.10.d) and PFC (Figure 
5.11.d), however in the neocortex (Figure 5.12.d) no change in Klf15 mRNA was detected at any 
timepoint.  
BLPM conditions led to a rise in amygdala hnRNA and mRNA levels of Klf9 and Klf15 (Figure 5.10). 
Under late baseline conditions in the PFC (Figure 5.11), hnRNA and mRNA levels of all Klfs were 
increased. In the neocortex, Klf2 mRNA levels, and hnRNA and mRNA levels of Klf9 and Klf15 were 

























Figure 5.7 Amygdala MR and GR binding at GREs within Klf2, Klf9 and Klf15 under baseline and 
stressed conditions 
Rats were killed under early morning (BLAM) or late afternoon (BLPM) baseline conditions or 30 min 
(FS30) after the start of FS (15 min, 25 ºC water). Graphs show enrichment of MR and GR, expressed 
as bound/input (mean ± SEM, n = 4 per group), at GREs within Klf2 (A and B), Klf9 (C and D), Klf15 (E-
H) as determined by MR and GR ChIP-qPCR. Statistical analysis; One-way ANOVA (A) F(2, 9)=51.49, 
p<0.0001, (B) F(2, 9)=63.46, p<0.0001, (C) F(2, 9)=42.92, p<0.0001, (D) F(2, 9)=114, p<0.0001, (E) F(2, 
9)=34.73, p<0.0001, (F) F(2, 9)=56.24, p<0.0001, (G) F(2, 9) =72.83, p<0.0001, (H) F(2, 9)=68.58, p<0.0001. 

























Figure 5.8 PFC MR and GR binding at GREs within Klf2, Klf9 and Klf15 under baseline and 
stressed conditions  
Rats were killed under early morning (BLAM) or late afternoon (BLPM) baseline conditions or 30 min 
(FS30) after the start of FS (15 min, 25 ºC water). Graphs show enrichment of MR and GR, expressed 
as bound/input (mean ± SEM, n = 4 per group), at GREs within Klf2 (A and B), Klf9 (C and D), Klf15 (E-
H) as determined by MR and GR ChIP-qPCR. Statistical analysis; One-way ANOVA (A) F(2, 9)=14.63, 
p=0.0015, (B) F(2, 9)=17.82, p=0.0007, (C) F(2, 9)=9.935, p=0.0053, (D) F(2, 9)=11.84, p=0.0030, (E) F(2, 
9)=14.57, p=0.0015, (F) F(2, 9)=9.89, p=0.00531, (G) F (2, 9)=20.33, p=0.0005, (H) F(2, 9)=18.46, p=0.0007. 

























Figure 5.9 Neocortex MR and GR binding at GREs within Klf2, Klf9 and Klf15 under baseline and 
stressed conditions 
Rats were killed under early morning (BLAM) or late afternoon (BLPM) baseline conditions or 30 min 
(FS30) after the start of FS (15 min, 25 ºC water). Graphs show enrichment of MR and GR, expressed 
as bound/input (mean ± SEM, n = 4 per group), at GREs within Klf2 (A and B), Klf9 (C and D), Klf15 (E-
H) as determined by MR and GR ChIP-qPCR.  Statistical analysis; One-way ANOVA (A) F(2, 9)=10.07, 
p=0.0051, (B) F(2, 9)=10.49, p=0.0045, (C) F(2, 9)=7.987, p=0.0101, (D) F(2, 9)=5.788, p=0.0242. (E) F(2, 
9)=5.267, p=0.0306, (F) F (2, 9)=6.535, p=0.0177, (G) F (2, 9)=3.71, p=0.066, (H) F(2, 9)=4.49, p<0.0444. 





Figure 5.10 Amygdala hnRNA and mRNA of KLFs under baseline conditions and following stress 
Rats were killed under early morning (BLAM) or late afternoon (BLPM) baseline conditions or 30 min 
(FS30), 60 min (FS60) or 120 min (FS120) min after the start of FS (15 min, 25 ºC water). Graphs show 
hnRNA (blue bars) and mRNA (red bars) levels of Klf2 (A), Klf4 (B) Klf9 (C) and Klf15 (D).  Data are 
shown as relative RNA copy number calculated using the Pfaffl method of analysis, standardised to the 
expression of the house keeping genes Hprt1 and Gapdh (mean ± SEM, n = 8-9 per group). Statistical 
analysis: one-way ANOVA; (A) Klf2 hnRNA F(4, 40)=23.36, p<0.0001, Klf2 mRNA F(4, 40)=79.11,  
p<0.0001, (B) Klf4 hnRNA F(4, 40)=2.04, p=0.35, Klf4 mRNA F(4, 40)=78.69, p<0.0001, (C) Klf9 hnRNA 
F(4, 40)=11.07, p<0.0001, Klf9 mRNA F(4, 40)=26.97, p<0.0001, (D) Klf15 hnRNA F(4, 40)=5.493, p=0.00131, 
Klf15 mRNA F(4, 39)=11.32, p<0.0001. Dunnett’s post hoc test, *P<0.05, **P<0.01, *** P<0.001 










Figure 5.11 PFC hnRNA and mRNA of KLFs under baseline conditions and following stress 
Rats were killed under early morning (BLAM) or late afternoon (BLPM) baseline conditions or 30 min 
(FS30), 60 min (FS60) or 120 min (FS120) min after the start of FS (15 min, 25 ºC water). Graphs show 
hnRNA (blue bars) and mRNA (red bars) levels of Klf2 (A), Klf4 (B) Klf9 (C) and Klf15 (D).  Data are 
shown as relative RNA copy number calculated using the Pfaffl method of analysis, standardised to the 
expression of the house keeping genes Hprt1 and Ywhaz (mean ± SEM, n = 8-9 per group). Statistical 
analysis: one-way ANOVA; (A) Klf2 hnRNA F(4, 40)=24.53, p<0.0001, Klf2 mRNA F(4, 40)=113.1, 
p<0.0001, (B) Klf4 hnRNA F(4, 40)=6.373, p<0.001, Klf4 mRNA F(4, 40)=62.04, p<0.0001, (C) Klf9 hnRNA 
F(4, 40)=27.81, p<0.0001, Klf9 mRNA F(4, 40)=12.88, p<0.0001, (D) Klf15 hnRNA F(4, 40)=18.54, p<0.0001, 
Klf15 mRNA F(4, 40)=22.03, p<0.0001. Dunnett’s post hoc test, *P<0.05, **P<0.01, ***P<0.001 









Figure 5.12 Neocortex hnRNA and mRNA of KLFs under baseline conditions and following 
stress 
Rats were killed under early morning (BLAM) or late afternoon (BLPM) baseline conditions or 30 min 
(FS30), 60 min (FS60) or 120 min (FS120) min after the start of FS (15 min, 25 ºC water). Graphs show 
hnRNA (blue bars) and mRNA (red bars) levels of Klf2 (A), Klf4 (B) Klf9 (C) and Klf15 (D).  Data are 
shown as relative RNA copy number calculated using the Pfaffl method of analysis, standardised to the 
expression of the house keeping genes Rpl10a and Cyclophilin A (mean ± SEM, n = 8-9 per group). 
Statistical analysis: one-way ANOVA; (A) Klf2 hnRNA F(4, 39)=37.63, p<0.0001, Klf2 mRNA F(4, 39)=119.4,  
p<0.0001, (B) Klf4 hnRNA F(4, 40)=3.659, p=0.0124, Klf4 mRNA F(4, 37)=17.19,  <0.0001, (C) Klf9 hnRNA 
F(4, 39)=53.45, p<0.0001, Klf9 mRNA F(4, 40)=6.177, p<0.001, (D) Klf15 hnRNA F(4, 39)=38.56, p<0.0001, 
Klf15 mRNA F(4, 40)=6.2606, p=0.0006. Dunnett’s post hoc test, *P<0.05, **P<0.01, ***P<0.001 









These experiments have validated some of our novel genome-wide hippocampal ChIP- and RNA-seq 
findings presented in Chapter 3, which suggest that Klfs are important GC hormone target genes 
following acute stress and during the circadian rise. Furthermore, the high prevalence of KLF motifs 
within genome-wide loci bound by hippocampal MRs and GRs (Chapter 3) and the predictions that a 
number of KLFs may act as upstream regulators of downstream MR and GR target genes (Chapter 4) 
suggests that the KLFs may act as coregulators of genomically acting MRs and GRs. The KLFs 
encompass a family of transcription factors exhibiting diverse regulatory functions in the brain. Their 
role in the brain in relation to acute stress or the circadian drive has not been fully elucidated, however 
given their prominent role in neuronal development and regeneration (Yin et al., 2015) they provide 
interesting targets for further examination. This investigation was extended to elucidate the regulation 
of the Klfs by genomically acting MRs and GRs throughout the brain. We found that MRs and GRs 
indeed regulate the expression of Klfs in the amygdala, PFC and neocortex, indicating a brain-wide 
targeting of the Klfs by MRs and GRs following HPA axis activation. Furthermore, these findings reveal 
a more widespread expression of the MR than predicted based on previous radioligand binding studies 
(Reul and de Kloet, 1985, Reul and de Kloet, 1986). This observation may prompt further investigation 
into genomically acting MRs and GRs throughout the brain, as studies examining the genomic actions 
of MRs and GRs outside the hippocampus are currently lacking.  
ChIP- and RNA-seq validation experiments involved an almost indistinguishable experimental design 
carried out in a different cohort of rats from those used for the sequencing experiments. For ChIP-seq 
validation, rats were killed under identical conditions; early morning baseline (BLAM), 30 min following 
FS (FS30) or under late baseline conditions (BLPM). Due to the discontinuation of the antibodies used 
in the original ChIP-seq experiments, new MR and GR antibodies were used in validation ChIP-qPCR 
experiments. The ability to reproduce the ChIP-seq results using different antibodies for ChIP-qPCR 
further strengthens the validation and confirms the high quality and robustness of the data. For RNA-
seq validation, rats were killed under BLAM and BLPM conditions, however a compacted FS time 
course was carried out. No further validation was performed at the FS180 and FS360 timepoints as 
these were from a scientific point of view of less interest and because of our endeavour to reduce animal 
numbers. While the FS180 timepoint was removed simply because very few significant changes in RNA 




regarding the influence of the upcoming circadian rise. Despite a few minor changes in the experimental 
protocols for ChIP- and RNA-qPCR, the data was largely reproducible and strongly agreed with results 
of ChIP- and RNA-seq. 
The pattern of MR and GR enrichment observed in the hippocampal ChIP-qPCR validation experiment 
was in agreement with the findings of hippocampal ChIP-seq. Hippocampal ChIP-qPCR revealed 
significantly increased binding of MRs and GRs at GREs within Klf2, Klf9 and Klf15 following both acute 
stress and during the circadian rise. MR enrichment at Klf15 GRE1 was not found to be significantly 
increased under BLPM conditions by ChIP-seq, however there was a trend towards significance (p = 
0.06) and enrichment was found to be significantly increased by ChIP-qPCR. This is likely due to the 
increased sensitivity of qPCR compared with sequencing; qPCR is less likely to suffer from background 
signal as the amplification is directed to a defined DNA sequence rather than an entire DNA library of 
genome-wide sequences. The results of the RNA-qPCR validation experiment closely mirrored results 
of RNA-seq and demonstrated inRNA and exRNA counts measured by RNA-seq to be a good 
representation of hnRNA and mRNA levels, respectively, measured by RNA-qPCR. In the majority of 
cases, levels of inRNA/hnRNA and exRNA/mRNA for all Klfs were shown to be significantly increased 
at the same timepoints in RNA-seq and RNA-qPCR experiments. Significantly elevated levels of Klf2 
exRNA at BLPM and of Klf4 inRNA at FS30 shown by RNA-seq were not replicated by RNA-qPCR. It 
is unclear why these differences were observed under FS conditions, however as the BLPM timepoint 
represents a wide timeframe in which CORT levels are rising, it is possible that the precise point at 
which GC levels and changes in RNA levels are occurring may vary between animals. 
Findings of ChIP-qPCR throughout the hippocampus, amygdala, PFC and neocortex indicate a more 
widespread expression of the MR than previously believed. Early radio-ligand binding studies 
demonstrated high levels of MRs in the hippocampus, with low to very low levels detected in the 
amygdala, PFC and neocortex (Reul and de Kloet, 1985). This may be the reason why MR binding to 
GREs within these brain regions has hardly been examined. Following stress or circadian input, 
enrichment levels of the MR were slightly lower in the PFC and neocortex compared with the 
hippocampus and the amygdala, however MR binding was found to significantly increase at GREs 
within Klf2, Klf9 and Klf15 in these regions. In the neocortex, however, levels of MR binding to GREs 
within Klf15 did not significantly change following acute stress. During the circadian rise, no significant 




rise leads to a smaller change in MR binding compared with acute stress, and due to the lower levels 
of MR enrichment in this region, these changes may be harder to detect with a sample size of only 4 
rats. GR binding to Klf GREs increased throughout all brain regions in a similar manner to the MR 
following elevations in GC hormones, however during the circadian rise, neocortex GR binding did not 
significantly increase at any Klf GRE. In some cases, such as for Klf9, this may be due to increased 
variation in neocortex GR enrichment levels observed within the BLPM group, while in other instances 
it may be due to lower overall levels of neocortex GR enrichment. As the neocortex consists of various 
layers that exhibit a heterogeneity of cell types (Hodge et al., 2019), it is likely that variations exist in 
MR and GR receptor expression within these layers. 
Although a few studies have shown increased mRNA expression of Klf4 and Klf9 following increases in 
GCs (Datson et al., 2011, Reddy et al., 2009), until now, no study has investigated changes in hnRNA 
and mRNA expression of Klf2, Klf4, Klf9 and Klf15 throughout brain regions under acute stress and 
circadian conditions. Here, for the first time we show significantly increased levels of Klf2 hnRNA and 
mRNA following acute stress or the circadian rise in multiple brain regions. KLF2 is highly expressed 
within endothelial cells (ECs) where it plays a central role in the regulation of EC function within the 
BBB (Wu et al., 2013); a structure essential for healthy CNS functioning (Salvador et al., 2014). Many 
CNS disorders are accompanied by compromised integrity of the BBB, including stroke (Shi et al., 2013) 
and Alzheimer’s disease (Fang et al., 2017). In the cerebral cortex, KLF2 has been shown to regulate 
the function of the BBB following stroke, thus exerting a neuroprotective effect on the brain. Larger 
stroke volumes and increased permeability of the BBB following intracerebral injection of the pro-
inflammatory cytokine TNF-α were observed in KLF2-/- mice, while KLF2 overexpressing mice had 
smaller stroke volumes and were protected against TNF-α-mediated BBB dysfunction (Shi et al., 2013). 
Decreased expression of Klf2 mRNA and KLF2 protein was observed in a mouse model of Alzheimer’s 
disease and in Human brain microvascular endothelial cells (HBMECs) treated with the amyloid beta 
protein fragment; Aβ1-42. Moreover, KLF2 overexpression attenuated the reduction in mRNA levels of 
Occludin, a vascular endothelial associated gene, observed in HBMEs treated with Aβ1-42 (Wu et al., 
2013). Decreased expression of Klf2 mRNA and protein were reported in post-mortem tissue of 
Alzheimer’s disease patients and primary mouse brain microvascular endothelial cells (mBMECs) 




Stress exposure and GCs have been linked to damage to the BBB in the hippocampus, amygdala and 
PFC. Morphological changes in tight junction structural proteins claudin-5 and occludin were 
accompanied by increased levels of the glucose transport protein GLUT-1in the frontal cortex and 
hippocampus following exposure to acute and chronic restraint stress (Santha et al., 2015). Rats 
exposed to restraint stress for up to 21 days exhibited hyperpermeability of the amygdala BBB and 
elevated expression of BBB permeability markers (Xu et al., 2019). GCs have been linked to improved 
BBB integrity and the regulation of the expression of many vascular endothelium genes encoding for 
proteins which maintain endothelial barrier structure such as Occludin, Claudin 1 and 2 and Vascular 
Endothelial Cadherin (Salvador et al., 2014). No evidence of MR or GR binding to GREs within these 
genes was seen in our ChIP-seq experiments or reported by other studies, therefore the regulation of 
these genes by GC hormones may involve a non-genomic mechanism and/or the induction of other 
(transcription) factors. Possibly, the upregulation in hnRNA and mRNA levels of Klf2 following elevations 
in GC hormones serves to promote the integrity of the BBB after stress. However, protein expression 
levels and the localisation of KLF2 would need to be examined by western blot and 
immunohistochemistry to confirm whether this link exists.  
Despite lacking significant MR or GR binding, RNA levels of Klf4 were investigated to provide a negative 
control for further studies involving the manipulation of MR and GR binding. hnRNA levels of Klf4 
remained stable, apart from a small increase in the PFC at FS30, while mRNA levels were increased 
at FS30 in all brain regions examined. It is probable that hnRNA levels of Klf4 have risen prior to the 
FS30 timepoint, and as there is no significant MR or GR binding occurring within Klf4 it is likely that 
more rapidly acting transcription factors are regulating the expression of this gene. Interestingly, the 
application of NMDA to primary cortical neuron cultures induced a rapid upregulation of Klf4 mRNA 
which was accompanied by upregulated KLF4 protein expression. Antagonism of the NMDAR by 
MK801 completely abolished the induction of Klf4 mRNA expression, an effect that antagonists of 
AMPA or kainite receptors failed to produce (Zhu et al., 2009). Following exposure to an acute stressor, 
activated GRs have been shown to participate in the MAPK/ERK signalling cascade initiated by the 
NMDAR, resulting in changes of chromatin structure which expose target genes for transcription 
(Gutierrez-Mecinas et al., 2011). It is possible that the induction of Klf4 hnRNA and mRNA observed in 
our study occurs via this mechanism, and unpublished findings of histone modification ChIP-seq 




modification, H3K9acS10p, within close proximity to Klf4 following FS and during the circadian rise 
(Price et al., unpublished observations).  
KLF4 has been shown to play a central role in a number of important physiological and pathological 
processes within the brain. In vitro studies have identified KLF4 as a transcriptional repressor of axon 
growth in retinal ganglion cells (RGCs) and embryonic day 18 (E18) hippocampal neurons. 
Overexpression of KLF4 reduced axon and dendrite length and decreased the number of neurites and 
branches of E18 hippocampal neurons. KLF4 overexpressing RGCs exhibited decreased neurite and 
branch numbers and a slower rate of neurite extension (Moore et al., 2009). An extensive study into the 
role of KLF4 during brain development has also demonstrated repressed neural growth following 
overexpression of the gene. High embryonic expression of KLF4 within the mouse forebrain was 
followed by postnatal downregulation by PND7, and neurons and astrocytes exhibited a dramatic 
decrease in KLF4 expression when compared with neural stem cells (NSCs). KLF4 overexpression 
within cultured NSCs resulted in structural abnormalities accompanied by reduced growth, 
differentiation and self-renewal. In transgenic mice, KLF4 overexpression led to a hydrocephalus 
phenotype characterised by ventricular enlargement and an excess of CSF. The hydrocephalus 
phenotype was accompanied by morphological abnormalities of the corpus callosum, hippocampus and 
cerebral cortex. The Subcommissural organ (SCO), a structure thought to regulate CSF reabsorption, 
was also reduced in these mice and fewer ependymal cilia were observed. Cilia comprise flagella-like 
projections made up of microtubules and are thought to facilitate the flow of CSF. Of the ependymal 
cilia that were detected, a shorter disorganised structure was seen (Qin et al., 2011). A central role of 
KLF4 in the neurogenesis and radial neuronal migration of developing cerebral cortex cells has also 
been shown in mice. Constitutive expression of KLF4 prevented the migration and differentiation of cells 
within the cerebral cortex and kept cells in a glia-like fate. Overexpression of KLF4 prevented the 
migration of cells to the cortical plate from the ventricular and subgranular zones and led to a round 
multipolar morphology of cells. When KLF4 was downregulated, increased cellular migration to the 
cortical plate was observed, cells exhibited more neuronal processes and more unipolar and bipolar 
cells were seen (Qin and Zhang, 2012).  
These experiments show that a downregulation of KLF4 expression in the developing brain is of critical 
importance to allow the proper differentiation, migration and maturation of neurons. Interestingly, in the 




low GC hormone levels coincides with the postnatal period at which cell birth and death is maximal 
within the DG (Gould et al., 1991). Early postnatal exposure to GCs has been shown to inhibit 
neurogenesis (Bohn, 1980) and decrease migration of pyknotic cells to the granule cell layer (Gould et 
al., 1991). As we have shown that a rise in GC levels results in upregulated hnRNA and mRNA of Klf4, 
it would be interesting to investigate whether postnatal exposure to GCs leads to increased levels of 
KLF4 expression and whether this upregulation is responsible for the inhibition of neurogenesis and 
migration of new-born cells.  
Klf9, originally named basic transcription element-binding protein (BTEB), was the first member of the 
KLFs to be identified (Imataka et al., 1992) and despite ubiquitous tissue expression of the gene, the 
translation of Klf9 mRNA appears be limited to the brain (Imataka et al., 1994). Early studies identified 
Klf9 as a thyroid responsive gene in the developing rat brain. Klf9 mRNA levels were shown to increase 
postnatally in the cerebral hemisphere between PND 15-30, remaining elevated in the adult rat. 
Hypothyroidism reduced Klf9 mRNA levels significantly throughout PND 5-22, while T3 treatment 
rescued Klf9 mRNA expression. By postnatal day 30, Klf9 mRNA levels remained elevated irrespective 
of thyroid levels. In mouse Neuro2a (N2a) cells, Klf9 mRNA and protein levels were upregulated by T3 
and overexpression of KLF9 induced neurite outgrowth (Denver et al., 1999). In the developing mouse 
brain, KLF9 expression was observed in the hippocampal pyramidal cell layer and cerebellar cortical 
layer from PND6 and PND7, respectively. Klf9 KO mice demonstrated impaired motor learning and 
motor coordination and deficits in contextual-dependent fear conditioning in behavioural paradigms 
involving the cerebellum and hippocampus, respectively (Morita et al., 2003). Developmental and 
behavioural deficits were also reported in Klf9 KO mice, with impaired differentiation of dendritic spines 
in the DG, impaired maturation of adult-born DG neurons, reduced synaptic plasticity and impairments 
in anxiety-like behaviours and contextual fear discrimination learning (Scobie et al., 2009).  
Klf9 was identified as a GC receptor target gene in later studies and exposure of frogs to shaking stress 
led to an increase in plasma CORT and KLF9 expression within the amygdala and optic areas. RU486 
treatment attenuated the induction of Klf9 mRNA in vivo and in vitro, while in vitro treatment with 
spironolactone caused only a slight reduction in CORT-induced mRNA levels of Klf9, indicating that 
induction of the gene is primarily GR-mediated. Forced expression of KLF9 in vivo resulted in an 
increased number of Golgi-stained cells, reflective of neuronal differentiation and maturation (Bonett et 




mice injected postnatally with CORT exhibited increased Klf9 hnRNA and mRNA levels, while treatment 
of mouse hippocampal-derived (HT-22) cell lines with CORT caused dose- and time-dependent 
increases in Klf9 mRNA. RU486 abolished the induction of Klf9 mRNA in HT-22 cells, while aldosterone 
caused a small but significant increase in Klf9 mRNA, indicating that while both MR and GR contribute 
to the induction of Klf9 mRNA expression, GR is the principal regulator. Electrophoretic mobility shift 
assay (EMSA) and ChIP experiments demonstrated CORT-dependent GR binding to two highly 
conserved GREs within Klf9. ChIP also showed a CORT-dependent increase in H3 acetylation at one 
of the two GREs (Bagamasbad et al., 2012). These GREs are reported to exhibit 100% homology 
between the mouse and rat, the two GREs described by (Bagamasbad et al., 2012) are found within 
the MR/GR peak identified by our hippocampal ChIP-seq experiment.  
Klf9 clearly plays a role in early brain development, and in contrast with Klf4, mRNA levels are 
upregulated postnatally to facilitate processes such as neuronal differentiation and maturation (Bonett 
et al., 2009). The upregulation of Klf9 mRNA, however, occurs after the stress-hyporesponsive period 
has ended (PND15-30) (Denver et al., 1999), therefore may be under GC hormone regulation. The 
observation that Klf9 mRNA levels are maintained in the absence of thyroid hormone at PND30 further 
supports this hypothesis (Denver et al., 1999), however this would need to be assessed by additional 
experiments. 
In comparison with Klf2, Klf4 and Klf9, the role of Klf15 has hardly been examined in the brain in relation 
to GC hormone activity. KLF15 expression is enriched within tissues such as skeletal muscle (Shimizu 
et al., 2011), kidney (Mallipattu et al., 2012), heart, adipose and liver tissue (McConnell and Yang, 
2010). Evidence is emerging, however, for a role of KLF15 in the CNS. KLF15 was identified as a 
potential transcriptional regulator of rhodopsin in bovine retinal cells. Klf15 mRNA expression was 
detected in multiple bovine neural tissues such as the cerebellum, visual cortex and ciliary epithelium 
of the iris. Transfection of cells with KLF15 led to transcriptional repression of the Rhodopsin promoter 
(Otteson et al., 2004). KLF15 has been implicated as a regulator of glial development, with 
overexpression of the protein resulting in the induction of Glial fibrillary acidic protein (GFAP) expression 
in astrocytes of mouse spinal cord explant cultures (Fu et al., 2009). Gene expression profiling of cells 
from mouse embryos revealed upregulated expression of KLF15 within the dorsolateral telencephalon 
at embryonic day 17. Overexpression of KLF15 inhibited neuronal differentiation, while KLF15 




(Ohtsuka et al., 2011). Microarray and qPCR revealed a strong induction of Klf15 mRNA expression 
following DEX treatment of primary human airway smooth muscle (ASM) cells, an effect thought to be 
mediated by the GR (Masuno et al., 2011). Within rat skeletal muscle, Klf15 was identified as a direct 
target of GR as increased mRNA levels were observed following DEX administration, while RU486 
inhibited DEX-induction of Klf15 within myoblasts. GREs were also identified within the promoter of 
Klf15 and RU486 attenuated DEX induced activity within these GREs. ChIP also demonstrated 
significantly increased GR binding at two GREs within Klf15 following DEX treatment (Shimizu et al., 
2011). The Klf15 GRE2 identified by (Shimizu et al., 2011) lies within the MR and GR binding peak 
detected by our hippocampal ChIP-seq study which was labelled as Klf15 GRE1. 
The lack of studies investigating the role of Klf15 in the brain may be due to low expression levels in 
this region. Although MR and GR binding at Klf15 GREs did significantly increase throughout all brain 
regions following acute stress and in the circadian rise, enrichment levels were slightly lower compared 
with levels seen at Klf2 and Klf9 GREs. RNA of Klf15 did rise in all brain regions at multiple timepoints 
following acute stress and during the circadian rise, however in contrast with the other Klfs, the induction 
of Klf15 RNA did not exceed 2-fold in any brain region. It is also possible, however, that Klf15 is 
expressed in relatively few cells, hence the low MR and GR enrichment and RNA expression observed. 
A more distinct pattern of Klf15 expression, however, may have an underlying functional significance, 
thus expression of Klf15 in relatively few cells may be worth pursuing. Quantification of the absolute 
expression levels of Klf15 and the expression pattern could provide further insight into whether the gene 
is a target warranting further examination in the brain.  
Overall, the results of the validation experiments mirrored findings of the hippocampal genome-wide 
ChIP- and RNA-seq, confirming the reproducibility and robustness of the data. These findings also show 
MR expression occurring in brain regions such as the PFC and neocortex, in which expression of the 
receptor was originally believed to be very low (Reul and de Kloet, 1985). Members of the KLF family 
of transcription factors have also been identified as targets of genomically acting MRs and GRs 
throughout the brain. Many studies have highlighted an important role of the KLFs in a number of 
neurobiological processes, however it is unclear whether GC hormone activity regulates KLF 
expression with regard to these processes. A number of KLFs have also been implicated in neurological 
and psychiatric disorders that are linked to GC hormones, such as Alzheimer’s disease (Fang et al., 




al., 2009). These observations indicate that future studies are needed to elucidate whether a connection 
























Chapter 6 The effects of MR and GR antagonism on the genomic regulation 
of KLFs in the hippocampus under early morning baseline conditions and 
following acute stress  
6.1 Abstract    
Genomically acting MRs and GRs target a number of KLF family members following elevations in GC 
hormone levels throughout the brain. These KLFs have been shown to play a role in various 
neurobiological processes under GC hormone regulation and are implicated in neurological disorders 
linked to stress, suggesting these genes to be important targets of genomically acting MRs and GRs. 
In Chapter 5, we showed that increased MR and GR binding to GREs within Klf2, Klf9 and Klf15 was 
accompanied by elevated hnRNA and mRNA expression of these genes in the hippocampus, 
amygdala, PFC and neocortex following acute stress and during the circadian rise. It has not been 
shown yet, however, whether MRs and GRs are mediators of the circadian- and stress-induced effects 
on transcriptional activity of the Klfs.  
In this chapter, the effect of the MR and GR antagonists, spironolactone (SPIRO) and RU486 (RU), 
respectively, on hippocampal MR and GR binding to GREs within the Klfs and associated transcriptional 
responses of these genes are investigated under early circadian trough conditions and following acute 
stress. For a comparison, hippocampal transcriptional responses were also examined in ADX rats under 
identical conditions. Under baseline conditions, drug treatment appeared to have an effect on receptor 
binding, whereas RNA levels of the Klfs were mainly unaffected. Drug treatment had no influence on 
FS-induced MR and GR binding to GREs within the Klfs. After FS, at the dose of 30 mg/kg, RU alone 
did not change the FS-induced transcriptional response of Klf2, Klf9 and Klf15. A combination of SPIRO 
and RU, however, attenuated the transactivation of Klf2, Klf9 and Klf15 following FS stress. ADX 
completely abolished the transcriptional responses of Klf9 and Klf15 to stress. The transactivation of 
Klf2, however, was only partially inhibited by ADX. These findings confirm genomically acting MRs and 
GRs as transcriptional regulators of the Klfs. Other coregulators are likely participating in MR/GR 
regulation of the Klfs, therefore further studies are needed to elucidate the regulation of the Klfs under 






The genomic action of MRs and GRs is thought to underlie many GC-dependent behavioural and 
physiological changes observed after stress or associated with circadian rhythm (Mifsud and Reul, 
2018, Reul, 2014). In Chapter 3 and 5, ChIP-qPCR and RNA-qPCR have identified the KLF family 
members Klf2, Klf9 and Klf15 as transcriptional targets of genomically acting MRs and GRs following 
conditions under which GC levels are elevated (i.e. acute stress and the circadian rise in GC secretion). 
These KLFs have been linked to numerous neurobiological processes, such as BBB function (Shi et 
al., 2013), neurogenesis (Qin and Zhang, 2012), synaptic plasticity (Scobie et al., 2009) and neuronal 
differentiation and migration (Ohtsuka et al., 2011).  
As described in chapter 5, acute stress and circadian influences led to increased binding of MRs and 
GRs to GREs within Klf2, Klf9 and Klf15 in the hippocampus, amygdala, PFC and neocortex. Increased 
hnRNA and mRNA levels of these Klfs were also observed, suggesting that increased MR and GR 
binding to GREs within Klfs leads to enhanced transcriptional activity of these genes. Despite the 
absence of MR or GR binding, mRNA levels of Klf4 were significantly elevated following acute stress 
throughout all brain regions examined, and in the PFC during the circadian rise. Constitutive formation 
of the chromatin relaxing-dual histone modification H3K9acS10p within close proximity to Klf4 has also 
been shown under acute stress and circadian conditions (Price E.M. et al., unpublished observations, 
Gutierrez-Mecinas et al., 2011), indicating that a non-genomic GC-regulated mechanism may play a 
part in the transcriptional regulation of this gene. Thus, it is unclear whether the binding of MR and GR 
to GREs within Klfs is directly leading to transcriptional activation of these genes, or whether alternative 
TFs or non-genomic mechanisms may be involved as well.  
As the transcriptional effects of MRs and GRs are ligand-dependent, an effective (pharmacological) 
intervention strategy for elucidating their genomic actions would involve blocking these receptors with 
competitive antagonists. SPIRO and RU486 are widely used antagonists that compete with ligand for 
the occupancy of MR (Rogerson et al., 2003) and GR (Nordeen et al., 1995), respectively. SPIRO has 
been shown to compete with DEX for the LBD of the MR in vitro (Rogerson et al., 2003), but also 
displays a very weak affinity for the GR (Couette et al., 1992). MR antagonism by SPIRO has been 
shown to inhibit the transcriptional activity of MRs in ADX rats (Herman and Spencer, 1998). RU486 




binding, however, prevents the induction of transcriptional responses (Nordeen et al., 1995), likely by 
preventing interactions of DNA-bound GRs with transcriptional machinery (Baulieu, 1991). RU486 can 
exhibit partial GR agonistic activity (Bachmann et al., 2003) depending on interactions between 
coactivators and corepressors (Liu et al., 2002). In mouse cell lines, RU486 has been shown to fully 
attenuate DEX-induced GR-mediated transcriptional activity (Qin et al., 2014).  
The aim of the following experiments was to determine whether MR and GR binding to Klf GREs leads 
to changes in RNA expression of the corresponding Klf gene. Moreover, for sake of comparison. We 
also investigated the effects of CORT removal by ADX on stress-induced RNA expression of the Klfs. 
To prevent non-specific binding of by GR by SPIRO (Couette et al., 1992), RU486 was administered 
alongside SPIRO as it displays no affinity for the MR (Baulieu, 1991). Rats were voluntarily dosed with 
a combination of SPIRO and RU486 or RU486 alone and killed under early baseline conditions (BLAM) 
or at various timepoints after FS. In a second experiment, rats underwent sham surgery or bilateral ADX 
and were killed, alongside an intact group, under early baseline conditions (BLAM) or at various 
timepoints after FS. ChIP-qPCR and RNA-qPCR were performed on the hippocampus to investigate 
the effects of MR and/or GR antagonism, or removal of endogenous CORT, on MR and GR binding 
and RNA expression.  
Following exposure to stress, plasma CORT secretion and MR/GR to GRE binding was unaffected by 
drug treatment. Plasma CORT levels remained elevated, however, over an extended period in drug 
treated animals, indicating impaired negative feedback of the HPA-axis. Despite an enhanced plasma 
CORT profile, drug treatment with a combination of both antagonists partially attenuated the 
transcriptional response of Klf2, Klf9 and Klf15. The observation that Klf4 RNA levels were left 
unaffected by drug treatment demonstrated that neither drug elicited effects on transcription 
independently of their effects on MRs and GRs. ADX abolished the FS-induced transcriptional 
responses of Klf9 and Klf15. RNA levels of Klf2 were only partially attenuated, however, indicating that 
alternative TFs may be regulating the transcription of this gene independently of GC hormone action. 
Levels of Klf4 RNA were attenuated by ADX, suggesting that this gene is regulated by a non-genomic 
GC-dependent mechanism. These findings show that the Klfs are regulated by both MRs and GRs 
following acute stress, however alternative transcription factors are also likely contributing to the 
transcriptional regulation of the Klfs. Further investigation, however, is required to identify the mediators 




6.3 Materials and Methods 
6.3.1 Animals 
Adult male Wistar rats (150-175g on arrival) were purchased from Envigo (Oxon, UK) and group-housed 
(2-3 per cage). Rats were housed under standard lighting (lights on 05:00– 19:00 h, approximately 80-
100 Lux) and environmentally controlled conditions (temperature 21 ± 1°C; relative humidity 40–60%) 
with food and water available ad libitum. All rats were handled daily (2 min per rat per day; min. 5 days) 
to reduce any nonspecific stress effects. 
6.3.2 Drug treatment 
To block MR and GR mediated effects, rats were voluntarily dosed with the MR antagonist SPIRO 
(Sigma, Dorset, UK) or the GR antagonist RU486 (RU, ‘Mifepristone’, Sigma, Dorset, UK) as described 
in Chapter 2.  
6.3.3 Surgical procedures  
Rats underwent bilateral underwent bilateral ADX or sham surgery as described in Chapter 2.  
6.3.4 Animal experiments 
For the antagonist ChIP study, baseline rats were voluntarily dosed in their home cage 90 min before 
being killed between 9-11am (circadian trough (BLAM)). For the acute stress groups, rats were 
voluntarily dosed 60 min before FS (15 min, 25 °C (±1) water) and killed 30 minutes after. For the 
antagonist RNA study, baseline rats were voluntarily dosed in their home cages 120 min before being 
under BLAM conditions. Stressed rats were voluntarily dosed 60 min before FS and killed 60 minutes 
after. For the ADX study, intact, sham and ADX rats were killed straight from their home-cages under 
BLAM conditions or 60 min after the start of FS as described in Chapter 2. 
6.3.5 Measurement of corticosterone by RIA 
Plasma CORT concentrations were measured using a commercial CORT RIA Kit (MP Biomedicals) as 







Standard ChIP was performed as previously described in Chapter 2, using the antibodies listed in Table 
2.5. All samples (bounds and inputs) were diluted to a standardized concentration with nuclease-free 
water and analysed by qPCR using primers/probes listed in Table 2.6. Data are expressed as quantity 
of bound DNA divided by the respective quantity of input DNA (i.e., B/I), which is a measure of the 
enrichment of steroid receptor bound to specific genomic sequences. 
6.3.7 RNA-qPCR 
RNA was extracted as previously described in Chapter 2. RNA-qPCR was performed as described in 
Chapter 2 using primers and probes listed in Table 2.7 (hnRNA) and Table 2.8 (mRNA). Expression of 
hnRNA and mRNA in each sample was calculated based on the Pfaffl method of relative quantification 
(Pfaffl, 2001) and standardized to the expression of house- keeping genes listed in Table 2.9. 
6.3.8 Statistical analysis 
Data were statistically analysed using GraphPad Prism software 7.04. Results are presented as group 
means ± SEM; sample sizes are indicated in the figures. Multiple statistical comparisons were 
conducted with one-way or two-way ANOVA, and if significant, a Dunnett’s or Sidak’s post hoc test was 
performed. Statistical results are provided in the legends of the figures. P<0.05 was considered 













6.4.1 The effects of SPIRO and/or RU on hippocampal MR and GR binding to GREs within Klfs 
under BLAM conditions and following acute stress   
To determine the effect of SPIRO and/or RU on the binding of MRs and GRs to GREs within Klf genes, 
rats were administered vehicle, a combination of SPIRO (50 mg/kg) and RU (30 mg/kg) or RU only (30 
mg/kg) and killed at BLAM or FS30. Under BLAM conditions, plasma CORT levels were unaffected by 
drug treatment. Following FS, plasma CORT levels were significantly elevated in all groups (Figure 6.1).  
Drug treatment had no effect on MR enrichment at Klf2, Klf9, Klf15 GRE1 and Klf15 GRE2 (Figure 6.2) 
under BLAM or stress conditions. In vehicle-treated rats, FS resulted in increased MR enrichment at 
Klf2 and Klf15 GRE1 (Figure 6.2). Rats treated with a combination of SPIRO/RU showed elevated levels 
of MR binding at Klf2 and Klf15 GRE1 (Figure 6.2) following FS.  
Treatment with SPIRO/RU and RU increased baseline levels of GR enrichment at Klf2, Klf9 and Klf15 
GRE2 (Figure 6.3) compared with the vehicle controls. In vehicle-treated rats, FS stress resulted in 
increased GR binding at Klf2, Klf9 (Fig. 6.3), Klf15 GRE1 and Klf15 GRE2 (Figure 6.3). GR enrichment 
at Klf2 was elevated at FS30 in rats which had received SPIRO/RU and RU, while RU-treated rats 
exhibited enhanced GR binding at Klf15 GRE1 (Figure 6.3.c) following FS. It appeared that the effect 
of drug treatment on GR binding at these GREs depended on the experimental conditions (BLAM vs 
FS) which is underlined by the significant interaction term in the two-way ANOVA analysis (see legend 






Figure 6.1 The effect of SPIRO and RU on plasma CORT levels under BLAM conditions and 
following acute FS stress   
Rats were voluntarily dosed with vehicle, a combination of SPIRO (50 mg/kg) and RU (30mg/kg) or RU 
only (30mg/kg). Baseline rats were killed 90 minutes after voluntary dosing under early morning 
baseline conditions (~9:00 am (BLAM)). Stressed rats were voluntarily dosed 60 minutes before the 
onset of FS and killed 30 min after the start of FS (15 min, 25°C water). Plasma CORT levels are 
expressed as ng/ml (mean ± SEM, n=6-8 per group). Statistical analysis: two-way ANOVA, effect of 
drug: F(2, 38)=2.724, p=0.0785, effect of stress: F(1, 38)=372.5, p<0.0001, interaction drug x stress: F(2, 38) 
=0.648, p=0.528, Sidak’s post hoc tests, ****P<0.0001 significantly different from BL within the same 













Figure 6.2 The effect of SPIRO and RU on hippocampal MR binding to GREs within Klf2, Klf9 and 
Klf15 under BLAM conditions and following acute FS stress  
Rats were voluntarily dosed with vehicle, a combination of SPIRO (50 mg/kg) and RU (30mg/kg) or RU 
only (30mg/kg). Baseline rats were killed 90 minutes after voluntary dosing under early morning 
baseline conditions (~9:00 am (BLAM)). Stressed rats were voluntarily dosed 60 minutes before the 
onset of FS and killed 30 min after the start of FS (15 min, 25°C water). Graphs show enrichment of 
MR, expressed as bound/input (mean ± SEM, n=4 per group), at GREs within Klf2 (A) and Klf9 (B) and 
Klf15 (C and D). Statistical analysis: two-way ANOVA; (A) effect of drug: F (2, 18) = 0.647, p =0.535, effect 
of stress: F(1, 18)=34.68, p<0.0001, interaction drug x stress: F(2, 18)=2.701, p=0.094, (B) effect of drug: 
F(2, 18)=0.566, p=0.577, effect of stress: F(1, 18)=4.338, p=0.0518, interaction drug x stress: F(2, 18) = 2.559, 
p=0.105, (C) effect of drug: F(2, 18)=0.184, p=0.833, effect of stress: F(1, 18)=27.07, p<0.0001, interaction 
drug x stress: F(2, 18)=0.588, p=0.565, (D) effect of drug: F(2, 18)=0.112, p=0.895, effect of stress: F(1, 18) 
=4.994, p=0.0384, interaction drug x stress: F(2, 18)=2.34 p=0.125. Sidak’s post hoc tests, *P<0.05, 






Figure 6.3 The effect of SPIRO and RU on hippocampal GR binding to GREs within Klf2, Klf9 and 
Klf15 under BLAM conditions and following acute FS stress 
Rats were voluntarily dosed with vehicle, a combination of SPIRO (50 mg/kg) and RU (30mg/kg) or RU 
only (30mg/kg). Baseline rats were killed 90 minutes after voluntary dosing under early morning 
baseline conditions (~9:00 am (BLAM)). Stressed rats were voluntarily dosed 60 minutes before the 
onset of FS and killed 30 min after the start of FS (15 min, 25°C water). Graphs show enrichment of 
GR, expressed as bound/input (mean ± SEM, n=4 per group), at GREs within Klf2 (A) and Klf9 (B) and 
Klf15 (C and D). Statistical analysis: two-way ANOVA; (A) effect of drug: F(2, 18)=2.702, p=0.094, effect 
of stress: F(1, 18)=70.16, p<0.0001, interaction drug x stress: F(2, 18)=5.148, p=0.0171, (B) effect of drug: 
F(2, 18)=1.256, p=0.309, effect of stress: F(1, 18)=30.42, p<0.0001, interaction drug x stress: F(2, 18) = 5.68, 
p=0.0122,  (C) effect of drug: F(2, 18)=0.358, p=0.704, effect of stress: F(1, 18)=51.12, p<0.0001, interaction 
drug x stress: F(2, 18)=6.877, p=0.0060,  (D) effect of drug: F(2, 18)=0.809, p=0.461, effect of stress: F(1, 
18)=26.62, p<0.0001, interaction drug x stress: F(2, 18)=7.53, p=0.0042. Sidak’s post hoc tests, *P<0.05, 
**P<0.01, ****P<0.0001 significantly different from BL within the same vehicle/drug treatment group. 







6.4.2 The effects of SPIRO and/or RU on hippocampal RNA expression of Klfs under BLAM 
conditions and following acute FS stress 
Changes in hippocampal RNA expression of Klf genes were examined in rats receiving the same drug 
treatment with SPIRO and RU as previously described. Rats were killed under BLAM conditions or at 
FS60. Under baseline conditions, drug treatment appeared to have no effect on plasma CORT levels 
(Figure 6.4). At FS60, plasma CORT was significantly elevated in rats receiving SPIRO/RU and RU 
treatment. Furthermore, rats receiving RU alone had significantly higher stress-induced plasma CORT 
levels compared with rats receiving vehicle and SPIRO/RU. 
Drug treatment had no effect on the hnRNA levels of Klf2 or Klf4, however stress led to enhanced 
hnRNA levels of Klf2 in all groups, and elevated Klf4 hnRNA in vehicle-treated rats only (Fig. 6.5). 
Levels of Klf9 hnRNA and Klf15 hnRNA were significantly increased by stress in all groups (Fig. 6.5). 
Rats receiving SPIRO/RU exhibited significantly lower levels of Klf9 hnRNA and Klf15 hnRNA at FS60 
compared with vehicle-treated rats (Figure 6.5). 
Klf2 mRNA levels were significantly increased following acute stress in vehicle-, SPIRO/RU- and RU-
treated rats (Figure 6.6). Treatment with SPIRO/RU attenuated the stress-induced levels of Klf2 mRNA 
compared with vehicle-treated rats. Stress led to an increase in mRNA levels of Klf4, Klf9 and Klf15 











Figure 6.4 The effect of SPIRO and RU on plasma CORT levels under BLAM conditions and 
following acute FS stress  
Rats were voluntarily dosed with vehicle, a combination of SPIRO (50 mg/kg) and RU (30mg/kg) or RU 
only (30mg/kg). Baseline rats were killed 120 minutes after voluntary dosing under early morning 
baseline conditions (~9:00 am (BLAM)). Stressed rats were voluntarily dosed 60 minutes before the 
onset of FS and killed 60 min after the start of FS (15 min, 25°C water). Plasma CORT levels are 
expressed as ng/ml (mean ± SEM, n=7-8 per group). Statistical analysis: two-way ANOVA, effect of 
drug: F(2, 41)=20.98, p<0.0001, effect of stress: F(1, 41)=104,  <0.0001, interaction drug x stress: F(2, 41)= 
20.47, p<0.0001. Sidak’s post hoc tests, ****P<0.0001 significantly different from BL within the same 
vehicle/drug treatment group. $$$$P<0.0001 significantly different from vehicle within the same BLAM 
or FS group, ####P<0.0001 significantly different from SPIRO/RU treated rats within the same BLAM 









Figure 6.5 The effect of SPIRO and RU on hippocampal hnRNA expression of KLFs under BLAM 
conditions and following acute FS stress 
Rats were voluntarily dosed with vehicle, a combination of SPIRO (50 mg/kg) and RU (30mg/kg) or RU 
only (30mg/kg). Baseline rats were killed 120 minutes after voluntary dosing under early morning 
baseline conditions (~9:00 am (BLAM)). Stressed rats were voluntarily dosed 60 minutes before the 
onset of FS and killed 60 min after the start of FS (15 min, 25°C water). Graphs show hnRNA levels of 
Klf2 (A), Klf4 (B) Klf9 (C) and Klf15 (D). Data are shown as relative RNA copy number calculated using 
the Pfaffl method of analysis, standardised to the expression of the house keeping genes Hprt1 and 
Gapdh (mean ± SEM, n=7-8 per group). Statistical analysis: two-way ANOVA; (A) Klf2 hnRNA effect of 
drug: F(2, 41) =1.975, p=0.1975, effect of stress: F(1, 41)=57.38, p<0.0001, interaction drug x stress: F (2, 41) 
=2.454, p=0.0985, (B) Klf4 hnRNA effect of drug: F(2, 41)=0.4071, p=0.6683, effect of stress: F(1, 41) =7.37, 
p=0.0097, interaction drug x stress: F(2, 41)=1.858, p=0.1688, (C) Klf9 hnRNA effect of drug: F(2, 
41)=1.388, p=0.2612, effect of stress: F(1, 41)=272.9, p<0.0001, interaction drug x stress: F(2, 41) =8.799, 
p=0.0007, (D) Klf15 hnRNA effect of drug: F(2, 41)=1.142, p=0.3292, effect of stress: F(1, 41)=212.4, 
p<0.0001, interaction drug x stress: F(2, 41)=3.474, p=0.0404. Sidak’s post hoc tests, *P<0.05, **P<0.01, 
***P<0.001, ****P<0.0001 significantly different from BL within the same vehicle/drug treatment group. 







Figure 6.6 The effect of SPIRO and RU on hippocampal mRNA expression of KLFs under early 
baseline conditions and following acute stress  
Rats were voluntarily dosed with vehicle, a combination of SPIRO (50 mg/kg) and RU (30mg/kg) or RU 
only (30mg/kg). Baseline rats were killed 120 minutes after voluntary dosing under early morning 
baseline conditions (~9:00 am (BLAM)). Stressed rats were voluntarily dosed 60 minutes before the 
onset of FS and killed 60 min after the start of FS (15 min, 25°C water). Graphs show mRNA levels of 
Klf2 (A), Klf4 (B) Klf9 (C) and Klf15 (D). Data are shown as relative RNA copy number calculated using 
the Pfaffl method of analysis, standardised to the expression of the house keeping genes Hprt1 and 
Gapdh (mean ± SEM, n=7-8 per group). Statistical analysis: two-way ANOVA; (A) Klf2 mRNA effect of 
drug: F(2, 41)=3.287, p=0.0474, effect of stress: F(1, 41)=112.1, p<0.0001, interaction drug x stress: F(2, 
41)=4.542, p=0.0165, (B) Klf4 mRNA effect of drug: F(2, 41)=1.763, p=0.1846, effect of stress: F(1, 41) = 
62.31,  <0.0001, interaction drug x stress: F(2, 41)=0.006145, p=0.9939, (C) Klf9 mRNA effect of drug: 
F(2, 37)=2.802, p=0.0736, effect of stress: F(1, 37)=47.84, p<0.0001, interaction drug x stress: F(2, 37)=8.746, 
p=0.0008, (D) Klf15 mRNA effect of drug: F(2, 37)=0.25, p=0.7801, effect of stress: F(1, 37)=52.55, 
p<0.0001, interaction drug x stress: F(2, 37)=2.345, p=0.01100. Sidak’s post hoc tests, *P<0.05, **P<0.01, 
***P<0.001, ****P<0.0001 significantly different from BL within the same vehicle/drug treatment group. 
$P<0.05, $$$P<0.001, $$$$P<0.0001 significantly different from vehicle within the same BLAM or FS 





6.4.3 The effects of ADX on hippocampal RNA expression of Klfs under BLAM conditions and 
following acute FS stress 
To examine the effects of the removal of endogenous CORT on downstream transcriptional responses 
following acute stress, rats underwent ADX or sham surgery. Alongside an intact group, sham and ADX 
rats were killed under BLAM conditions or at FS60. Plasma CORT levels and hippocampal 
transcriptional responses were determined. At FS60, plasma CORT levels (Figure 6.7) of sham rats 
were significantly increased compared with baseline sham and intact stressed rats. Following FS, ADX 
rats exhibited reduced levels of plasma CORT compared with rats undergoing sham surgery.  
FS led to significant increases in hnRNA levels of Klf2, Klf9 and Klf15 in intact and sham rats but not in 
hnRNA Levels of Klf4 (Figure 6.8). Under BLAM conditions and at FS60, hnRNA levels of Klf9 (Figure 
6.8.c) and Klf15 (Figure 6.8.d) were lower in sham operated rats compared with intact rats. ADX 
abolished the stress-induced rises in hnRNA levels of Klf2, Klf9 and Klf15 observed in the intact and 
sham groups (Figure 6.8).  
Intact and sham groups showed elevated mRNA levels of Klf2, Klf4, Klf9 and Klf15 at FS60 (Figure 
6.9). In ADX rats, the FS effects on Klf9 and Klf15 mRNA were abolished but an attenuated, albeit 
significant effect of the stressor was retained regarding Klf2 mRNA (figure 6.9). In contrast, ADX had 


















Figure 6.7 The effect of sham and ADX surgery on plasma CORT levels under BLAM conditions 
and following acute FS stress 
Rats underwent sham surgery or adrenalectomy (ADX) and 1 week later, alongside an intact group, 
were killed under early morning baseline conditions (~9:00 am (BLAM)) or 30 min after the onset of FS 
(15 min, 25°C water). Plasma CORT levels are expressed as ng/ml (mean ± SEM, n=6 per group). 
Average CORT levels of ADX rats under baseline conditions; 3.92 ng/ml, and at FS60; 20.69 ng/ml. 
Statistical analysis: two-way ANOVA, effect of surgery: F(2, 29)=5.196, p<0.05, effect of stress: F(1, 29) = 
4.54, p<0.05, interaction stress x surgery: F(2, 29)=1.874, p=0.172, Sidak’s post hoc test *P<0.05 
significantly different from BL within the same treatment group, $P<0.05, significantly different from 
intact within same behaviour group, ##P <0.01, significantly different from sham within same behaviour 






Figure 6.8 The effect of ADX on hippocampal hnRNA expression of KLF genes under BLAM 
conditions and following acute FS stress  
Rats underwent sham surgery or adrenalectomy (ADX) and 1 week later, alongside an intact group, 
were killed under early morning baseline conditions (~9:00 am (BLAM)) or 60 min after the onset of FS 
(15 min, 25 °C water). Graphs show hnRNA levels of Klf2 (A), Klf4 (B) Klf9 (C) and Klf15 (D). Data are 
shown as relative RNA copy number calculated using the Pfaffl method of analysis, standardised to the 
expression of the house keeping genes Hprt1 and Ywhaz (mean ± SEM, n = 6 per group). Statistical 
analysis: two-way ANOVA; (A) effect of surgery: F(2, 29)=1.215, p=0.311, effect of stress: F(1, 29)=19.6, 
p<0.001, interaction surgery x stress: F(2, 29)=1.655, p=0.209, (B) effect of surgery: F(2, 29)=5.529, p 
=0.0092, effect of stress: F(1, 29)=0.620, p=0.438, interaction surgery x stress: F(2, 29)=0.211, p=0.810, 
(C) effect of surgery: F(2, 29)=57.44, p<0.0001, effect of stress: F(1, 29)=148.5, p<0.0001, interaction 
surgery x stress: F(2, 29)=23.09, p<0.0001, (D) effect of surgery: F(2, 29)=24.17, p<0.0001, effect of stress: 
F(1, 29) =55.88, p<0.0001, interaction surgery x stress: F(2, 29)=12.37, p=0.0001, Sidak’s post hoc tests, 
*P<0.05, **P<0.01, ****P<0.0001 significantly different from BLAM within the same surgery group. 
$P<0.05, $$P<0.01, $$$P<0.001, $$$$P<0.0001 significantly different from intact within same 





Figure 6.9 The effect of ADX on hippocampal mRNA expression of KLF genes under BLAM and 
following acute FS stress  
Rats underwent sham surgery or adrenalectomy (ADX) and 1 week later, alongside an intact group, 
were killed under early morning baseline conditions (~9:00 am (BLAM)) or 60 min after the onset of FS 
(15 min, 25 °C water). Graphs show mRNA levels of Klf2 (A), Klf4 (B) Klf9 (C) and Klf15 (D). Data are 
shown as relative RNA copy number calculated using the Pfaffl method of analysis, standardised to the 
expression of the house keeping genes Hprt1 and Ywhaz (mean ± SEM, n = 6 per group). Statistical 
analysis: two-way ANOVA; (A) effect of surgery: F(2, 29)=5.624, p=0.0087, effect of stress: F(1, 29)=107.4, 
p <0.0001, interaction surgery x stress: F(2, 29)=5.615, p<0.01, (B) effect of surgery: F(2, 29)=2.304, p 
=0.118, effect of stress: F(1, 29)=69.78, p<0.0001, interaction surgery x stress: F(2, 29)=0.663, p=0.523, 
(C) effect of surgery: F(2, 29)=21.59, p<0.0001, effect of stress: F(1, 29)=58.54, p<0.0001, interaction 
surgery x stress: F(2, 29)=3.738, p=0.0359, (D) effect of surgery: F(2, 29)=23.71, p<0.0001, effect of stress: 
F (1, 29)=36.28, p<0.0001, interaction surgery x stress: F(2, 29)=14.66, p<0.0001, Sidak’s post hoc tests, 
*P<0.05, ***P<0.001, ****P<0.0001 significantly different from BLAM within the same surgery group. 
$P<0.05, $$P<0.01, $$$$P<0.0001 significantly different from intact within same behaviour group, #### 







6.5 Discussion  
Findings of these experiments have shown, for the first time, the effects of antagonising genomically 
acting MRs and GRs on receptor binding to GREs within Klfs and associated transcriptional responses 
under acute stress and circadian conditions. Under baseline conditions, SPIRO and RU486 enhanced 
GR binding, and quite possibly MR binding, to Klf GREs. RNA expression was for the most part 
unaffected, however SPIRO/RU treatment did lead to higher Klf9 mRNA expression at baseline. 
Following an acute FS stressor, SPIRO and RU486 had no effect on MR and GR binding to GREs 
within the Klfs, however RNA expression of the Klfs was attenuated by the combined SPIRO/RU 
treatment. Meanwhile, ADX fully abolished the FS-induced rise in RNA expression of Klf9 and Klf15, 
while partially reducing the FS-triggered rise of Klf2 mRNA expression. These results indicate that 
genomically acting MRs and GRs coregulate the expression of Klfs following an acute FS stressor. 
Blockade of MR and GR action (at the used dosages), however, is insufficient to fully abolish Klf 
induction, therefore alternative TFs appear to be contributing to the Klf transcriptional response. 
Removal of CORT by ADX fully abrogated the changes in Klf9 and Klf15 RNA transcription and partially 
attenuated changes in Klf2 transcription, thus confirming the Klfs as GC-hormone target genes during 
the acute stress response.  
Rats were administered a combination of SPIRO and RU486 rather than SPIRO alone. SPIRO has 
been shown to display a weak affinity for the GR (Couette et al., 1992), while RU486 displays no affinity 
for the MR (Baulieu, 1991). Therefore, administration of RU486 in combination with SPIRO would 
prevent potential GR binding by SPIRO from occurring. Preliminary data regarding the well 
characterised GC target genes, Fkbp5, Per1 and Sgk1, indicated that administration of SPIRO alone 
was insufficient to attenuate the FS-induced transcriptional response. Moreover, administration of 
RU486 at a higher dose (100mg/kg), resulted in a much more potent antagonism of transcriptional 
responses. Here, we chose a dose of 30mg/kg of RU486 to co-administer alongside SPIRO, to 
determine whether an interaction was present between MR and GR antagonism. From a technical point 
of view, we had decided, to avoid potential flaws due to injection stress, to choose voluntary dosing to 
administer the MR and GR antagonists. A vehicle control group was also included to control for any 
effects of voluntary dosing. Under baseline conditions and at the peak of the stress-evoked rise in GC 
secretion (FS30), plasma CORT levels were virtually identical among all groups. Interestingly, at FS60, 




significantly elevated in SPIRO/RU486 and RU486 treated rats. It is possible that antagonism of the 
MR and GR by SPIRO and RU486 prevented MR- and GR-mediated negative feedback on the HPA-
axis, thus prolonging CORT secretion by the adrenals (De Kloet and Reul, 1987). It is unclear, however, 
why selective blockade of the GR leads to higher plasma CORT in comparison with MR and GR 
blockade. It appears that MR antagonism is interfering with antagonism of the GR, however the precise 
mechanism needs to be investigated in the future.  
The absence of an effect of SPIRO and/or RU486 on FS-induced hippocampal MR or GR binding to 
GREs within Klf2, Klf9 or Klf15 was not surprising. Both drugs behave as antagonists that compete with 
endogenous ligand (in this case CORT) for receptor binding. SPIRO competes with CORT for the LBD 
of MR (Corvol et al., 1981), while RU486 competes with CORT for the LBD of GR. Once bound by 
SPIRO or RU486, conformational changes ensue that allow DNA binding however without resulting in 
transcriptional activation (Baulieu, 1991). Under baseline conditions, however, levels of MR enrichment 
appear higher in vehicle-treated rats in comparison to the enrichment levels observed at baseline in 
hippocampus of rats in Chapter 5. Moreover, the lack of a FS-induced rise in MR binding to Klf9 and 
Klf15 GRE2 strongly suggested that baseline enrichment levels were elevated. It is possible that the 
act of voluntary dosing has an arousing/stimulating effect on the rat, inducing a small CORT response 
sufficient to occupy the high affinity MR (Reul et al., 1987) and lead to DNA-binding. As a no-treatment 
group was not included in the experiment, however, it is presently not possible to deduce whether MR 
binding levels were actually higher in vehicle-treated control rats. Enrichment levels may simply vary 
between cohorts of rats or between ChIP experiments. When investigating the MR, future experiments 
should include a non-vehicle control, as the receptor displays a high sensitivity to even small changes 
in CORT.  
In vehicle-treated controls, GR enrichment levels under baseline conditions appear similar to those 
observed in previous experiments (Chapter 5). Moreover, in the control rats, a significant FS-induced 
rise in GR binding was seen at all Klfs, indicating that GR binding is unaffected by voluntary dosing 
under baseline conditions. In comparison to the MR, the GR is much less sensitive to small changes in 
CORT levels. This is due to the low affinity of GR for CORT, and as a result, GR occupancy and DNA 
binding is barely detectable under low CORT conditions (Reul et al., 1987). GR binding was, however, 
significantly increased under baseline conditions following SPIRO and/or RU486 treatment at Klf2, Klf9 




translocation and DNA binding (Baulieu, 1991). For Klf2 and Klf15, elevated levels of GR binding at 
baseline did not elicit a transcriptional response of these genes. Klf9 mRNA levels in the SPIRO/RU-
treated rats were, however, increased under baseline conditions compared with vehicle and RU486 
treated rats, indicating that RU486 was behaving as an agonist rather than an antagonist under these 
conditions. Alternatively, the dose we chose in these experiments may explain our observations, as 
preliminary data indicated that 100mg/kg of RU486 elicited a far stronger attenuation of the FS-induced 
transcriptional response. It is possible that SPIRO was also exerting agonistic activity on Klf9 under 
baseline conditions, however a non-vehicle control is needed to assess whether MR binding to Klf9 was 
elevated during the circadian trough.  
Treatment with RU486 alone had no effect on the RNA levels of any Klf examined, while combination 
of SPIRO and RU486 resulted in a partial attenuation of the FS-induced transcriptional activation of Klf2 
mRNA, Klf9 hnRNA and Klf15 hnRNA. The observation that antagonism of both receptors is required 
to induce an inhibitory effect on transcription suggests that heterodimerisation of receptors are taking 
place at GREs within Klfs. Compelling evidence for MR and GR heterodimerisation following FS has 
previously been shown at Fkbp5, Per1 and Sgk1 (Mifsud and Reul, 2016). It is possible that in the 
presence of RU alone (selective GR-blockade), MR may coregulate Klf expression by interacting with 
other co-factors, such as other members of the KLF family. Findings of transcription factor binding site 
motif analysis described in Chapter 3 indicated a high presence of KLF motifs within genomic loci bound 
by MRs and GRs, while pathway analysis predicted the KLFs as upstream regulators of genes in our 
ChIP-seq and RNA-seq datasets. Moreover, KLF15 has been shown to promote the transcription of 
Klf3 in adipocytes. ChIP showed binding of KLF15 in the promoter of Klf3 which was accompanied by 
increased mRNA expression of Klf3 (Guo et al., 2018). KLF4 was shown, in vitro, to activate the 
promoter of the Klf4 gene, while KLF5 exerted inhibitory effects via binding to the promoter of the Klf4 
gene (Dang et al., 2002). It is also possible that MR binding alone may lead to Klf transactivation, 
therefore examining the effects of SPIRO alone on Klf transactivation is needed. To establish whether 
heterodimerisation is occurring between MRs and GRs at Klf GREs, tandem ChIP could be employed 
as described by (Mifsud and Reul, 2016). ChIP for KLFs at KLF motifs in close proximity to GREs would 
enable the identification of candidate TFs that may be acting as coregulators of MR/GR regarding the 




Another explanation for our observations may be that RU486 is acting as an agonist at the concentration 
administered in these experiments (30 mg/kg). Many studies have reported agonistic and antagonistic 
effects of RU486 in vitro. Stimulation of cAMP signalling has been shown to result in agonistic activity 
of RU486 (Beck et al., 1993). Cell- and coactivator-specific agonistic effects of RU486 have also been 
demonstrated, with RU486 activating transcription in T47D breast cancer cell lines while negatively 
regulating transcription in HeLa cervical cancer cell lines. Agonistic activity of RU486 was further shown 
in the presence of the coactivator SRC-1, while the corepressor complexes SMRT inhibited RU486-
induced transcription (Liu et al., 2002). At a dose of 200nM, RU486 was shown to reduce Klf9 mRNA 
under baseline conditions and fully abolished CORT-induced transcriptional responses in vivo. SPIRO 
induced only a small attenuation in baseline and CORT-induced Klf9 mRNA expression (Bonett et al., 
2009). In foetal hippocampal neurons, RU486 (10µM) abolished DEX-mediated repression of total Bdnf 
mRNA, consistent with GR antagonism (Chen et al., 2017). Higher doses of RU486 than that used in 
our study may be required in vivo in order to elicit the antagonist effects required.  
Although our results demonstrate an antagonistic effect of SPIRO, studies have reported agonistic 
effects. Cell- and promoter-specific agonist effects of SPIRO were demonstrated in hMR expressing 
HepG2 cells, H5 cell and CV1 cell lines. In HepG2 and H5 cell lines, SPIRO enhanced MMTV 
transcriptional activity in the presence of the MR ligand aldosterone. In CV1 cell lines, however, SPIRO 
demonstrated full antagonist activity at the highest concentration used (100 nM). The agonistic effects 
of SPIRO were shown to be promoter-dependent and of comparable efficiency to aldosterone (Massaad 
et al., 1997). The antagonistic effects of SPIRO may be gene-dependent, as the drug was shown to 
affect the transcripts of over 1,000 genes in activated mononuclear cells, leading to the downregulation 
of 831 genes and the upregulation of the remainder (Sonder et al., 2006). It is likely that the upregulation 
observed is due to antagonism of MR activity at negative GREs.  
The absence of any effect of drug treatment on Klf2 hnRNA expression and Klf15 mRNA expression is 
likely due to the timepoint chosen to examine RNA levels. The results of our RNA-seq time course 
described in Chapter 3 indicated FS60 to be the timepoint at which the highest number of changes in 
gene expression are occurring, therefore this timepoint was chosen for these experiments. Based on 
findings of our FS timecourse in Chapter 5, however, we know that Klf2 hnRNA levels have fallen 
considerably by FS60, therefore FS30 may have been a more suitable timepoint to detect the effects 




changes in transcription would be FS120, during which mRNA levels have risen significantly. 
Meanwhile, ADX fully attenuated the FS-induced rise of hnRNA and mRNA levels of Klf9 and Klf15. 
mRNA levels of Klf2, however, were only partially attenuated by ADX, indicating that alternative 
coregulators acting independently of CORT regulate the transcription of this gene. Potential 
coregulators include the KLFs themselves, as pathway analysis described in Chapter 4 predicted a 
number of KLF family members to regulate the expression of MR and GR target genes.  
RNA levels of Klf4 were also investigated, as our ChIP-seq and RNA-seq experiments indicated that 
FS-induced changes in Klf4 RNA expression was not regulated by genomically acting MRs and GRs. 
hnRNA and mRNA levels of Klf4 were unaffected by SPIRO and/or RU486, thus indirectly confirming 
that the effects of SPIRO and RU486 on the RNA expression of the other investigated Klfs are a result 
of blocking MR and GR action. ADX also had no effect on the FS-induced rise in Klf4 mRNA. 
Unpublished data from histone modification ChIP-seq shows constitutive formation of the histone 
modification H3S10p-14ac (which is associated with active, open chromatin) in proximity to Klf4 (Price 
EM et al., unpublished observations). GRs have been shown to contribute to the formation of H3S10p-
14ac via a non-genomic mechanism following FS stress (Bilang-Bleuel et al., 2005, Gutierrez-Mecinas 
et al., 2011). It is possible that in the absence of CORT, alternative coregulators contribute to H3S10p-
14ac formation and subsequent induction of Klf4.  
Overall, findings of these experiments contribute to the presently lacking knowledge regarding genomic 
regulation of the Klfs by MRs and GRs following acute stress. Clearly, MR and GR coregulate 
transcription of the Klfs, possibly by heterodimerisation at GREs. Other coregulators, however, are likely 
contributing to MR/GR regulation of Klf transactivation, as receptor antagonism induced only a partial 
attenuation of the transcriptional response. Probable candidates are the KLFs themselves, due to our 
observations of KLF motifs within MR and GR binding sites and predictions made by pathway analysis. 
Further exploration is required, however, to identify the coregulatory factors interacting with MRs and 
GRs to regulate Klf transactivation. Immunohistochemistry would allow the identification of candidate 
KLFs, while ChIP and tandem ChIP would enable the investigation of KLF binding and MR/GR co-
binding following stress. KLF inhibitors or Klf KO animal models may facilitate further elucidation of the 





Chapter 7 Unexpected effects of metyrapone on genomically acting MRs and 
GRs and GC target gene transcription in the rat hippocampus 
7.1 Abstract 
Genomically acting MRs and GRs bind to GREs within the DNA, exerting transcriptional responses of 
target genes following an acute stressful challenge. Antagonism of the MR and/or the GR, however, 
does not fully abrogate transcriptional responses. In chapter 6, the effects of administering antagonists 
of the MR and GR on receptor to GRE binding and associated transcriptional responses was examined 
in the rat hippocampus under acute stress conditions. We showed that antagonism of genomically 
acting MRs and GRs led to partial attenuation of the transcriptional responses of GC target genes. 
Removal of CORT by ADX, however, abrogated FS-induced transactivation of the Klfs. An alternative 
pharmacological mechanism of blocking CORT is using the CORT-synthesis blocker metyrapone 
(MET). How MET affects GC action at the genomic level, however, is still unclear.  
Therefore, in this chapter, the effects of MET on plasma CORT levels and hippocampal MR and GR 
binding to GREs within the GC target genes Fkbp5, Per1 and Sgk1 as well as transcriptional responses 
of these genes are investigated under baseline and acute stress conditions in rats. For comparison, 
these endpoints were also examined in ADX rats. Results of these experiments revealed effects of 
metyrapone, which were contradictory to the expected GC-reducing effects of the drug. As a 
comparison, the effects of complete removal of endogenous GCs by bilateral ADX were additionally 
investigated. ADX completely abolished the effects of stress on MR/GR GRE-binding and Fkbp5, Per1 
and Sgk1 transcriptional responses. This work shows that when using metyrapone unexpected effects 
at the genomic level need to be considered that may preclude proper interpretation of the data on the 










Stress and circadian input were shown, in Chapter 3, to elicit transactivation and transrepression of 
thousands of genes in the rat hippocampus. The binding of genomically acting MRs and GRs to GREs 
in close proximity to or within these genes is believed to underlie the observed transcriptional 
responses, however the expression of many genes is activated/inhibited in the absence of receptor 
binding. Thus, it is unclear whether MR/GR binding is responsible for changes in RNA expression 
following exposure to stress or during the circadian drive. The genomic action of MRs and GRs is 
thought to underlie many GC-dependent behavioural and physiological changes observed following 
stress or circadian input. Thus, elucidating the mechanisms by which MRs and GRs regulate 
transcription is of critical importance.  
In Chapter 6, we addressed this question by antagonising MRs and GRs and examining RNA levels 
under early morning baseline and stress conditions. Antagonism of both the MR and GR partially 
attenuated the FS-induced transcriptional responses of Klf2, Klf9 and Klf15. ADX was shown to fully 
abolish the transcriptional responses of Klf9 and Klf15, indicating that the removal of the endogenous 
source of CORT is required to block the effects of genomically acting MRs and GRs. ADX, however, is 
an invasive surgical procedure which has been shown to result in neuronal cell death (Sloviter et al., 
1989) and behavioural changes such as increased anxiety levels (File et al., 1979). An alternative 
strategy would be to block or remove GC secretion from the adrenal glands. Metyrapone (MET), an 
inhibitor of the enzyme 11-β-hydroxylase (thus, preventing the conversion of deoxycorticosterone to 
CORT (Strashimirov and Bohus, 1966)), has been used to block endogenous GC synthesis in 
behavioural paradigms (Roozendaal et al., 1996, Liu et al., 1999). Until now, however, the 
consequences of metyrapone administration on the molecular effects of GCs at the genomic level have 
not been investigated. 
Recently, an acute stressful challenge was shown to result in a substantial rise in the binding of MRs 
and GRs to GREs in Fkbp5, Per1 and Sgk1, leading to enhanced transcriptional activity of the GC target 
genes (Mifsud & Reul, 2016). These findings were validated by our ChIP-seq and RNA-seq experiments 
described in Chapter 3, where we observed MR and GR peaks within GREs of Fkbp5, Per1 and Sgk1 
in addition to changes in inRNA and exRNA expression. In contrast to Klfs investigated in Chapter 5 




regulation of GR binding by ligand by encoding for the steroid receptor immunophilin FKBP51; a 
negative regulator of GR sensitivity for CORT (Binder, 2009). Per1 encodes for the PER1 protein; a 
member of the clock gene family essential for the circadian regulation of learning-induced histone 
modifications and hippocampal plasticity (Rawashdeh et al., 2014) while Sgk1 is essential for spatial 
memory consolidation (Tsai et al., 2002). Given the important neurobiological roles of these genes, it is 
astonishing that the mechanisms underlying their transcriptional regulation following stress have hardly 
been examined.  
Therefore, the aim of this final chapter was to study the effects of the enzyme inhibitor metyrapone on 
MR and GR binding to GREs within Fkbp5, Per1 and Sgk1 and transcriptional responses of these genes 
in the hippocampus under early morning baseline conditions and acute stress conditions. Although MET 
had no effect on (unstressed) control levels of CORT, the drug increased MR and GR to GRE binding 
within the GC target genes and the transcriptional activity of these genes. Acute FS stress as expected 
strongly increased plasma CORT levels, hippocampal MR and GR to GRE binding within Fkbp5, Per1 
and Sgk1, and transcriptional activity (mainly hnRNA levels) of these genes. MET attenuated, but not 
abolished, these effects of stress on plasma CORT and MR and GR to GRE binding. The drug effects 
on FS-induced transcriptional activity were gene-dependent with a reduction seen in Fkbp5 hnRNA (but 
not Fkbp5 mRNA), an enhancement in Per1 hnRNA (but not Per1 mRNA), and no effect on both Sgk1 
hnRNA and mRNA levels. In contrast, ADX completely abrogated the effects of FS stress on plasma 
CORT as well as hippocampal MR and GR to GRE binding and transcriptional responses. These results 
indicate that when aiming to elucidate genomic action of MRs and GRs via CORT suppression, ADX 











7.3 Materials and Methods 
7.3.1 Animals 
Adult male Wistar rats (150-175g on arrival) were purchased from Envigo (Oxon, UK) and group-housed 
(2-3 per cage). Rats were housed under standard lighting (lights on 05:00– 19:00 h, approximately 80-
100 Lux) and environmentally controlled conditions (temperature 21 ± 1°C; relative humidity 40–60%) 
with food and water available ad libitum. All rats were handled daily (2 min per rat per day) for at least 
5 days prior to experimentation to reduce non-specific handling stress on the day of the experiment.  
7.3.2 Drug treatment 
To block CORT mediated effects, rats were intraperitoneally (i.p.) injected with the 11-β-hydroxylase 
inhibitor metyrapone, or with the same amount of vehicle, as previously described in Chapter 2.  
7.3.3 Surgical procedures  
Rats underwent bilateral underwent bilateral ADX or sham surgery as described in Chapter 2. For RNA-
qPCR, the group of rats are the same as described in Chapter 6.  
7.3.4 Animal experiments  
Metyrapone experiments were conducted between 7:00 am and 1:00 pm. Baseline rats received 
treatment with metyrapone or the respective vehicle and were killed 2 hrs later under baseline 
conditions. Rats received treatment with metyrapone or the respective vehicle 90 min prior to FS (15 
min, 25 °C (±1) water) and were killed 30 min (FS30) or 60 min (FS60) after the start of FS. Full 
schedules of the metyrapone dosing experiments are shown in Table 2.1, Table 2.2 and Table 2.3. 
ADX experiments were conducted between 9:00 am and 11:30 am. Rats were killed straight from the 
home cage under baseline conditions (~9:00 am (BLAM)) or following FS (15 min, 25 °C (±1) water). 
For ChIP, rats were killed 30 min (FS30) after the start of FS, for RNA rats were killed 60 min (FS60) 
after the start of FS.   
7.3.5 Measurement of corticosterone by RIA 
Plasma CORT concentrations were measured using a commercial CORT RIA Kit (MP Biomedicals) as 





Standard ChIP was performed as previously described in Chapter 2, from hippocampal tissues of single 
rats. The following antibodies; MR (MR H-300 antibody; sc11412X; Santa Cruz) or GR (GR H-300 
antibody, sc8992X; Santa Cruz) were used. All samples (bounds and inputs) were diluted to a 
standardized concentration with nuclease-free water and analysed by qPCR using primers/probes listed 
in Table 2.6. Data are expressed as quantity of bound DNA divided by the respective quantity of input 
DNA (i.e., B/I), which is a measure of the enrichment of steroid receptor bound to specific genomic 
sequences. 
7.3.7 RNA-qPCR 
RNA was extracted as previously described in Chapter 2. RNA-qPCR was performed as described in 
Chapter 2 using primers and probes listed in Table 2.7 (hnRNA) and Table 2.8 (mRNA). Expression of 
hnRNA and mRNA in each sample was calculated based on the Pfaffl method of relative quantification 
(Pfaffl, 2001) and standardized to the expression of house- keeping genes listed in Table 2.9. 
7.3.8 Statistical analysis 
Data were statistically analysed using GraphPad Prism software. Results are presented as group 
means ± SEM; sample sizes are indicated in the figures. Multiple statistical comparisons were 
conducted with one-way or two-way ANOVA, and if significant, a Dunnett’s or Sidak’s post hoc test was 
performed. Significant differences within treatments group refers to drug treatment, while significant 
differences within behaviour groups refers to baseline or FS conditions. Statistical results are provided 











7.4.1 The effects of MET on plasma CORT levels under early morning baseline conditions and 
following acute FS stress   
To determine the ability of MET to block CORT synthesis following exposure to an acute stressor, rats 
were killed at the peak of the stress-evoked plasma CORT rise 30 min after the start of an acute, 15 
min FS challenge (FS30). Two doses of MET (75mg/kg or 100mg/kg) were administered to determine 
the optimal dose at which CORT synthesis is suppressed. Full details of the dosing schedule are shown 
in Table 2.1. At FS30, plasma CORT levels were significantly lower in rats receiving both doses of MET 
compared with non-injected and vehicle injected rats (Figure 7.1.a). Rats receiving vehicle injection had 
significantly higher plasma CORT levels compared with non-injected rats, indicating a potential injection 
stress. No significant difference between the two doses of MET were detected, however levels of CORT 
following 100mg/kg MET were observably lower than levels of CORT following 75mg/kg of MET.   
Based on these results, a dose of 100mg/kg MET was selected for subsequent experiments as it 
produced maximal suppression of plasma CORT. Furthermore, to eliminate a potential CORT response 
due to injection stress, groups of rats received either a single or double injection of MET, with a 90-
minute interval between repeated injections. Full details of the dosing schedule are shown in Table 2.2. 
Rats were injected once with vehicle, or once or twice with MET and killed under early baseline (BLAM) 
conditions or at FS30. At FS30, rats receiving both single and double injection of MET exhibited 
significantly decreased levels of CORT compared to vehicle-injected rats (Figure 7.1.b). Furthermore, 
rats receiving a double injection of metyrapone had significantly lower CORT levels at FS30 compared 
with rats receiving a single injection of MET, demonstrating that administration of a second dose is 
required to attenuate a CORT response due to injection stress. Levels of CORT, however, were 

















Figure 7.1 The effect of MET on plasma CORT levels under BLAM conditions and following acute 
FS stress   
To determine the optimal dose of MET to suppress CORT synthesis following an acute stressor (A) rats 
were injected with vehicle, 75 mg/kg or 100 mg/kg MET, 90 minutes before the onset of FS. To prevent 
a potential CORT response due to injection stress (B) rats were injected with vehicle or MET (100mg/kg) 
and killed under early morning baseline conditions (BLAM) or underwent FS 90 minutes later. All rats 
were killed 30 min after the start of FS (15 min, 25 °C water).  A second injection of MET (100mg/kg) 
was administered to a subset of rats, with a 90-minute interval between injections. Plasma CORT levels 
are expressed as ng/ml (mean ± SEM, n=6-8 per group). Statistical analysis: one-way ANOVA (A) F(3, 
19)=107.9, p<0.0001, Dunnett’s post hoc test, *P <0.05, significantly different from non-injected control, 
$$$$ P <0.0001, significantly different from vehicle-injected control. Two-way ANOVA (B), effect of 
drug: F(2, 42)=120.2 p<0.0001, effect of stress: F(1, 42)=388.4, p<0.0001, interaction drug x stress: F(2, 42) 
=133.7, p<0.0001, Sidak’s post hoc test, ****P<0.0001 significantly different from BL within the same 
vehicle/drug treatment group, $$$$P<0.0001 significantly different from vehicle within the same BLAM 
or FS group, ###P<0.001 significantly different from metyrapone single injection within the same BLAM 





7.4.2 The effects of MET on hippocampal MR and GR binding to GREs in Fkbp5, Per1 and Sgk1 
under early morning baseline conditions and following acute FS stress   
To examine MR and GR binding to GREs, rats were injected once with vehicle, or once or twice with 
MET and killed under early baseline (BLAM) conditions or at FS30. Full details of the dosing schedule 
are shown in Table 2.2. In rats receiving vehicle injection, levels of MR binding at Fkbp5, Per1 and Sgk1 
(Figure 7.2) were increased following FS. At FS30, rats receiving both single and double injections of 
MET had lower levels of MR binding at Fkbp5 compared with rats receiving vehicle (Figure 7.2). At 
Per1, MR binding was decreased following both single and double injections of metyrapone (Figure 
7.2). Rats receiving a single injection of metyrapone had decreased MR binding to Sgk1 compared with 
vehicle injected rats at FS30 (Figure. 7.2). There were no differences in the binding of either receptor 
between rats receiving single or double injections of metyrapone. 
In rats receiving vehicle injection, levels of GR binding at Fkbp5, Per1 and Sgk1 (Figure 7.3) were 
increased following FS. At FS30, rats receiving both single and double injections of MET had 
significantly lower levels GR binding at Fkbp5 compared with rats receiving vehicle (Figure 7.3). At 
Per1, GR binding was decreased following double injection of MET only at FS30 compared with vehicle 
(Figure 7.3). GR binding to Sgk1 was unaffected by either single or double injection of MET (Figure 
7.3).  
The FS effect was not completely abolished in either group, however, with a single injection of 
metyrapone resulting in increased binding of GR to all GREs tested (Figure 7.3) and MR at Fkbp5 and 
Per1 (Figure 7.2) while double injection of metyrapone led to elevated MR binding at Fkbp5 and Sgk1  
following FS (Figure 7.2). There was also an increase in MR binding at Sgk1 under baseline conditions 








Figure 7.2 The effects of MET on hippocampal MR binding to GREs in Fkbp5, Per1 and Sgk1 
under BLAM conditions and following acute FS stress    
Rats were injected with vehicle or MET (100mg/kg) 90 minutes before the onset of FS. A second 
injection of MET (100mg/kg) was administered to a subset of rats, with a 90-minute interval between 
injections. Rats were killed under BLAM conditions or 30 min after the start of FS (15 min, 25 °C water). 
Graphs show enrichment of MR, expressed as bound/input (mean ± SEM, n=3-4 per group), at GREs 
within Fkbp5 (A), Per1 (B) and Sgk1 (C). Statistical analysis: two-way ANOVA; (A) effect of drug: F(2, 
17)=5.603, p =0.0135, effect of stress: F(1, 17) =161.6, p<0.0001, interaction drug x stress: F(2, 17)=22.43, 
p<0.0001, (B) effect of drug: F(2, 17)=1.363, p=0.2825, effect of stress: F(1, 17)=62.5, p<0.0001, interaction 
drug x stress: F(2, 17)=9.143, p=0.0020, (C) effect of drug: F(2, 17)=3.297, p=0.0616, effect of stress: F(1, 
17)=50.47, p<0.0001, interaction drug x stress: F(2, 17)=9.787, p =0.0015. Sidak’s post hoc test, *P <0.05, 
****P<0.0001 significantly different from BL within the same treatment group, $P<0.05, $$P<0.01, 









Figure 7.3 The effects of MET on hippocampal GR binding to GREs in Fkbp5, Per1 and Sgk1 
under BLAM conditions and following acute FS stress   
Rats were injected with vehicle or MET (100mg/kg) 90 minutes before the onset of FS. A second 
injection of MET (100mg/kg) was administered to a subset of rats, with a 90-minute interval between 
injections. Rats were killed under BLAM conditions or 30 min after the start of FS (15 min, 25 °C water). 
Graphs show enrichment of GR, expressed as bound/input (mean ± SEM, n=3-4 per group), at GREs 
within Fkbp5 (A), Per1 (B) and Sgk1 (C). (A) effect of drug: F(2, 16)=4.629, p=0.0259, effect of stress: F(1, 
16)=92.65, p<0.0001, interaction drug x stress: F(2, 16)=20.54, p<0.0001, (B) effect of drug: F(2, 18) =0.6013, 
p=0.5587, effect of stress: F(1, 18) = 36.53, p<0.0001, interaction drug x stress: F(2, 18) = 6.187, p=0.0090, 
(C) effect of drug: F(2, 18)=0.7892, p=0.4693, effect of stress: F(1, 18)=48.13, p<0.0001, interaction drug x 
stress: F(2, 18)=4.058, p=0.0351. Sidak’s post hoc test, **P<0.01, ***P<0.001, ****P<0.0001 significantly 
different from BL within the same treatment group, $P<0.05, $$P<0.01, $$$$P<0.0001 significantly 








7.4.3 The effects of MET on hippocampal RNA expression of Fkbp5, Per1 and Sgk1 under early 
morning baseline conditions and following acute FS stress   
Rats were injected twice with vehicle or MET and killed under early morning baseline (BLAM) conditions 
or 60 minutes after the start of FS (FS60). Full details of the dosing schedule are shown in Table 2.3. 
Plasma CORT and RNA levels were examined to determine the effects of vehicle and MET injection 
under these conditions on plasma CORT levels and RNA transcription. Following acute stress, plasma 
CORT levels (Figure 7.4) were significantly elevated in vehicle injected rats, while a double injection of 
MET significantly attenuated the FS-induced rise in CORT secretion.  
RNA levels of Fkbp5, Per1 and Sgk1 were subsequently examined following acute stress. Under 
baseline conditions, hnRNA levels of Fkbp5, Per1and Sgk1 were elevated following MET injection 
(Figure 7.5), in comparison with vehicle injection. In vehicle injected rats, hnRNA levels of Fkbp5, Per1 
and Sgk1 were elevated following acute stress (Figure 7.5). At FS60, levels of Fkbp5 hnRNA were 
lower following MET injection (Figure 7.5), while levels of Per1 hnRNA were higher following MET 
injection, in comparison with vehicle injection (Figure 7.5). 
Under baseline conditions, mRNA levels of Fkbp5, Per1and Sgk1were elevated following MET injection, 
in comparison with vehicle injection (Figure 7.6). In vehicle injected rats, mRNA levels of Per1 and Sgk1 
were elevated following acute stress (Figure 7.5). MET injection resulted in elevated mRNA levels of 
Fkbp5 at FS60 compared with vehicle injected rats at FS60 (Figure 7.6). Levels of Per1 mRNA were 
















Figure 7.4 The effect of MET on plasma CORT levels under BLAM conditions and following acute 
FS stress   
Rats were injected twice with vehicle or MET (100mg/kg) 90 minutes before the onset of FS, with a 90-
minute interval between injections. Rats were killed under BLAM conditions or 60 min after the start of 
FS (15 min, 25 °C water). Plasma CORT levels are expressed as ng/ml (mean ± SEM, n=6 per group). 
Statistical analysis: two-way ANOVA; effect of drug: F(1, 19)=10.31, p=0.0046, effect of stress: F(1, 
19)=38.39, p<0.0001, interaction drug x stress: F(1, 19)=18.75, p=0.0004. Sidak’s post hoc test, 
****P<0.0001 significantly different from BL within the same treatment group, $$$$P<0.0001 
significantly different from vehicle within the same behaviour group. Inter-assay coefficient of variation; 


























Figure 7.5 The effect of MET on hnRNA levels of Fkbp5, Per1 and Sgk1 under BLAM conditions 
and following acute FS stress  
Rats were injected twice with vehicle or MET (100mg/kg) 90 minutes before the onset of FS, with a 90-
minute interval between injections. Rats were killed under BLAM conditions or 60 min after the start of 
FS (15 min, 25 °C water). Graphs show hnRNA levels of Fkbp5 (A), Per1 (B) and Sgk1 (C). Data are 
shown as relative RNA copy number calculated using the Pfaffl method of analysis, standardised to the 
expression of the house keeping genes Hprt1 and Ywhaz (mean ± SEM, n=6 per group). (A) effect of 
drug: F(1, 20)=28.42, p<0.0001, effect of stress: F(1, 20)=212.9, p<0.0001, interaction drug x stress: F(1, 20) 
=199.6, p<0.0001, (B) effect of drug: F(1, 20)=56.49, p<0.0001, effect of stress: F(1, 20)=52.48, p<0.0001, 
interaction drug x stress: F(1, 20)=1.027,  p=0.3229, (C) effect of drug: F(1, 20)=33.13, p<0.0001, effect of 
stress: F(1, 20)=46.63, p<0.0001, interaction drug x stress: F(1, 20)=28.89, p<0.0001. Sidak’s post hoc test, 
*P<0.05, ***P<0.001, ****P<0.0001 significantly different from BL within the same treatment group, 





















Figure 7.6 The effect of MET on mRNA levels of Fkbp5, Per1 and Sgk1 under BLAM conditions 
and following acute FS stress  
Rats were injected twice with vehicle or MET (100mg/kg) 90 minutes before the onset of FS, with a 90-
minute interval between injections. Rats were killed under BLAM conditions or 60 min after the start of 
FS (15 min, 25 °C water).  Graphs show mRNA levels of Fkbp5 (A), Per1 (B) and Sgk1 (C). Data are 
shown as relative RNA copy number calculated using the Pfaffl method of analysis, standardised to the 
expression of the house keeping genes Hprt1 and Ywhaz (mean ± SEM, n=6 per group). (A) effect of 
drug: F(1, 20)=27.48, p<0.0001, effect of stress: F(1, 20)=0.07551, p=0.7863, interaction drug x stress: F(1, 
20)=1.527, p=0.2309, (B): effect of drug: F(1, 20)=21.13, p=0.0002, effect of stress: F(1, 20)=29.65, 
p<0.0001, interaction drug x stress: F(1, 20)=2.762, p=0.1122, (C) effect of drug: F(1, 20)=32.04, p<0.0001, 
effect of stress: F(1, 20)=81.45, p<0.0001, interaction drug x stress: F(1, 20)=48.42, p<0.0001. Sidak’s post 
hoc test, ***P<0.001, ****P<0.0001 significantly different from BL within the same treatment group, 








7.4.4 The effects of ADX on plasma CORT levels under early morning baseline conditions and 
following acute FS stress   
Rats underwent ADX to determine whether the removal of the bodies endogenous source of CORT 
would prevent the genomic activity of MRs and GRs following acute stress. A group of rats underwent 
sham surgery which involved an identical surgical procedure to ADX without removal of the adrenals, 
to determine whether surgery alone had any effect on the CORT response and subsequent receptor 
activity. An intact group was also included for comparison. Rats were killed under early morning 
baseline conditions (~9:00 am (BLAM)) or 30 min after the onset of FS (FS30).  
At FS30, plasma CORT was increased in intact and sham rats (Figure 7.7). ADX completely abolished 
the FS induced rise in plasma CORT at FS30 and under baseline conditions, no differences in plasma 



























Figure 7.7 The effect of ADX on plasma CORT levels under BLAM conditions and following acute 
FS stress   
Rats underwent sham or ADX surgery and alongside an intact group, were killed under early morning 
baseline conditions (~9:00 am (BLAM)) or killed 30 min after the start of FS (15 min, 25 °C water). 
Plasma CORT levels are expressed as ng/ml (mean ± SEM, n=4 per group). Average CORT levels for 
intact rats; 17.51 ng/ml and sham rats; 29.51 ng/ml at baseline, and ADX rats at baseline; 20.17 ng/ml 
and FS60; 12.72 ng/ml. Statistical analysis: two-way ANOVA; effect of surgery: F(2, 18)=87.11, p<0.0001, 
effect of stress: F(1, 18)=325.8, p<0.0001, interaction surgery x stress: F(2, 18)=85.4, p<0.0001. Average 
levels under BLAM conditions, Sidak’s post hoc test, *P<0.05, ***P<0.001 significantly different from BL 
within the same treatment group, $$$$P<0.0001 significantly different from intact within the same 
behaviour group, ####P<0.0001 significantly different from sham within the same behaviour group. 









7.4.5 The effects of ADX on hippocampal MR and GR binding to GREs within Fkbp5, Per1 and 
Sgk1 under early morning baseline conditions and following acute FS stress   
Rats underwent ADX to determine whether the removal of the bodies endogenous source of CORT 
would prevent the genomic activity of MRs and GRs following acute stress. Intact, sham and ADX rats 
were killed under early baseline conditions (~9:00 am (BLAM)) or 30 min after the onset of FS (FS30). 
MR and GR binding to GREs within Fkbp5, Per1 and Sgk1 following FS was subsequently examined. 
At FS30, MR binding was increased at Fkbp5 and Per1 in intact and sham animals (Figure 7.8). At 
Sgk1, MR binding was increased following acute stress in intact rats only (Figure 7.8). ADX abolished 
the FS-induced rise in MR binding at Fkbp5, Per1 and Sgk1 (Figure 7.8). Under baseline conditions, 
levels of MR enrichment were lower in ADX rats compared with intact and sham rats at Per1 and Sgk1 
(Figure 7.8). Following acute stress, GR binding was increased at Fkbp5, Per1 and Sgk1 (Figure 7.9) 









Figure 7.8 The effects of ADX on hippocampal MR binding to GREs in Fkbp5, Per1 and Sgk1 
under BLAM conditions and following acute FS stress   
Rats underwent sham or ADX surgery and alongside an intact group, were killed under early baseline 
conditions (~7:00 am (BLAM)) or killed 30 min after the start of FS (15 min, 25 °C water). Graphs show 
enrichment of MR, expressed as bound/input (mean ± SEM, n=3-4 per group), at GREs within Fkbp5 
(A), Per1 (B) and Sgk1 (C). Statistical analysis: two-way ANOVA; (A) effect of surgery: F(2, 18)=69.81, 
p<0.0001, effect of stress: F(1, 18)=177.3, p<0.0001, interaction surgery x stress: F(2, 18)=38.41, p<0.0001, 
(B) effect of surgery: F(2, 18)=31.32, p<0.0001, effect of stress: F(1, 18)=18.77, p=0.0004, interaction 
surgery x stress: F(2, 18)=3.366, p=0.0573, (C) effect of surgery: F(2, 18)=22.11, p<0.0001, effect of stress: 
F(1, 18)=10.79, p=0.0044, interaction surgery x stress: F(2, 18)=1.99, p=0.1673. Sidak’s post hoc test, 
*P<0.05, **P<0.01, ****P<0.0001 significantly different from BL within the same treatment group, 
$P<0.05, $$$P<0.001, $$$$P<0.0001 significantly different from intact within the same behaviour 
group, #P<0.05, ##P<0.01, ###P<0.001, ####P<0.0001 significantly different from sham within the 








Figure 7.9 The effects of ADX on hippocampal GR binding to GREs in Fkbp5, Per1 and Sgk1 
under BLAM conditions and following acute FS stress   
Rats underwent sham or ADX surgery and alongside an intact group, were killed under early baseline 
conditions (~7:00 am (BLAM)) or killed 30 min after the start of FS (15 min, 25 °C water). Graphs show 
enrichment of GR, expressed as bound/input (mean ± SEM, n=3-4 per group), at GREs within Fkbp5 
(A), Per1 (B) and Sgk1 (C). Statistical analysis: two-way ANOVA; (A) effect of surgery: F(2, 18)=32.31, 
p<0.0001, effect of stress: F(1, 18)=108, p<0.0001, interaction surgery x stress: F(2, 18)=26.47, p<0.0001, 
(B) effect of surgery: F(2, 18)=54.47, p<0.0001, effect of stress: F(1, 18)=169, p <0.0001, interaction surgery 
x stress: F(2, 18)=34.12, p<0.0001, (C) effect of surgery: F(2, 18)=36.01, p<0.0001, effect of stress: F(1, 
18)=107.3, p<0.0001, interaction surgery x stress: F(2, 18)=18.86, p<0.0001. Sidak’s post hoc test, 
****P<0.0001 significantly different from BL within the same treatment group, $$$$P<0.0001 
significantly different from intact within the same behaviour group, ####P<0.0001 significantly different 







7.4.6 The effects of ADX on hippocampal RNA expression of Fkbp5, Per1 and Sgk1 under early 
morning baseline conditions and following acute stress   
As described in Chapter 6, rats underwent ADX to determine whether the removal of the bodies 
endogenous source of CORT would prevent the FS-induced rise in hippocampal RNA expression of 
Fkbp5, Per1 and Sgk1. Intact, sham and ADX rats were killed under early baseline conditions (~9:00 
am (BLAM)) or 60 min after the onset of FS (FS60). 
At FS60, plasma CORT levels were not increased in intact or ADX rats (Chapter 6 – Figure 6.7). There 
was, however, an increase in CORT levels in sham rats at FS60, indicating a potential effect of surgery. 
Removal of the adrenals abolished the potential stress effect of surgery, however, as plasma CORT 
levels were decreased in ADX rats compared with sham rats.  
Following FS, hnRNA levels of Fkbp5, Per1 and Sgk1 hnRNA were increased in both intact and sham 
rats (Figure 7.10). ADX completely abolished the FS-induced rise in hnRNA levels of Fkbp5, Per1 and 
Sgk1. At FS60, ADX rats had lower hnRNA levels of Fkbp5, Per1 and Sgk1 compared with intact and 
sham rats (Figure 7.10). 
Under baseline conditions and following acute stress, mRNA levels of Fkbp5 were lower in ADX rats 
compared with intact and sham rats (Figure 7.11).  Following FS, mRNA levels of Per1 and Sgk1 hnRNA 
were increased in both intact and sham rats (Figure 7.11). ADX completely abolished the FS-induced 
rise in mRNA levels of Per1 and Sgk1. At FS60, ADX rats had lower mRNA levels of Per1 and Sgk1 












Figure 7.10 The effect of ADX on hnRNA levels of Fkbp5, Per1 and Sgk1 under BLAM conditions 
and following acute FS stress  
Rats underwent sham or ADX surgery and alongside an intact group, were killed under early baseline 
conditions (~7:00 am (BLAM)) or killed 60 min after the start of FS (15 min, 25 °C water). Graphs show 
hnRNA levels of Fkbp5 (A), Per1 (B) and Sgk1 (C). Data are shown as relative RNA copy number 
calculated using the Pfaffl method of analysis, standardised to the expression of the house keeping 
genes Hprt1 and Gapdh (mean ± SEM, n=6 per group). Statistical analysis: two-way ANOVA; (A) effect 
of surgery: F(2, 29)=32.8, p<0.0001, effect of stress: F(1, 29)=126.4, p<0.0001, interaction surgery x stress: 
F(2, 29)=25.47, p<0.0001, (B): effect of surgery: F(2, 29)=13.42, p<0.0001, effect of stress: F(1, 29)=34.27, 
p<0.0001, interaction surgery x stress: F(2, 29)=6.069, p=0.0063, (C) effect of surgery: F(2, 29)=17.45, 
p<0.0001, effect of stress: F(1, 29)=49.3, p<0.0001, interaction surgery x stress: F(2, 29)=15.18, p<0.0001. 
Sidak’s post hoc test, ***P<0.001, ****P<0.0001 significantly different from BL within the same treatment 
group, $$$$P<0.0001 significantly different from intact within the same behaviour group, #### 





Figure 7.11 The effect of ADX on mRNA levels of Fkbp5, Per1 and Sgk1 under BLAM conditions 
and following acute FS stress  
Rats underwent sham or ADX surgery and alongside an intact group, were killed under early baseline 
conditions (~7:00 am (BLAM)) or killed 60 min after the start of FS (15 min, 25 °C water). Graphs show 
mRNA levels of Fkbp5 (A), Per1 (B) and Sgk1 (C). Data are shown as relative RNA copy number 
calculated using the Pfaffl method of analysis, standardised to the expression of the house keeping 
genes Hprt1 and Gapdh (mean ± SEM, n=6 per group). Statistical analysis: two-way ANOVA; (A) effect 
of surgery: F(2, 29)=21.02, p<0.0001, effect of stress: F(1, 29)=2.089, p=0.1045, interaction surgery x 
stress: F(2, 29)=0.3, p=0.7431, (B): effect of surgery: F(2, 29)=13.29, p<0.0001, effect of stress: F(1, 
29)=91.85, p<0.0001, interaction surgery x stress: F(2, 29)=13.26, p<0.0001, (C) effect of surgery: F(2, 
29)=60, p<0.0001, effect of stress: F(1, 29)=189.7, p<0.0001, interaction surgery x stress: F(2, 29)=51.26, 
p<0.0001. Sidak’s post hoc test, ****P<0.0001 significantly different from BL within the same treatment 
group, $P<0.05, $$P<0.01, $$$P<0.001, $$$$P<0.0001 significantly different from intact within the 









This study reveals unexpected genomic effects in the hippocampus following metyrapone treatment 
which appear to be unrelated to the drug’s effects on GC secretion. Despite failing to exert any effect 
on CORT levels under baseline conditions, metyrapone treatment resulted in enhanced MR and GR to 
GRE binding within the GC target genes and increased transcriptional activity of these genes. 
Metyrapone reduced stress-induced GC levels, however failed to fully attenuate the stress response. 
Following exposure to acute stress, drug treatment led to a partial inhibition of MR and GR to GRE 
binding and transcriptional activation in some cases. Thus, under stress conditions, the observed 
changes in MR and GR binding and transcriptional activity after metyrapone treatment appear to be the 
combined result of unspecific, GC-unrelated effects (apparent under early baseline conditions) and GC-
reducing effects. In particular regarding effects on transcriptional activity, the drug effects were gene 
dependent. In contrast, ADX abolished the stress effects on plasma CORT as well as hippocampal MR 
and GR to GRE binding and transcriptional responses. These clear-cut genomic effects directly 
correspond with the absence of endogenous GCs as a result of the removal of the adrenals.  
ChIP data show that vehicle-treated control rats as well as intact and sham-ADX rats present very low 
MR and GR binding to GREs within the classical GC target genes Fkbp5, Per1 and Sgk1. FS resulted 
in significant increases in receptor binding to these GREs. These results are highly consistent with 
previously reported findings in (untreated) intact rats (Mifsud and Reul, 2016). Similarly, the FS-induced 
RNA responses in the vehicle-treated, intact and sham-operated rats paralleled previously published 
data (Mifsud & Reul, 2016). This present study shows that ADX completely abolished the stress-evoked 
responses in receptor binding and gene transcription indicating that the presence of endogenous GCs 
is crucial for these responses. Earlier work has shown that CORT is metabolized rapidly and MRs and 
GRs become unoccupied within a few hours post-ADX (Reul et al., 1987) . Thus, similarly, in the present 
study in the case of ADX, MRs and GRs will have become devoid of ligand shortly after withdrawal of 
CORT from the drinking water. This data shows for the first time that these receptors indeed require 







The purpose of this study was to investigate the role of endogenous GCs in baseline and stress-induced 
genomic responses in GC target genes by using the CORT-synthesis inhibitor metyrapone. Treatment 
with this drug, however, produced contradictory results with regard to plasma CORT levels versus MR 
and GR to GRE binding and RNA responses concerning the genes Fkbp5, Per1 and Sgk1. Metyrapone 
attenuated, albeit not abolished, the stress-induced increases in plasma CORT and GRE-binding of MR 
and GR. In view of the drug’s effect on GC levels, a reduction in stress-induced receptor binding was 
expected but was not as stark as may have been predicted given the strong reduction in stress-evoked 
CORT levels. Surprisingly, however, although metyrapone produced no detectable changes in 
circulating GC levels in the unstressed control rats, drug treatment resulted in significant increases in 
MR binding and also to some extent GR binding (i.e. Fkbp5) to GREs within the target genes. These 
observations are rather surprising as CORT levels were unchanged. A possible reason for the elevated 
MR binding after metyrapone treatment may be 11-deoxycorticosterone (DOC), the CORT precursor 
known to accumulate after inhibition of 11β-hydroxylase (Daniel and Newell-Price, 2015). DOC is a 
mineralocorticoid with very high affinity for binding to MR (Funder, 2010) and is thought to be 
responsible for some of the side effects of metyrapone treatment (e.g. hypertension, hypokalaemia, 
oedema) observed in humans treated for instance for Cushing’s disease (Juszczak et al., 2016). As 
metyrapone has been shown to increase plasma levels of ACTH in a dose-dependent manner (Rotllant 
et al., 2002), increases in plasma ACTH may potentiate the build-up of DOC. 
As hippocampal MRs are at least 75-80% occupied under early morning baseline conditions (Reul et 
al., 1987, Reul and de Kloet, 1985), DOC could bind to the 20-25% rest-capacity in MR binding 
potentially resulting in the enhanced MR to GRE binding observed after metyrapone. Whilst this perhaps 
may be an explanation for the increased MR to GRE binding after metyrapone under control conditions, 
it fails to explain the elevated GR to GRE binding after drug administration under these conditions. 
Increased DOC levels after metyrapone may not be as relevant for GR, as this steroid has been reported 
to possess very low affinity for binding to GRs. DOC has been shown to occupy the GR in mouse 
fibroblasts (Brookes et al., 2012), however further evidence is needed to determine whether DOC is 
binding GR in this instance. Based on our recent study (Mifsud and Reul, 2016), it may be argued that 
possibly increased GR to GRE binding may be indirectly brought about through heterodimerization with 
MR whose GRE-binding is found to be enhanced after metyrapone. This is however an unlikely 




the receptor would not be in a GRE-binding state (Reul et al., 1987, Reul and de Kloet, 1985). Thus, 
presently, the mechanisms underlying the increased MR and GR to GRE binding are unclear. Elevated 
post-metyrapone DOC levels can partially provide an explanation. Most likely, other, as yet unknown, 
effects of the enzyme inhibitor are very likely to play a role in the observations made in the drug-treated 
control rats.  
In view of the diverse effects of metyrapone on the binding of MR and GR to Fkbp5, Per1 and Sgk1 
GREs under control and stress conditions, it is difficult to explain the effects of the drug on the responses 
in hnRNA and mRNA of these genes. The increased hnRNA and mRNA levels observed under baseline 
conditions following metyrapone administration appear to correspond with the enhanced MR and GR 
to GRE binding under these conditions. The stress-induced responses in hnRNA after metyrapone 
treatment are highly varied. The drug inhibited, enhanced, or had no effects on the stress-induced 
changes in Fkbp5 hnRNA, Per1 hnRNA, and Sgk1 hnRNA, respectively. These results appear not to 
point to a single, consistent mechanism underpinning the gene transcriptional effects of metyrapone. 
Factors contributing to these distinct effects may include differences in the relative contribution of MR 
and GR to gene activity, inherent differences between genes regarding transcriptional regulation (e.g. 
multiple GREs within genes or in enhancer regions, chromatin looping mechanisms), and differences 
in the timeline of transcriptional activation and RNA processing. ADX, in contrast, produced highly 
consistent effects on both receptor to GRE binding as well as gene transcriptional responses.  
It is also plausible that metyrapone could activate other transcription factors (TFs) which bind to 
responsive elements within Fkbp5, Per1 and Sgk1 leading to enhanced gene transcription under 
baseline conditions and following acute stress. A likely candidate is the progesterone receptor (PR); a 
member of the steroid and nuclear hormone receptor superfamily alongside the MR and GR. PRs share 
many structural similarities with the MR and GR (Conneely et al., 1986, Jeltsch et al., 1986) and their 
expression in the hippocampus has been reported (Guerra-Araiza et al., 2001). Furthermore, PRs 
recognize GREs (Shaffer et al., 2004) and a study on cell lines expressing inducible chimeric PR 
demonstrated transcriptional activity of the PR with increased levels of Fkbp5 and Sgk1 RNA following 
treatment with the PR agonist R5020 (Trevino et al., 2016). Levels of the endogenous PR ligand, 
progesterone, has been shown to significantly increase in male rats following exposure to certain 




levels in males, an observation which is thought to be due to altered steroid synthesis indicating the 
drug to have extra-adrenal effects on central corticosteroid metabolism (Jahn et al., 2003).  
Surgical intervention was also investigated as a method of modulating HPA-axis activity. ADX involves 
removal of the adrenal gland thus removing the bodies endogenous source of CORT. In addition to the 
synthesis of CORT, the adrenal gland also responsible for the synthesis of small amounts of 
progesterone (Wagner, 2006). Removal of the adrenals prevents steroidogenesis from occurring thus 
eliminating the possibility that by-products of the steroidogenic pathway may acting as MR or GR 
ligands. Despite the benefits of ADX when investigating HPA-axis activity, it has been shown that ADX 
results in the loss of hippocampal dentate granule cells (McNeill et al., 1991, Sloviter et al., 1989). 
CORT replacement can, however, completely prevent ADX-induced granule cell apoptosis (Hu et al., 
1997) and in this study, rats were supplemented with CORT in their drinking water following surgery.  
Removal of CORT 1 day prior to experimentation for 24 hours only avoided the oxidative stress and cell 
loss reported in many experiments. 
At FS30, ADX completely abolished the FS-induced rise in plasma CORT, resulting in levels 
comparable to those seen at baseline which was not achieved with either dose of metyrapone or 
repeated injections. At FS60, plasma CORT levels of sham rats were significantly elevated compared 
with intact rats. It is known that peri-operative stress can lead to an increase of adrenal CORT secretion 
persisting several days following surgery (Hogan et al., 2011). At baseline, CORT levels appeared to 
be unaffected, therefore sham surgery may have led to a heightened or sensitized stress response in 
these rats which was activated by FS. ADX fully attenuated MR and GR binding to GREs following 
acute stress and, in some cases, reduced levels of MR binding at baseline. This observation further 
supports early studies which report MR occupancy (Reul and de Kloet, 1985) in the presence of low 
circulating CORT, and indicates the ADX surgery has reduced levels of CORT sufficiently to prevent 
even basal levels of MR occupancy and binding. In a study investigating MR and GR binding to a subset 
of GREs in the rat hippocampus following ADX, CORT replacement revealed a dose-dependent effect 
on GR binding and MR binding occurring at lower CORT concentrations (Polman et al., 2013).  
An examination of transcriptional responses revealed that following acute stress, ADX rats had 
significantly lower hnRNA and mRNA levels of all genes compared with both intact and sham rats. 




receptor mRNA expression following both short- and long-term ADX  (Liao et al., 1993, Meijer and de 
Kloet, 1994) and a more recent study using ChIP and RNA-seq which has also shown ADX to abolish 
acute-stress induced mitochondrially transcribed mRNA (mtRNA) of genes involved in the electron 
transport chain in the rat (Hunter et al., 2016). Some studies have reported ADX to affect the expression 
of MR and GR mRNA and protein levels, with increased levels of hippocampal MR and GR mRNA 
reported following short-term ADX in developing rats (Vazquez et al., 1993) and a significant increase 
in hippocampal MR and GR protein reported in ADX rats compared to sham rats at various timepoints 
following surgery (Kalman and Spencer, 2002). These observations were present when rats were not 
supplemented with CORT, however, and hippocampal MR protein levels were significantly reduced in 
rats receiving a 45-minute CORT treatment 24 hrs after ADX (Kalman and Spencer, 2002). 
Despite having significantly higher plasma levels of CORT compared to intact rats, there were no 
significant differences in gene expression between sham and intact rats indicating surgery did not have 
any effect on gene transcriptional responses at that timepoint. It is possible, however, the hnRNA and 
mRNA expression of these genes may remain significantly elevated for a longer period of time due to 
the prolonged increase in CORT levels observed. Previous timecourse analysis has revealed that 
hnRNA levels of Per1 and Sgk1 returns to levels similar to that at baseline 120 minutes following FS 
(FS120), while Fkbp5 hnRNA levels return by 180 minutes following FS (FS180) (Mifsud and Reul, 
unpublished observations).   
Interestingly, in ADX rats, Fkbp5 mRNA was significantly lower under early baseline conditions and 
following acute stress. This observation may be due to the role the FKBP5 protein plays in an 
intracellular negative feedback loop for GR activity. In the absence of CORT, unligated GRs are 
sequestered in the cytosol as part of a complex with heat shock proteins and FKBP5. Once GR 
becomes bound by CORT, FKBP5 is replaced by FKBP4 allowing the nuclear translocation of GR, 
where it increases the transcription of Fkbp5 RNA by binding GREs. Increased Fkbp5 transcription and 
translation of Fkbp5 RNA to FKBP5 protein thus decreases GR sensitivity for CORT (Binder, 2009, 
Mifsud and Reul, 2018). Following ADX, the complete absence of CORT may result in depleted levels 
of Fkbp5 mRNA due to a reduction in the translation to FKBP5 protein. Many studies have investigated 
the effect of FKBP5 overexpression on the stress response (Scammell et al., 2001, Westberry et al., 
2006, Buchmann et al., 2014, Ising et al., 2008), however very few have examined the effects of CORT 




on Fkbp5 expression in mice, increased levels of Fkbp5 RNA were reported in the hippocampus, 
hypothalamus and blood (Peeters et al., 2004). Another study has shown decreased levels of Fkbp5 
RNA in the prefrontal cortex of ADX mice compared to SHAM mice (Costin et al., 2013), however it is 
worth noting that ADX mice did not receive CORT replacement and had been habituated to saline 
injections over 2 days. These observations further support the important role of FKBP5 in the stress 
response and suggest ADX may be an interesting model to further explore these relationships. 
The aim of the present study was to investigate the role of endogenous GCs in the effects of an acute 
stressful challenge (FS) on MR and GR binding to GC target genes and the transcriptional responses 
of these genes. To block endogenous GCs, the CORT-synthesis inhibitor metyrapone was used in order 
to determine whether this pharmacological approach would be an appropriate alternative to the surgical 
procedure of ADX. These data show that the drug produces diverse genomic effects that can only 
partially be explained by its CORT-reducing activity and accumulation of DOC. In particular, its effects 
on gene transcriptional activity were highly diverse. In contrast, the effects of ADX on the GC-dependent 
genomic endpoints were clear. Importantly, the genes Fkbp5, Per1 and Sgk1 in the hippocampus play 
important roles in GC sensitivity and negative feedback regulation, circadian regulation of physiological 
and behavioural activities, and neuroplasticity processes underlying learning and memory, respectively 
(Mifsud and Reul, 2016). Moreover, these genes as well as many other GC-regulated genes play 
important roles in many organs throughout the entire body. Therefore, evidently the unexpected 
genomic effects of metyrapone question its suitability for conducting studies on the GC dependency of 
physiological and behavioural processes. These observations indicate that results on such processes 
may be difficult to interpret or may be liable to misinterpretation. In conclusion, ADX remains the method 
















Chapter 8 General Discussion 
8.1 Summary 
The purpose of this thesis was to expand our knowledge regarding the genomic actions of MRs and 
GRs throughout the brain, particularly in the hippocampus, under physiological conditions of 
relevance for GC secretion. Previous work carried out by this research group has led to the 
characterisation of MR/GR GRE-binding and transcriptional responses following exposure to FS and 
during the circadian rise. Although this work has provided invaluable insight into the regulation of well-
established GC-target genes by genomically acting MRs and GRs, these experiments were limited by 
the ability to examine the regulation of a handful of genes at a time. Investigations undertaken by 
other research groups in the field have characterised MR and GR binding throughout the entire 
genome, however this work was carried out in animal models that do not represent true physiological 
conditions. Moreover, these studies neglect to investigate the transcriptional responses of the 
corresponding MR or GR bound gene; therefore the data is interpreted based on the assumption that 
receptor binding initiates a transcriptional response. Therefore, the aim of this thesis was to expand 
on previous work carried out by our research group and others, by identifying the loci to which MRs 
and GRs bind throughout the entire genome under acute stress and circadian conditions and to 
examine the transcriptional responses associated with MR and/or GR binding.  
ChIP- and RNA-seq experiments described in Chapter 3 fulfilled the initial aim of this thesis and 
revealed striking differences in the manner by which MRs and GRs bind to the genome in response to 
stress and circadian input. This data underwent extensive transcription factor binding site motif 
analysis and was integrated with RNA-seq findings. Comprehensive pathway analysis (Chapter 4) 
enabled the identification of novel targets for further investigation, which was carried out in Chapter 5. 
The regulation of the KLFs by hippocampal GC hormone action was validated in a separate cohort of 
rats, thus confirming findings of ChIP- and RNA-seq. In addition, this investigation was extended to 
other brain regions of relevance for GC action, including the amygdala, PFC and neocortex. These 
brain regions have not received nearly as much attention as the hippocampus regarding MR and GR 
genomic actions; however our findings indicate further endeavours to be worthwhile. Finally, to fully 




pharmacological and surgical interventions to interfere with genomically acting MRs and GRs in 
Chapter 6 and 7.  
8.2 Genome-wide targets of hippocampal GC hormone action and their 
associated biological functions  
In Chapter 3, ChIP-seq identified over 1000 genome-wide loci becoming differentially bound by MRs 
and GRs following elevations in GC hormone levels. A unique aspect of our study was the decision to 
examine MR and GR binding under both acute stress and circadian conditions, which enabled us to 
characterise peaks based on the physiological condition under which they became receptor bound. 
Moreover, we identified a subset of constitutively bound genomic loci, largely associated with the MR. 
Traditionally, the main focus of ChIP-seq studies is to identify changes in receptor binding, therefore 
the exploration of constitutive binding has been entirely neglected. For the MR, the concept of 
constitutive DNA binding is in agreement with the high degree of ligand occupancy exhibited by the 
MR under all physiological conditions (Reul et al., 1987, Reul and de Kloet, 1985). Our data suggests 
that constitutive receptor binding is as physiologically relevant as dynamic receptor binding and 
warrants further investigation. 
We constructed a comprehensive transcription factor binding motif profile of MR and GR bound loci, 
which differed depending on the physiological conditions leading to receptor binding. We showed that 
while GREs were found in the majority of stress and/or circadian responsive peaks, a far lower 
proportion of constitutively bound loci were associated with GREs. Alternative transcription factor 
motifs such as ZNF, SP, KLF, EGR and RFX were seen to be most prominent within these 
constitutively bound loci. These findings were to some extent in agreement with previous ChIP-seq 
studies on ADX rat hippocampus, that showed an association between SP motifs and non-GRE 
containing GR peaks (Polman et al., 2013) and reported the presence of ZNF and EGR sites in MR 
and GR bound loci (van Weert et al., 2017). The NeuroD transcription factor motif has been a focal 
point of MR and/or GR ChIP-seq studies (Pooley et al., 2017, van Weert et al., 2017), and although a 
marked proportion of our MR and GR peaks did contain the NeuroD motif (also known as ATOH1), 
other transcription factor motifs were far more prominent. It is possible that ADX leads to changes in 




conditions present a different transcription factor binding motif profile. Thus far, KLF and RFX motifs 
have received no attention in regard to genomically acting MRs and GRs.  
We conducted an extensive RNA-seq timecourse which enabled us to examine transcriptional 
responses of genes at various timepoints following exposure to FS stress. Furthermore, the 
sequencing of inRNA and exRNA transcripts, which are a good representative of hnRNA and mRNA 
respectively, enabled us to identify more subtle changes in transcription. Far more genes responded 
with changes in inRNA transcripts compared with exRNA transcripts, therefore had we not sequenced 
inRNA, GC hormone regulation of these genes may never have been shown. The majority of inRNA 
changes occurred at FS60, while FS120 was the timepoint at which the majority of exRNA changes 
were seen, which corresponds with the timeframe of hnRNA transcription from the genome and 
splicing to produce mRNA. For the first time, RNA-seq data was cross-correlated with ChIP-seq data 
to determine whether MR and/or GR binding elicited a transcriptional response in the corresponding 
gene. We showed that a very small proportion of MR and/or GR GRE-binding led to a transcriptional 
response of the gene in closest proximity, however a significant correlation was still seen between 
changes in receptor binding and changes in RNA expression. The small overlap between genes 
containing binding sites and genes exhibiting transcriptional changes likely reflects the 3-D 
architecture of the genome, in which binding of a transcription factor at one site may lead to a 
conformational change precipitating transcriptional response of a gene at a completely different 
location (Matharu and Ahituv, 2015, Rajarajan et al., 2016).  
Overall, this study provides the most in-depth analysis of genomically acting MRs and GRs in the 
hippocampus under physiological conditions to date. Compared with other studies, which may be 
confounded by the effects of ADX, our experimental model best represents the situation of stress in 
vivo. In terms of technicality, our study was carried out using the highest number of biological 
replicates per timepoint, at the highest sequencing depth and aligned to the most current version of 
the rat genome in contrast with other studies (Polman et al., 2012, Pooley et al., 2017, van Weert et 
al., 2017). A potential limitation of our study was that ChIP-seq was carried out on whole 
hippocampus tissue, and that both left and right hippocampi were combined for sequencing. 
Differences in gene expression has been demonstrated among hippocampal subfields (Datson et al., 
2004), between the left and right hippocampi (Klur et al., 2009) and within different cell types 




acting MRs and GRs differs dependent on these conditions. Future experiments could involve MR 
and GR ChIP-seq on more specific hippocampal cell populations, to determine whether differences 
exist in the genomic regulation of transcriptional responses following stress or circadian input.  
Pathway analysis of ChIP- and RNA-seq datasets, as described in Chapter 4, further contributed to 
our elucidation of GC hormone action in the hippocampus. Results of DAVID pathway analysis 
performed on ChIP-seq data has so far have lacked novelty and clarity regarding GC hormone action 
in the hippocampus (Polman et al., 2012, Polman et al., 2013, Pooley et al., 2017, van Weert et al., 
2017). IPA Core analysis of our datasets, however, has provided extensive insight into the biological 
consequences of GC hormone genomic action. In addition to confirming the robust nature of the data 
by highlighting pathways consistent with our experimental model, a number of novel relationships 
were unearthed by our pathway analysis. A limitation of our pathway analysis was the requirement by 
IPA of large reference datasets (ideally 200 genes or more) to perform predictions. This meant that 
although we had previously categorised the ChIP-seq peaks and RNA-seq genes based on 
physiological response, pathway analysis was performed on the entire dataset, as low n numbers for 
some peak/RNA categories impeded proper interpretation of the data. 
The ability to predict upstream regulators of genes in our datasets was highly beneficial, as we could 
search for the corresponding TFs of the most prominent TF binding motifs found within MR and GR 
bound loci, described in Chapter 3. Strikingly, many of these TFs, including the KLFs, were predicted 
to regulate the genes in our datasets; indicating a potential coregulatory role alongside MRs and GRs 
at non-GRE containing sites. Neurodevelopmental and synaptic functions were linked to genes in our 
sequencing datasets, suggesting that the transactivation of these genes by genomically acting MRs 
and GRs may underlie GC hormone regulation of these processes. Neurological diseases scarcely 
linked to GC hormone action appeared with high significance in our analyses. The aetiology of many 
of these disorders, such as Schizophrenia, is currently poorly characterised; therefore, these findings 
may provide novel targets for further exploration in the elucidation of these illnesses. The observation 
that neurological disorders not traditionally associated with the hippocampus, such as Huntington’s 
disease, were reported by IPA indicates the potential to extrapolate our findings to predict GC 





8.3 KLFs are transcriptional targets of genomically acting MRs and GRs 
throughout the brain following stress and circadian input 
Findings of Chapter 4 led us to select the KLFs as GC hormone targets with which to validate results 
of our sequencing experiments. The purpose of the experiments described in Chapter 5 was to not 
only to confirm the validity of our ChIP- and RNA-seq data, but to also further investigate the KLFs as 
potentially significant targets of GC hormone action. We maintained a consistent experimental design 
between sequencing and validation experiments, however validation experiments described in 
Chapter 5 were carried out in an entirely separate cohorts of animals and ChIP-qPCR was conducted 
using different MR and GR antibodies to those used for ChIP-seq. From a technical point of view, the 
validation was a complete success as the results of our hippocampal ChIP and RNA-qPCR 
experiments mirrored findings of our ChIP- and RNA-seq data, thus confirming the high quality and 
reproducibility of our sequencing data. As we chose to sequence a substantial number of biological 
replicates (n = 4) compared with previous studies, it allowed us to determine with higher confidence 
whether the changes in receptor binding or RNA expression we observed were in fact true changes.  
From an experimental perspective, our findings were the first to establish the Klfs as transcriptional 
targets of genomically acting MRs and GRs in the hippocampus. The KLF family of TFs exhibit 
structural similarity accompanied by considerable functional diversity (Pearson et al., 2008), and have 
been proposed to play important roles in processes such as BBB function (Wu et al., 2013), 
neurogenesis (Qin and Zhang, 2012), synaptic plasticity (Scobie et al., 2009) and glial development 
(Fu et al., 2009). Elevations in GC hormones had previously been shown to result in the 
transcriptional activation of Klf4 and Klf9 (Datson et al., 2011, Reddy et al., 2009), however no links 
between GC hormone action and Klf2 or Klf15 have so far been established. Our findings that 
hippocampal MRs and GRs bind to GREs within Klfs resulting in transcriptional activation suggests 
that GC hormone regulation of these genes may underlie important neurodevelopmental and 
neurophysiological functions. 
This investigation was extended to other brain regions known to be influenced by GC hormone action 
in which the genomic actions of MRs and GRs have hardly been examined. Interestingly, the manner 
with which MRs and GRs regulated Klf expression throughout the hippocampus, amygdala, PFC and 




stress and circadian input. It is possible that due to the sensitivity of the entire brain to changes in GC 
hormone levels, many genes are regulated in a similar fashion throughout the brain. On the other 
hand, the characterisation of tissue-specific changes in gene expression would be of interest, to 
identify functional roles for certain genes dependent on the function of the brain region. Future work 
may involve identifying potential tissue-specific genes based on the pathway analysis findings 
described in Chapter 4 and conducting brain-wide ChIP-qPCR for validation. The hippocampus has 
been the most extensively studied brain region regarding both GC hormone action and the genomic 
actions of MRs and GRs, however we have clearly shown that other brain regions such as the 
amygdala, PFC and neocortex should be the focus of future studies. Surprisingly, MR binding was 
shown in the PFC and neocortex, despite the widespread belief that MR is scarcely expressed in 
these regions (Reul and de Kloet, 1985). Hardly any MR ChIP has been published in neocortical 
regions, however our findings will hopefully encourage more investigations of this type.  
 
8.4 Elucidating the genomic actions of MRs and GRs via pharmacological 
and surgical interventions  
Following Chapter 5, we decided to antagonise the MR and/or the GR and examine the resultant 
transcriptional responses of the Klfs, to determine whether the ligand-activation of MRs and GRs was 
in fact responsible for the observed elevations in Klf RNA levels. Based on our own pilot data, that 
showed blockade of the MR alone was insufficient to affect transcriptional responses, we decided to 
co-administer the MR and GR antagonists; spironolactone and RU486. Our rationale was based on 
the hypothesis that MR and GR heterodimerisation may be occurring at GREs within the Klfs; 
therefore blockade of both receptors would be required to prevent initiation of transcription. Indeed, in 
our ChIP-seq findings, the MR and GR binding sites appeared to overlap considerably within the Klfs. 
We also selected an intermediary dose of RU486, to prevent a maximal dose from concealing any 
effect of spironolactone. In terms of CORT response, our findings were astonishing, as RU486 alone 
was shown to result in prolonged significant elevations CORT levels; even more so than 
spironolactone and RU486 combined. Previous experiments reported in the literature could not 





Our receptor binding results were in agreements with the antagonists mechanism of action, as MRs 
and GRs could still bind to GREs within the Klfs upon antagonist occupancy (Baulieu, 1991). The 
transcriptional response of the corresponding gene, however, was only attenuated when both the MR 
and GR were antagonised. It is possible that MR and GR heterodimerisation at Klf GREs is required 
to initiate a transcriptional response, however the partial attenuation of the rise in RNA indicates other 
coregulatory factors to be playing a role. The observation that blockade of the GR alone was 
insufficient to have any effect on transcription suggests that the MR may be able to interact with 
alternative co-regulators and initiate transcription in the absence of GR activity. Again, we have 
shown that the genomic actions of MRs and GRs are not as clear cut as we may have previously 
believed. Alternatively, our decision to administer an intermediary dose of RU486 may be underlying 
this observation, as other studies have demonstrated antagonistic activity of RU486 (Qin et al., 2014). 
Testing the effects of a maximal dose of RU486 (100mg/kg) on the transcriptional responses of the 
Klfs is a future experiment planned by our lab. No currently published studies have examined MR and 
GR binding under such conditions, therefore interpretation of our results by comparison to other 
studies is not presently possible. Removal of endogenous CORT by ADX led to a far stronger 
attenuation of Klf transcriptional responses, with the RNA responses of Klf9 and Klf15 completely 
abolished; suggesting any potential co-regulators to be GC hormone dependent. Levels of Klf2 RNA, 
however, were attenuated in ADX animals, indicating GC independent mechanisms to be involved in 
the transcriptional regulation of this gene. Our observations that ADX had no effect on Klf4 acted as a 
negative control; as the gene is not associated with any MR or GR binding.  
In light of our findings, it was clear that surgical removal of CORT led to a far more reliable blockade 
of MR and GR genomic activity. Thus, we decided to explore the effects of a pharmacological 
alternative to ADX, the CORT synthesis blocker; metyrapone, on the MR and GR genomic activity in 
the hippocampus. We took advantage of our recent characterisation of Fkbp5, Per1 and Sgk1 as 
genomic targets of MRs and GRs (Mifsud and Reul., 2016) by examining the transcriptional 
responses of these genes following metyrapone administration. Metyrapone has been widely used in 
many studies reporting effects of CORT blockade on behaviour (Liu et al., 1999, Roozendaal et al., 
1996), however few studies have administered the drug with the aim of blocking MR- and GR-
mediated transcriptional effects. Our results indicate the drug to be completely unsuitable to 




reduction in the transcriptional activation of MR and GR target genes following a decrease in CORT 
levels, however we showed that metyrapone led to transcriptional activation of Fkbp5, Per1 and Sgk1 
despite lowering CORT levels and reducing MR and GR binding to GREs. Explanations of our 
observations include the possibility of MR/GR occupancy by metyrapone by-products (DOC) (Funder, 
2010) or alternative GC hormones (progesterone) (Jahn et al., 2003); however the bottom line of 
these findings is that metyrapone should be avoided when examining the transcriptional responses of 
MR and GR target genes. Again, we have shown the HPA axis and the genomic actions of MRs and 
GRs to be far more complex than originally thought and demonstrated that pharmacological 
manipulations of the HPA axis require extensive validation to ensure no unwanted effects on 
transcription are occurring.  
We have provided strong evidence for the Klfs as significant GC target genes warranting further 
investigation. A next step would be to identify the co-regulators interacting with MRs and GRs to 
initiate Klf transcription and observe the effects of blocking these processes on processes such as 
neurogenesis or neuronal migration. ChIP-qPCR would identify whether KLFs themselves are binding 
at KLF motifs in close proximity to MR and GR binding sites within the Klfs, exerting a coregulatory 
role. Administration of GC receptor antagonists to rats during the early postnatal phase, followed by 
immunohistochemistry for markers of cell proliferation such as BrdU (Wojtowicz and Kee, 2006) would 
determine whether GC-induced expression of the Klfs was required for neurogenesis during 
development, and FS followed by a 24 hour or 4-week retest would determine whether this blockade 
had a negative or positive effect on learning and memory.   
 
8.5 Conclusion and future directions  
Work carried out during this PhD study has contributed substantially to the wider understanding of the 
mechanisms underlying GC hormone regulation of gene expression within the hippocampus and 
other brain regions. Many of the experiments undertaken are the first of their kind and will hopefully 
encourage the publication of studies of a similar nature. ChIP- and RNA-seq has provided the most 
thorough analysis of the genomic actions of MRs and GRs under physiological conditions of 
relevance for GC secretion to date. Once published, the datasets generated by these experiments 




further exploration. The manner in which we analysed, categorised and interpreted our data is unique 
to our study, and may change the way bioinformaticians and scientists decide to present sequencing 
data in the future. These experiments have provided the basis regarding NGS work conducted by our 
lab and future endeavours may further elucidate the genomic actions of MRs and GRs within more 
distinct hippocampal populations and potentially within other brain regions such as the amygdala, 
PFC or neocortex. Our data has also identified a plethora of novel genomic targets, biological 
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